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Abstract
Purpose: Fibroblast Growth Factor Homologous Factors (FHFs) are a group of
proteins known to associate with and modulate voltage-gated sodium channels (Nav) in
excitable cells. The four FHF genes are differentially expressed in specific cell-types,
with FHF2 expressed prominently in the hippocampus, cerebral cortex, heart and dorsal
root ganglia. Due to previous unavailability of an Fhf2 knockout mouse, this gene’s
functions have been understudied in comparison to other those encoding other FHFs. The
purpose of this research has been to better understand the normal physiological functions
of FHF2 at the cellular and system levels in the heart, sensory nervous system and central
nervous system. These studies also include functional analysis of a point mutation in
FHF2 that causes early-onset epileptic encephalopathy (EOEE) in humans. Methods: A
stable fertile Fhf2KO mouse line was derived and used for phenotypic observation, in vivo
experimentation, tissue harvest and primary cell culture for imaging, protein analysis and
electrophysiological recordings. Whole-cell patch clamp electrophysiology on primary
cultured cardiomyocytes and dorsal root ganglion (DRG) cells supplemented with ectopic
expression experiments in transfected HEK and Neuro2A cells was used to determine the
modulatory effects of various FHF2 isoforms on various sodium channels. Results:
FHF2 is required for proper cardiac function specifically under hyperthermic conditions.
In the absence of FHF2, there is a breakdown in cardiac conduction due to the
impairment of cardiomyocyte action potential generation. Without FHF2 there is a
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hyperpolarizing shift in cardiac Nav1.5 steady-state inactivation decreasing Nav1.5
availability. This reduces overall available sodium conductance at resting potential
which, when paired with accelerated inactivation brought about by elevated temperatures,
suppresses excitability. FHF2 is also necessary for topical heat nociception, as Fhf2KO
mice do not respond to noxious heat. The nociceptive deficit is reproduced in mice where
Fhf2 disruption is restricted to peripheral sensory neurons. Our experiments support an
underlying mechanism that parallels the cardiac phenotype, as the absence of FHF2
induces hyperpolarizing shifts in the predominant sodium channel isoforms Nav1.7 and
Nav1.8 expressed in DRG nociceptors. Reduced Nav1.7 availability is again exacerbated
by more rapid channel inactivation at elevated temperature, which correlates with
reversible temperature-sensitive conduction failure in Fhf2KO peripheral sensory fibers.
Lastly, in light of recently discovered missense mutations in the A-type first exon of the
FHF2 gene in several people suffering from EOEE, I have shown that these mutations
prevent anti-excitatory FHF2A-mediated Nav1.6 fast-onset long-term inactivation without
impairing the pro-excitatory modulation of Nav1.6 steady-state inactivation, likely
leaving CNS neurons hyperexcitable and susceptible to the epileptogenic phenotype.
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Chapter 1 Introduction
1.1 Fibroblast Growth Factor Homologous Factors
1.1.1 FGFs vs. FHFs
Fibroblast growth factor homologous factors (FHFs) were discovered and
delineated from the more traditionally studied fibroblast growth factors (FGFs) in the mid
1990’s (Hartung et al., 1997; Smallwood et al., 1996) based on their strong sequence and
structural similarity to standard FGFs. FHFs bear strong structural similarity to FGFs in
their approximately 125 amino acid b-trefoil core, but differ from FGFs at their termini
and these disparities give FHFs unique biochemical functionality that is completely
unrelated to that of traditional FGFs (Goldfarb, 2005). They do not act as growth factors
and are, at most, very weak activators of FGF receptors (Olsen et al., 2003; Sochacka et
al., 2020). The functional capacity of FHFs is perhaps most notably different from FGFs
in that while FGFs are secreted extracellularly (Goldfarb, 1990), FHFs remain
intracellular and bind to various proteins such as junctophilin-2 (Hennessey, Wei, & Pitt,
2013), IB2 kinase scaffold (Schoorlemmer & Goldfarb, 2001), and voltage gated sodium
channels (Nav) (C. J. Liu et al., 2001; C. J. Liu et al., 2003) to modulate their functions.

1.1.2 Genes & Expression Patterns
There are four FHF genes; FHF1, FHF2, FHF3 and FHF4. They were originally
identified as part of the traditional FGF family and were designated as FGF12, FGF13,
FGF11, and FGF14 respectively. All vertebrates have these four FHF genes, indicating
their emergence came before or in conjunction with that of vertebrates themselves
(Goldfarb, 2005).
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While their functions are generally similar, the primary differences between FHFs
lie in where they are expressed. Each brain region and neuronal cell-type express a
specific FHF or set of FHFs, with observations of cells expressing more than one FHF,
that there can be a single FHF or even a single FHF’s specific isoform that is
preferentially expressed over all others (Munoz-Sanjuan et al,, 2000; Wang et al,, 2000).
FHFs are also expressed in cardiac myocytes, which are similar to neuronal tissue in the
fact that they are excitable tissues (Hartung et al., 1997).
All four FHF genes are present in cerebral cortical neurons and hippocampal
pyramidal neurons. All except FHF2 are expressed in the cerebellum, specifically in
cerebellar granule neurons. In spinal motor neurons FHF1 and FHF4 have been detected.
FHF1 and FHF2 are expressed in peripheral sensory neurons as well as cardiomyocytes
(Goldfarb, 2005). In all of the central nervous system neuronal cells listed above, the
FHFs present are found concentrated in the portion of the cell where action potentials are
initiated called the axon initial segments (AIS). However, FHFs are undetectable in these
cells beyond the AIS in unmyelinated axons as well as at the sodium channel rich nodes
of Ranvier found along CNS myelinated axons (Dover et al., 2016). The exception to this
expression feature is found in peripheral sensory neurons where FHF2 is expressed
throughout the entire cell and it is found colocalized with Nav throughout the axonal
processes (Rush et al., 2006).

1.1.3 FHF Isoform Specific Functions
The most validated function of FHFs to date is their aforementioned modulation
of Nav. FHFs are tethered to the large pore-forming a subunit (Nava) inside the cell
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through the direct binding between the Nav C-terminal domains and the b-trefoil cores
conserved in all FHFs (Goetz et al., 2009; Wang et al,, 2012). While bound to Nava,
FHFs can modulate the gating properties of the channels by impeding fast inactivation or
by inducing long-term inactivation (LTI) which inversely modulate excitability (Dover et
al., 2010; Goldfarb et al., 2007; Rush et al., 2006).
FHFs can be pro-excitatory by increasing Nav availability by impeding the
channels intrinsic voltage dependence of inactivation. They induce a depolarizing shift of
V1/2 inactivation, allowing greater Nav availability at resting potential and slowing
inactivation rate at different voltages (Goldfarb et al., 2007; Lou et al., 2005; Rush et al.,
2006). This impediment to fast inactivation increases neuronal excitability and enables
repetitive firing (Goldfarb et al., 2007). Mutations in the channel-binding surface in the
b-trefoil core render FHFs incapable of this impeding fast inactivation, showing that this
modulatory effect is due to direct binding of FHFs to Nav (Goetz et al., 2009).
Alternatively, some FHFs—specifically A-type FHFs—can decrease Nav
availability by inducing long-term inactivation (LTI) (Dover et al., 2010; Rush et al.,
2006). This is a type of rapid-onset Nav inactivation that recovers very slowly relative to
Nav fast inactivation. This reduction of channel availability for a prolonged time
decreases cellular excitability. This phenomenon was first discovered in hippocampal
neurons and was suggested to promote dendritic spike attenuation in these cells (Colbert
et al., 1997; Jung et al., 1997). All A-type FHFs cause rapid-onset LTI of Nava (Rush et
al., 2006) via their highly conserved N-termini (Dover et al., 2010). Functional
significance was added to these findings when subsequent members of our lab discovered
that this A-type FHF induced LTI contributes to driving spike accommodation (also
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termed spike frequency adaptation) in hippocampal pyramidal neurons, (Venkatesan, Liu,
& Goldfarb, 2014) which suggests that they play a significant role in neural firing in the
CNS.
Overall, previous data gathered in the field provides evidence that FHFs are at
minimum dual functional regarding their modulation of Nav. FHFs can either increase or
decrease Nav availability by impeding intrinsic Nava fast inactivation via the b-trefoil
core conserved in all FHF isoforms or by arresting the channels into LTI via the Ntermini conserved in all A-type FHF isoforms.

1.2 Fibroblast Growth Factor Homologous Factor 2
1.2.1 Gene & Expression Pattern
FHF2 is expressed at the axon initial segments of cerebral cortical neurons and
hippocampal pyramidal neurons, and throughout the processes of peripheral sensory
neurons (Goldfarb, 2005; Goldfarb et al., 2007) as well as in the heart in both the atrial
and ventricular cardiomyocytes (Hartung et al., 1997; Wang et al., 2011). The FHF2
gene is found on the X chromosome extending over approximately 200 kb (Gecz et al.,
1999) and shows tissue-specific alternative splicing and alternative transcription starts
(Munoz-Sanjuan et al., 2000). In sensory neurons, the predominant isoforms are FHF2A
and FHF2B (Barbosa et al., 2017; Rush et al., 2006), also referred to in some publications
as FHF2S and FHF2U, respectively, and the predominant FHF2 isoform in the heart is
FHF2VY (Wang et al., 2011).
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1.2.2 Known FHF2 Functions
There are many proposed functions attributed directly to FHF2. Unfortunately, a
number of these functions, as of date, stem from investigations in single labs that have
yet to be corroborated. These include its proposed role in regulating proper neural
migration and morphology during development (Wu et al., 2012) as a microtubule
stabilizer (Li et al., 2018). It has also been suggested that FHF2 plays a role in voltagegated calcium channel current density in cardiomyocytes through its interaction with
Junctophilin-2 (Hennessey et al., 2013), although more recent findings from the same lab
and others have failed to corroborate this earlier data (Wang et al., 2017; Park et al., 2020
[in press]). More recently FHF2 has been identified as a potential tumor promotion factor
(Bublik et al., 2017) and may even have some contributing role in obesity (Sinden et al.,
2019).
The well-validated functions of FHF2 confirmed by various research groups are
those regarding its role in modulating Nav inactivation. This should come as no surprise
since it has been long established that FHF2 binds directly to the c-terminal domain of
Nav (Goetz et al., 2009; Wang et al., 2011). Many labs have shown that various FHF2
isoforms cause a depolarizing shift in the voltage dependence of inactivation of Nav1.5
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and that this effect increases excitability by increasing channel availability (Park et al.,
2016; Wang et al., 2011; X. Wang et al., 2017; J. Yang et al., 2016). The same proexcitatory effect of FHF2A and FHF2B has been shown on the steady-state inactivation
of Nav1.6 (Barbosa et al., 2017; Dover et al., 2010; Rush et al.; Siekierska et al., 2016;
Wittmack et al., 2004). Very recently, this same FHF2 driven depolarized inactivation
shift was shown for the first time to additionally occur when it interacts with Nav1.7
(Effraim et al., 2019). As mentioned earlier in this chapter, in addition to the proexcitatory effect of the FHF2A isoform, it has also been shown to be able to arrest Nav1.6
in a long-term inactivated state, which decreases excitability by reducing channel
availability between stimulations (Dover et al., 2010; Rush et al., 2006; Venkatesan et al.,
2014).

1.2.3 Direct FHF2 Links to Disease
The X-linked property of the FHF2 gene has led to the postulated association of
FHF2 dysfunction with a number of familial disorders affecting males, including Xlinked mental retardation (Wu et al., 2012), genetic epilepsy and febrile seizures
(Puranam et al., 2015), Wildervanck Syndrome-related hearing loss (Abu-Amero et al.,
2014), X-linked congenital generalized hypertrichosis (DeStefano et al., 2013), a rare
neurological and developmental disorder called Börjeson-Forssman-Lehmann syndrome
(Gecz et al., 1999), as well as genetic cardiac arrhythmias (Hennessey, Wei, et al., 2013).

1.3 Other FHF Links to Human Disease
1.3.1 Mutated FHF1 in Epileptic Encephalopathy
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Members from our lab along with collaborator Dr. Gunnar Buyse of Belgium
found and investigated a single amino acid mutation. The mutation in the b-trefoil core of
FHF1 caused a pro-excitatory gain-of-function resulting in an even more dramatic
depolarizing shift in steady-state inactivation than that caused by the wild-type protein.
This resulted in an even greater increase of Nav availability at any given voltage,
terminating in fatal neonatal epilepsy originally discovered in a lone pair of siblings
(Siekierska et al., 2016). Since this original finding seven more cases of this same
mutation causing epileptic encephalopathy were found by other groups (Al-Mehmadi et
al., 2016; Guella et al., 2016) (Oda et al., 2019; Villeneuve et al., 2017). Furthermore,
FHF1 gene duplication has also been found associated with multiple cases of epileptic
syndromes (Shi et al., 2017).

1.4 Voltage-gated Sodium Channels
Voltage-gated sodium channels are sodium permeable transmembrane proteins
that are regulated by changes in membrane electrical potential and are responsible for
initiating the upstroke of action potentials in electrically excitable cells including neurons
and myocytes. Long before voltage-gated ion channels were identified, groundbreaking
voltage clamp experiments on squid giant axon by Nobel Prize laureates Hodgkin and
Huxley showed that currents generated by voltage-dependent selective sodium influx
initiated action potentials (Hodgkin & Huxley, 1952a, 1952b, 1952c, 1952d; Hodgkin,
Huxley, & Katz, 1952). The voltage-gated sodium channel protein was first characterized
almost three decades later around 1980 as a result of simultaneous work from several labs
(Catterall, 2012).
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1.4.1 General Structure & Isoforms

Figure 1: Generalized Nav Structure (left) the four six-transmembrane pore forming
domains (I-IV) of Nava. The reentrant P-loops between segments five and six of each
domain form the central conducting pore of the channel, the forth segment (red) of each
of the four domains form the voltage sensor and the intrinsic fast inactivation particle
(yellow circle) marks the link between DIII and DIV which is the site of the IFM motif
inactivation gate. (right) Example of modulatory proteins associated with Nava including
Navb and bound to the c-terminal domain of the channel, FHF proteins. [Adapted from
Purves et al., Neuroscience Ch. 4 and Goldfarb, Cell. Mole. Life Science, 2012]

Voltage-gated sodium channels consist of a large (260 kDa) a subunit (Nava)
consisting of four homologous domains (DI-DIV), which together constitute the central
pore, ion selectivity filter, and voltage-dependent gating mechanisms (Catterall, 2000).
These four domains are each comprised of six a-helical transmembrane segments (S1S6) and a partial reentrant P loop (Noda et al., 1984). The S5, P loop, and S6 segments of
the four domains form the central pore and selectivity filter, while segments S1-S4 of the
four domains impart voltage-dependent gating of channel permeability.
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The ion selectivity filter of Nav begins at the narrowest part of the channel pore at
the extracellular end. As with other ion selective voltage-gated channels and many
potassium leak channels, the ion selectivity pore is generated by the four partial reentrant
loops between segments S5 and S6 of each a subunit (Payandeh et al., 2011; Yu &
Catterall, 2003). Crystal structures of prokaryotic Nav suggest that the inner pore is filled
with water, allowing a hydrated sodium ion to be conducted by interacting with the
negatively charged glutamate residues that line the pore via its bound water molecules
(Payandeh et al., 2011).
The voltage sensor consists of the S4 segments of each of the four domains that
make up Nava. These segments are comprised of cationic residues that upon intracellular
depolarization will slide in the extracellular direction. The voltage sensor movement in
turn changes the conformation of the S4/S5 cytoplasmic-facing linker regions that
relieves a compression they exert on the inner half of the pore, allowing it to widen to
complete the permeation path (Catterall, 2010).
There are nine isoforms of Nava (Nav1.1-1.9) in mammals. They are all more than
50% identical to one another with the most significant differences being their tissuespecific expression profiles and their intracellular localization. Nav1.1, Nav1.2, and
Nav1.6 are the most prevalent Nav in the adult central nervous system with Nav1.1
generally being localized in the soma of cells while Nav1.2 and Nav1.6 are highly
concentrated at axon initial segments and distal axons of CNS neurons where they are
responsible for the initiation and conduction of action potentials. Nav1.3 is expressed in
fetal neural tissue and in the soma of neurons in the adult central nervous system. Nav1.6
is also expressed in peripheral nervous system (PNS), but Nav1.7-1.9 are the dominant
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Nav in the PNS with Nav1.8 and Nav1.9 being mostly exclusive to the small dorsal-root
ganglion sensory neurons responsible for pain sensation. Nav1.5 is expressed in
cardiomyocytes and Nav1.4 in skeletal muscle (Yu & Catterall, 2003).
Sodium channel conductivity is blocked by extracellular binding of tetrodotoxin
(TTX), although different Nav alpha subunits vary greatly in their TTX sensitivity.
Nav1.1-1.4, Nav1.6 and Nav1.7 are inhibited by sub-micromolar TTX concentrations,
while Nav1.5, Nav1.8 and Nav1.9 are relatively more TTX-resistant. Differential TTX
sensitivity among sodium channel isoforms can be exploited for experimental purposes
(Chen et al., 2005).
In addition to Nava, voltage-gated sodium channels interact with modulatory
accessory protein subunits. Accessory proteins include FHFs and Nav beta subunits
(Navb) (Beneski & Catterall, 1980). Mammalian Navbs are encoded by four genes (Navb1
– Navb4) and have been shown to stabilize Nav subcellular localization (Catterall, 2012),
trafficking and gating of Nav (Calhoun & Isom, 2014). Voltage clamp data suggest that
Navb exert a hyperpolarizing effect on the voltage dependence of Nav activation and
inactivation, (E. J. Yu et al., 2005). Separate from their association with Nava, Navb is
believed to function independently as a cell adhesion molecule that contributes to axonal
outgrowth (Calhoun & Isom, 2014).

1.4.2 Voltage-gated Sodium Channel Gating & Types of Inactivation
Upon membrane depolarization, Nav can go through a number of conformational
phases. The generalized cycle is that upon depolarization the voltage sensor shifts
causing a conformational change opening the pore of the channel thus allowing an influx
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of sodium ions. This is called activation, which is responsible for the rising phase of an
action potential. If the arriving stimulus has the capacity to depolarize a given region of
an excitable cell’s membrane enough to trigger a feed-forward opening of all available
Nav in that region—this voltage where feed-forward opening occurs is referred to as its
threshold—the cell will fire an action potential. After activation, the channel will enter
into an inactive state over a 1-3 millisecond time frame. In its inactive state the sodium
channel is non-conducting, despite the voltage sensors remaining more outwardly
positioned at the depolarized membrane potential. Nav inactivation and concomitant
opening of voltage-gated potassium channels causes net cation efflux that mediates the
declining phase of the action potential. Membrane repolarization allows sodium channels
to cycle from the inactivated state back to the closed state, thereby preparing the cell for
firing again if another depolarization cycle occurs.
Nav can go through these phases in order (active, inactive and closed), which
renders them ready to respond again to the next stimulus, or it can go from the closed
resting state directly to inactive in which it cannot be activated until the inactivation
ceases and the channel recovers back to its closed state. The dynamics between these
states are voltage-dependent and vary based on the intra and extracellular environment of
each cell type, the kinetics specific to the isoforms of Nava and the accessory proteins
expressed in that cell.
There are four known mechanisms of Nav inactivation that differ from each other
based on the mechanism driving the inactivation as well as the relationship between the
onset of inactivation and the time interval until recovery upon membrane repolarization.
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1.4.2.1 Fast Inactivation was first described by Hodgkin and Huxley in 1952
when they showed that the open conductance in the squid axon inactivates over 1-3
milliseconds after depolarization. It also has a rapid recovery rate upon membrane
repolarization, which allows for repetitive generation of action potentials. Nav fast
inactivation results from intrinsic properties of the Nava subunit structure at its
cytoplasmic face, which was originally demonstrated by showing the sensitivity of
inactivation to protease digestion applied to the cytoplasmic face of membrane
(Armstrong, Bezanilla, & Rojas, 1973; Rojas & Armstrong, 1971; Vandenberg & Horn,
1984). The generally accepted model is referred to as the “hinged lid model” in which,
within milliseconds of depolarization, the highly conserved intracellular loop connecting
domains 3 and 4 (DIII/IV) of the channel acts as an inactivation particle by binding to
and thereby blocking the intracellular opening of the channel’s pore (Yu & Catterall,
2003). Antibodies specific for the loop connecting Nava DIII/IV slows Nav fast
inactivation indicating that it serves a direct physical role in onset of fast inactivation
(Vassilev, Scheuer, & Catterall, 1988). Mutagenesis experiments showed that three
clustered hydrophobic residues in this loop; known as the IFM motif, were necessary for
initiating fast inactivation (West et al., 1992), and recent cryo-EM structures of
inactivated sodium channels reveal that the IFM motif in the DIII/IV loop is docked to a
hydrophobic pocket adjacent to the ion permeation path of the channel (Jiang et al.,
2020; Shen et al., 2019; Yan et al., 2017).
The voltage-dependence of fast inactivation is an intrinsic property specific to
each Nava isoform but can be shifted by various accessory proteins. Navb1 has been
shown to negatively shift the voltage dependence of fast inactivation, which in turn
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increases the rate of inactivation resulting in reduced sodium currents due to a decrease in
Nav availability at any given voltage (An et al., 1998; Spampanato et al., 2004).
Conversely, FHFs cause a depolarizing shift in the voltage dependence of fast
inactivation, which in turn decreases the rate of inactivation resulting in enhanced sodium
currents by increasing Nav availability at any given voltage (Dover et al., 2010; Lou et
al., 2005; Wittmack et al., 2004). While the shifts in the voltage dependence of fast
inactivation caused by accessory proteins such as those mentioned are well established,
the physical mechanisms affording them are to date unknown and being actively studied
by our lab and others.

1.4.2.2 Slow Inactivation onset occurs orders of magnitude slower than fast
inactivation following membrane depolarization and is further characterized by a very
slow recovery rate upon membrane repolarization (Rudy, 1978). Hence, membrane
depolarization triggers fast inactivation, which can transition to the slow inactivated state
if membrane depolarization persists. Slow inactivation is believed to modulate cell
excitability by reducing the availability of Nav after repetitive high-frequency stimulation
or a prolonged depolarizing pulse (Toib, Lyakhov, & Marom, 1998). Even though the
consensus opinion is that the mechanism of slow inactivation requires a conformational
change in the channel’s selectivity filter, it is believed that there are a number of various
complex interactions within the channel based on the stimulus initiating it that may
contribute to slow inactivation rather than a single driving mechanism since onset and
recovery of slow inactivation varies greatly based on properties of the input stimulus
itself (Chatterjee et al., 2018).
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1.4.2.3 Long-term Inactivation (LTI) was a term coined by our lab to distinguish
it from slow inactivation (Dover et al., 2010). LTI occurs rapidly, similar to fast
inactivation, but resulting in a state from which channels recover slowly. Sodium
channels are susceptible to LTI when they are associated with A-type splice isoforms of
FHF proteins (Dover et al., 2010). An N-terminal sequence motif, which is conserved
among all A-type FHFs, competes with the intrinsic fast inactivation mechanism in a
stochastic manner inserting into the pore similarly to Navb4 but with a greater affinity.
(Dover et al., 2010). LTI contributes to driving spike accommodation (spike frequency
adaptation) in hippocampal pyramidal neurons, (Venkatesan et al., 2014) which suggests
that it plays a significant role in neural firing in the CNS. The N-terminal sequence
element on the A-type FHF acts as an open channel blocking particle, meaning that
sodium channels can only enter the LTI state following channel opening (Venkatesan et
al., 2014). FHF2A in nociceptive neurons may also limit the stimulus to response
relationship of these cells, and neuroinflammation that heightens the stimulus/response
ratio is accompanied by some replacement of FHF2A by FHF2B, which does not
promote LTI (Barbosa et al., 2017).

1.4.2.4 Transient Open-channel Block is another mechanism by which open
channels can be inactivated. The mediator of this mechanism is a cytoplasmic motif on
channel-associated Navb4 protein. However, unlike the long-term inactivating effect of
the A-type FHF block, block mediated by Navb4 is very unstable upon membrane
repolarization, such that channels can re-open before returning to the closed state. This
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second phase of sodium current upon membrane repolarization is referred to as a
resurgent current (Wang et al., 2006), and resurgent sodium currents are important for
enabling certain neurons to fire high-frequency spike trains (Grieco et al., 2005).

1.5 Voltage-gated Sodium Channels in Cardiac Function & Heart
Disease
1.5.1 Nav in Cardiac Function
1.5.1.1 The Heart is a large muscular organ that is responsible for providing
every tissue in the body with the sufficient oxygen and nutrients required to perform all
functions by efficiently circulating blood throughout the entire body at all times.
Deoxygenated blood returning from the systemic circuit of the body enters the heart via
the venae cavae into the right atrium. Upon atrial contraction, the blood passes through
the tricuspid valve filling the right ventricle. Ventricular contraction pushes the blood
past the pulmonary semilunar valve into the pulmonary artery where it goes to the lungs
and becomes oxygenated. Oxygenated blood from the lungs fills the left atrium of the
heart via pulmonary veins. Upon atrial contraction, the oxygenated blood passes through
the mitral (bicuspid) valve filling the left ventricle and upon ventricular contraction,
passes through the aortic semilunar valve into the aorta, which eventually transports
oxygenated blood throughout the entire systemic circuit. This requires complex
electrically initiated rhythmic and synchronous contractions of every cardiomyocyte. In
the heart, there is precisely structured conduction system consisting of a series of
components each performing specific functions that allow the heart itself to generate and
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propagate the electrical impulses required to perform this task (van Weerd & Christoffels,
2016).

Figure 2: Cardiac Conduction (a) Schematic of the anatomical cardiac conduction
pathway (b) Representative Electrocardiogram: Atrial depolarization represented by the P
wave, ventricular depolarization by the QRS complex and the T wave indicating final
repolarization. Abnormalities in the shape of or intervals between these waveforms are
indicative of various types of heart disease including arrhythmias. [Adapted from Greg
Ikonnikov and Dominique Yelle, McMaster: Pathophysiology Review and Nerbonne & Kass, Physiological
Review, 2005]

1.5.1.2 The Cardiac Conduction System consists of non-contractile myofibers
and begins at the sinoatrial (SA) node, located at the junction of the superior vena cava
and the right atrium where specialized pacemaker cells initiate spontaneous cardiac
sodium action potentials. These action potentials initiate depolarization of the atrial
cardiomyocytes, and propagation of the action potential through atrial myocardium can
be visualized in an electrocardiogram (ECG) as the P wave (Kashou, Basit, & Chhabra,
2019). The action potential then travels through the atrial cardiomyocytes via gap
junctions, while also traveling via the conduction system to the atrioventricular (AV)
node (Barr, Dewey, & Berger, 1965). At this point the signal is delayed long enough to
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allow for atrial contraction to be completed, which fills the ventricles with blood and is
represented in an ECG as the PR interval (van Weerd & Christoffels, 2016). The impulse
can then propagate into the ventricular portion of the conduction system via the AV
node’s connection to the fast conducting atrioventricular bundle commonly referred to as
the bundle of His (Roguin, 2006). The fibers from the bundle of His bring the impulse
down the ventricular septum to the heart’s apex and then branch both left and right
propagating the impulse into the Purkinje fiber network. The action potentials from the
Purkinje fiber termini initiate the action potential in working ventricular cardiomyocytes,
resulting in an action potential wave through ventricular myocardium seen as the QRS
complex in an ECG. Ventricular excitation induces contraction that expels blood from
the heart into the systemic circuit of the body (He, Boyden, & Scheinman, 2018).
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Figure 3: The cardiac action potential lasts 200-300ms and consists of a series of phases.
(0) Rapid depolarization driven by sodium ion influx through Nav1.5 triggers action
potential. (1) Early repolarization via transient outward potassium current. (Sheets et al.,
2007) Plateau driven by calcium ion influx through voltage-gated calcium channels. (4)
Final repolarization via opening of both fast and slow potassium channels and closing of
voltage-gated sodium and calcium channels. [McMaster: Pathophysiology Review]
1.5.1.3 Nav1.5 is the primary Nav isoform expressed in the heart. It is encoded by
the SCN5A gene consisting of 28 exons on chromosome 3p21 (Wang et al., 1996) and is
expressed in both atrial and ventricular cardiomyocytes as well as throughout the
Purkinje fibers. Nav1.5 is responsible for initiating the rising phase of the cardiac action
potential that propagates from one cardiomyocyte to the next throughout the cardiac
conduction system and working cardiomyocytes (Detta, Frisso, & Salvatore, 2015).
1.5.1.4 Nav1.5 Post-translational Modifications and Interacting Proteins can
modulate channel function and can be necessary for proper function. The most
thoroughly studied post-translational modifications of Nav1.5 are its glycosylation and
phosphorylation. Glycosylation is required for maintaining proper Nav1.5 activation and
inactivation kinetics (Ednie, Horton, Wu, & Bennett, 2013). Phosphorylation of Nav1.5
by protein kinase A has been shown to increase Nav1.5 membrane channel density
therefore increasing generated sodium currents (Hallaq et al., 2006) while
phosphorylation by protein kinase C has shown to have the opposite effect (Hallaq et al.,
2012). Phosphorylation of Nav1.5 by CamKII can either increase or decrease channel
availability depending on the site that is phosphorylated (Ashpole et al., 2012; Hund et
al., 2010).
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Nav1.5 interacts with many other proteins resulting in differential effects on its
internal gating kinetics, its subcellular trafficking as well as its stabilization and insertion
in the plasma membrane (Detta et al., 2015). Of the many known Nav1.5 protein binding
partners (Table 1), most of these interactions occur at sites on the cystolic c-terminal
domain of the channel including stabilizers like calmodulin and gating modifiers such as
FHF proteins, including FHF2 (Goetz et al., 2009; Goldfarb et al., 2007).
Table 1: Nav1.5 Interacting Proteins (Shy, Gillet, & Abriel, 2013)

______________________________________________________
Protein

Nav1.5 interacting region

Channel regulation

SAP97

C-terminus (PDZ domain)

Trafficking

Ankyrin-G

interdomain D2–3 linker

MOG1

interdomain D2–3 linker

Nav1.5

N-terminus

α-actinin-2

interdomain D3–4 linker

Calmodulin

C-terminus (IQ motif) and
interdomain D3–4

Desmoglein-2

Not determined

Plakophilin-2

Not determined

FGF proteins

C-terminus (aa 1773–1897)

14-3-3η

interdomain D1–2 linker

Caveolin-3

Not determined

GPD1-L

Not determined

Telethonin

Not determined

ZASP

Not determined

PTPH1

C-terminus (PDZ domain)

Nedd4-like
family

C-terminus (PY domain)

CAMKIIδc

Interdomain D1-2 linker and via
spectrina

Syntrophin

C-terminus (PDZ domain)

Gating regulation

Post-translational
modifications

Adaptation and
stabilization

______________________________________________________
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1.5.2 Nav1.5 -Associated Heart disease
Since Nav1.5 is responsible for the initiation of the cardiac action potential, any
dysfunction or dysregulation of it can be detrimental to cardiac function and can result in
heart disease. Mutations in the SCN5A gene encoding Nav1.5 have already been linked to
a number of cardiac diseases collectively referred to as channelopathies.

1.5.2.1 Long QT Syndrome (LQT) is an inherited cardiac arrhythmia primarily
characterized by an elongated interval between the onset of ventricular depolarization and
its subsequent repolarization also referred to as the QT interval despite having no
anatomical cardiac abnormalities (Crotti et al., 2008). There are 13 subtypes of LQT that
give rise to arrhythmias including tachycardia, bradycardia and can result in sudden
cardiac death. LQT Subtype 3 are caused by Nav1.5 mutations and account for 7-10% of
all LQT diagnoses (Pérez-Riera et al., 2018). These mutations have been identified at
many different sites of the channel and result in a gain of function by increasing the
persistent sodium current, otherwise known as the late sodium current (Song & Shou,
2012). This excessive flux of sodium ions into the cell slows the repolarization phase of
the cardiac action potential which is what gives rise to the prolonged QT interval. LQT
mutations alter the action potential waveform and conduction velocity to different extents
in different directions through three-dimensional myocardium, thereby creating
opportunities for reentrant conduction and ventricular fibrillation. While there are
medicinal treatments available, many are largely ineffective and the most effective
treatment for high risk patients is the implantation or pacemaker cardioverter
defibrillation devices (Priori et al., 2013).
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1.5.2.2 Brugada Syndrome is an inherited cardiac arrhythmia which is unique in
that it both occurs in patients with no structural cardiac abnormalities and typically
affects those that are otherwise completely healthy and under 40 years old. Symptoms
includes bouts of losing consciousness and ventricular arrythmia—in some cases fever
may unmask the arrhythmia— which can lead to sudden cardiac death (Manohar, Dahal,
& Gitler, 2015). Brugada syndrome is difficult to diagnose because the arrhythmia varies
even within a single patient or may remain hidden until unmasked by other factors. It is
generally characterized when ECG shows irregularly shaped elevated ST interval often
referred to as coved-shaped ST in which the T wave merges with the S repolarization and
can be absent altogether or shows as a negative deflection. This is a product of Nav1.5
loss of function mutations which result in generating reduced sodium currents due to
impaired trafficking that decreases density of Nav1.5 inserted into the membrane or
mutations that impair channel gating, especially at elevated temperatures (Samani et al.,
2009). To date, it is unclear if the phenotype manifest by these loss of function mutations
is due to abnormal repolarization or depolarization and it may be a combination of both
or may vary between cases. Implantation of a cardioverter defibrillation device is the only
method to date to prevent Brugada Syndrome induced cardiac sudden death (Priori et al.,
2013). Similar to LQT, Brugada Syndrome mutations can alter action potential
waveform and conduction velocity in a heterogeneous manner through heart muscle,
thereby increasing the possible of conduction reentry and fibrilllation.
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1.5.2.3 Sick Sinus Syndrome (SSS) is a disease in which the pacemaker cells of
the sinoatrial node are altered in a way that disrupts its structure and/or function which
causes sinus bradycardia, conduction disturbances including exit block as well as
tachycardia-bradycardia syndrome and can be acquired genetically or epigenetically
however, many cases have no known origin. It generally affects individuals over the age
of 50 and symptoms include dizziness, lapses in judgment and digestive issues which
worsen under physical stress (Adan & Crown). Nav1.5 mutations contribute to the
recessive inherited form of SSS and can result in a loss of function resulting in decreased
electrical coupling between cells in the SA node which impairs cardiac action potential
generation (Veldkamp et al., 2003); or gain of function which prolongs the cardiac action
potential disrupting repolarization which compromises the ability to repetitively fire
action potentials thus reducing and deregulating SA node output (Makita et al., 2008).
Since drug treatment to date is ineffective for SSS, cases are monitored and the most
severe cases require pacemaker implantation (Gregoratos, 2003).
1.5.2.4 Progressive Cardiac Conduction Disease (PCCD) is a disease of the
cardiac conduction system caused by loss of function mutations in Nav1.5 which decrease
channel availability and cause cardiac action potential propagation failure between the
bundle of His and the Purkinje fibers and is visualized on an ECG as an enlarged QRS
complex. This conduction block can lead to loss of consciousness and sudden death and
patients with PCCD must have implanted pacemakers to protect them from sudden death
(Kawaguchi et al., 2013).
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1.6 Pain Sensation & Sensory Conduction
Pain has been defined as “an aversive sensation and a feeling associated with
actual or potential tissue damage” and all vertebrates and some invertebrates have
systems in place that afford the ability to sense it (Broom, 2001). Nociception is a
subclass of somatosensation and is the ability of an organism to sense and react to
physically painful and potentially damaging stimuli. This a vital function which helps
ensure survival of an organism. It affords an organism the ability to avoid dangerous
stimuli, prevent further physical tissue damage after onset of a dangerous stimuli as well
as notice and react to a manifestation of a disease or infection. The specialized cutaneous
peripheral sensory neurons that react to damage-causing pressure and temperature stimuli
are called nociceptors. The degree of high threshold stimulus required for activation
being what distinguishes these neurons as nociceptors rather than traditional sensory
neurons (Ramsey, Delling, & Clapham, 2006).
In a mature sensory neuron in a developed organism the peripheral terminal of the
nociceptor is the sensory stimulation detection center of the cell. It is at the peripheral
terminal that noxious stimulation is be detected and transmitted to the soma residing in
the dorsal root ganglion (DRG) of the spinal cord in the case torso and limb innervation,
or to the soma residing in cranial ganglia. The signal can then be passed on through a
series of neurons where it will result in a physical response via motor-reflex pathways
followed by a conscious awareness of feeling pain upon reaching and being processed in
the brain (Woolf & Ma, 2007). The investigations involving the sensory response in this
thesis will focus on nociception at the level of the peripheral nervous system and
specifically focus on the detection of noxious heat stimuli.
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1.6.1 Noxious Heat Pain Sensory Acquisition & Pathway
In mammals there are three stages of general pain sensation. First the noxious
stimulus applied from the environment onto the organism must be converted into an
electrical neuronal signal. This is called transduction and is accomplished by the applied
stimulus causing a chemical change at the peripheral tips of a specialized primary
afferent sensory neuron designed to react to that specific modal stimulus by expressing
the necessarily gated ion channel. In the case of noxious heat nociception, the ion channel
is primarily the transient receptor potential cation channel subfamily V member 1
(TRPV1). Opening at approximately 43ºC, TRPV1 causes an influx of cations resulting
in a depolarizing event that will open voltage-gated sodium channels and generate action
potentials that can be transmitted as an electrical representation of the stimulus (Dubin &
Patapoutian, 2010).
The next phase in heat pain sensation is the called transmission. This entails the
generated electrical representation of the stimulus being transported away from the site of
the stimulation. The signal is propagated from the tip of the neuron near the cutaneous
surface down thin unmyelinated sensory C-fiber axon bundles past the ganglionic
neuronal bodies and into the spinal cord (Woolf & Ma, 2007), culminating in arrival at
synapses onto CNS neurons. Upon reaching the synapse, the signal activates voltagegated calcium channels (Cav2.2) inducing a presynaptic vesicular release of
neurotransmitters inducing a postsynaptic response in the CNS neuron which can result in
a physical reaction to the stimulus (Castiglioni, Raingo, & Lipscombe, 2006).
The final phase that completes pain sensation is the modulation of the pain signal.
This will vary depending; among other factors, on the severity and duration of the
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noxious stimulus. This modulation can occur throughout the pain sensation pathway
including at the level of the primary afferent neuron, dorsal horn of the spinal cord and
higher brain centers (Yam et al., 2018).

Figure 4: Heat Nociception Pathway: 1- Noxious heat activates TRPV1 causing an influx
of cations. 2- Generated action potential propagates down afferent pathway to the spinal
cord. 3- Signal integration in spinal cord: Afferent neuron stimulates excitatory
interneurons, which activate motor neurons to biceps, inhibitory interneurons, which
inhibit motor neurons to the triceps, and interneurons linking to the ascending pathway to
the brain. 4/5- Efferent pathway causes simultaneous contraction of biceps and relaxation
of triceps pulling hand away from pain stimulus. 6- Pain signal reaches the brain resulting
in awareness of pain, memory storage etc. [Adapted from Thompson Learning, Brooks
Cole and Biology, McGraw-Hill Companies, 2001]
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1.6.2 Transient Receptor Protein Cation Channel V1
TRPV1 is a temperature gated non-selective cation channel that is the primary
sensory channel driving the transduction of noxious heat stimuli (Basbaum, Bautista,
Scherrer, & Julius, 2009). Activation of TRPV1 causes an influx of cations resulting in a
depolarizing event opening voltage-gated sodium channels which generates action
potentials that can be transmitted as an electrical representation of the stimulus (Dubin &
Patapoutian, 2010). TRPV1 was discovered as a receptor for the pain-causing chemical
capsaicin found in chili peppers and is expressed in most heat-sensitive neurons (Caterina
et al., 1997). It is part of the large family of transient receptor proteins and one of four in
the thermally gated vanilloid class. The temperature gating threshold of TRPV1 is
approximately 43°C, which coincides with tissue damage-causing pain threshold in
humans (Basbaum et al., 2009). Mice that do not express TRPV1 display heat
nociception deficits (Caterina et al., 2000), although one study contests the extent of this
conclusion (Woodbury et al., 2004). TRPV1 was initially believed to be solely
responsible for sensing heat pain, but it has since been shown that TRPV1-4 all
contribute to sensing warm and hot stimuli (Dhaka, Viswanath, & Patapoutian, 2006).
There are also contributors to heat nociception outside of the TRPV subfamily. For
example: the heat-sensitive potassium channel TREK-1 colocalizes with and is believed
to modulate TRPV1 (Alloui et al., 2006).
TRPV1 responds to multiple pain producing stimuli in addition to noxious heat
including pain-inducing chemicals such as vanilloids and inflammatory agents making it
a common pharmacological target for pain relief (Brederson, Kym, & Szallasi, 2013;
Tominaga et al., 1998). Beyond nociception, TRPV1 also has contributory sensory roles
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in audition (Zheng et al., 2003) and tasting salt (Lyall et al., 2004). TRPV1 also has
various physiological roles outside of sensation including contributing to gastrointestinal
motility (Geppetti & Trevisani, 2004), determining satiation (Ahern, 2003) and regulating
urinary bladder function (Birder et al., 2002). Due to its versatile function in various
tissue types, TRPV1 has been implicated in numerous diseases. This has made it a
potential drug target for not just for pain relief, but for treating various diseases (Brito,
Sheth, Mukherjea, Rybak, & Ramkumar, 2014).

1.6.3 Role of Peripheral Sensory Nervous System Navs in Nociception
1.6.3.1 Nav1.7 is preferentially expressed in peripheral sensory neurons
(Hoffmann et al., 2018) . Nav1.7 is similar to several other Navs in its being TTXsensitive and displaying a similar voltage-dependence to common CNS Navs (Ma et al.,
2019). Nav1.7 is expressed throughout sensory neurons, including at the nerve terminal of
nociceptors (Toledo-Aral et al., 1997). Although it is the most ubiquitous Nav in the PNS
and is expressed at the nerve ending, Nav1.7 is not the primary driver of action potential
generation in nociceptors. Only 40% of the current generated by the upstroke of a sensory
action potential is attributed to TTX-sensitive currents. This includes Nav1.7, but also
contributions from Nav1.1, Nav1.3 and Nav1.6 (Blair & Bean, 2002).
Nav1.7 displays fast activation and relatively slow recovery rate and closed-state
inactivation transition kinetics (Herzog et al., 2003). This gating profile enhances channel
availability, allowing it to respond longer to small and slower depolarization events
(Hameed, 2019), such as those generated by TRP channels. The gating profile of Nav1.7
and its expression at the site of sensory transduction suggests that it may serve to amplify
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the transducer signal by widening the window of excitability. Evidence supporting the
role of Nav1.7 as an amplifier is that gain of function Nav1.7 mutations reduce nociceptor
threshold causing hyperexcitability (Choi et al., 2009). Inversely, nociceptor specific
Nav1.7 knockout mice display increased thermal pain threshold (Nassar et al., 2004) This
indicates that Nav1.7 is a major contributor to nociception through its ability to enhance
nociceptor excitability.
Nav1.7 also plays a significant role in axonal propagation of action potentials in
DRG neurons. Knocking out Nav1.7 specifically in sensory neurons results in slowed
conduction velocity and decreased action potential amplitude (Alexandrou et al., 2016;
Hoffmann et al., 2018). Loss of function mutations in the SCN9 gene that codes for
Nav1.7 causes loss of pain sensation without a reduction in nociceptive neurons or a loss
of somatosensation (Cox et al., 2006; Goldberg et al., 2007), further highlighting the
importance of Nav1.7 in nociception.
While Nav1.7 has long been a drug target for pain relief due to its obvious
importance in pain sensation, all efforts to date have failed. While its role in normal
sensory pain acquisition and transmission is well categorized, its function in chronic
disease driven pain is disputed. It is speculated that this could be product of the difficulty
of translating data acquired using animal models to humans due the difficulties of
assessing internal pain in animal studies (Hameed, 2019).
1.6.3.2 Nav1.8 is selectively expressed in DRG sensory neurons. Nav1.8 regulates
the firing properties of the neurons expressing it and drives the rising phase of the
nociceptive action potential. It is solely responsible for over 60% of the current generated
by a pain induced action potential (Blair & Bean, 2002). Nav1.8 is TTX-resistant and
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displays slow activation and inactivation kinetics as well as a rapid rate of recovery. It
also has a very depolarized voltage-dependence relative to most other Navs (Akopian,
Sivilotti, & Wood, 1996). This gating profile results in an overlap of channel availability
that shortens spike interval, allowing for high-frequency repetitive action potential firing
(Gold, Reichling, Shuster, & Levine, 1996). Reduction of Nav1.8 expression in DRG
neurons in mice inhibits pain sensation without altering somatosensation (Lai et al., 2002)
displaying its importance and specificity to nociception. Interestingly, a nociceptor
specific double-knockout of Nav1.7 and Nav1.8 in mice displays twice the thermal pain
threshold than a Nav1.7 knockout alone (Nassar, Levato, Stirling, & Wood, 2005). This
indicates how crucial Nav1.8 is in nociception acquisition.
1.6.3.3 Nav1.9 is also selectively expressed in DRG sensory neurons. It is unstable
and expresses poorly in model cell systems (Dib-Hajj, Black, & Waxman, 2015). As a
result, it is by far the least understood of the PNS specific Nav. Nav1.9 is TTX-resistant
and displays even slower gating kinetics than Nav1.8 (Cummins et al., 1999). It has an
extremely hyperpolarized voltage dependence of activation relative to traditional Nav.
Together with its very slow kinetics, this results in there being significant overlap
between Nav1.9 activation and inactivation creating a large window for current
generation albeit relatively small in amplitude (Ma et al., 2019). This prolonged
generation of a mildly depolarizing current might help maintain Nav1.8 activation (Baker,
Chandra, Ding, Waxman, & Wood, 2003). It has also been suggested that Nav1.9 may
have a steady current which slightly depolarizes the cells resting membrane potential
(Herzog et al., 2003). This means it is likely that the primary functions of Nav1.9 is to
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increase excitability in DRG sensory neurons by setting resting membrane potential
closer to threshold and maintaining Nav1.8 activation.

1.7 Sodium Channelopathies and Epilepsy
Epilepsy is a common, multifactorial neurological disease in which the afflicted
experience recurrent episodes of uncontrolled neuronal activity called seizures. Accurate
descriptions of the disease are first found in ancient Mesopotamian documents dating
over 4500 years ago (Panteliadis, Vassilyadi, Fehlert, & Hagel, 2017). According to the
U.S. Center for Disease Control and Prevention, 3.4 million Americans and over 65
million people globally suffer from epilepsy. The national economic burden attributed to
epilepsy is estimated to be over $12.5 billion annually (Begley & Durgin, 2015).
Early-onset developmental epileptic encephalopathy (EOEE) is a form of epilepsy
that manifests neonatally or in early infancy. EOEE patients display severe EEG
abnormalities and their seizures typically cannot be managed well with medication.
EOEE patients also suffer from delayed development and severe cognitive deficiencies
(Nieh & Sherr, 2014). A defining feature of epileptic encephalopathies is that the
electrical epileptic events themselves cause further neurological damage. This tissue
damage progressively worsens other symptoms such as cognitive or behavioral deficits
(Berg et al., 2010).
EOEE does not have a single cause and the phenotype can vary greatly between
individual cases, but genetics is indeed a primary component. Over a hundred genes have
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been suggested as causes of individual cases of EOEE (Lemke et al., 2012). Still, in over
50% of EOEE cases a direct cause is never identified (Hebbar & Mefford, 2020). Various
mutations in the genes coding for Nav1.1, Nav1.2 and Nav1.6—the most abundant Nav in
the CNS—have been identified as underlying causes of specific epilepsy cases (Oyrer et
al., 2018). The majority of epilepsy cases, however, do not involve direct impairment of
an ion channel. Mutations in genes that encode ion channels actually only account for
25% of epilepsy cases. (Oyrer et al., 2018). Since Nav mutations have been shown to
directly cause epilepsy, it is logical to believe that mutations in the proteins that modulate
Nav have potential to do the same. One of the first Nav gating modulators implicated as
such was Navb1 when mutation in the gene that encodes it was identified as a contributor
to a case of generalized epilepsy with febrile seizures plus (GEFS+) (Wallace et al.,
1998).
There have already been mutations in FHFs that have been identified as being
epileptogenic. A single point mutation in FHF1 causes a pro-excitatory gain of function
resulting in a dramatic depolarizing shift in steady-state inactivation. This resulted in a
severe increase of Nav availability at any given voltage and hyperexcitability, terminating
in fatal neonatal epilepsy. To date at least eight patients with this exact epileptogenic
FHF1 point mutation have been identified (Al-Mehmadi et al., 2016; Siekierska et al.,
2016; Villeneuve et al., 2017).
FHF2 was first directly linked to a human epilepsy case when a partial
translocation of the FHF2 gene was associated with GEFS+. It was determined that if the
translocation reduced FHF2 expression, the likely cause of seizures was a decreased
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inhibitory neuron excitability resulting in overall overexcitability of excitatory neurons
(Puranam et al., 2015).

1.8 Preview to Dissertation Research
The overall aim for my research has been to identify the functions of FHF2 and to
better understand what role this protein plays physiologically specifically in the heart,
sensory nervous system and central nervous system. This knowledge will help explain the
evolutionary significance of this modulatory protein as well as potentially assist in
diagnosis and treatment of diseases associated with Nav gating such as cardiac
arrhythmias and epilepsy.
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Chapter 2: Materials & Methods
2.1 Plasmids & Mutagenesis
2.1.1 Nav Plasmids:
The Nav1.5 plasmid used in this project was provided by R. Kass: Human Nav1.5
cDNA was cloned into the pcDNA3.1vector. The TTX-resistant Nav1.6 plasmid was
derived by previous Goldfarb lab members (Dover et al., 2010): TTX-resistant murine
Nav1.6 (Nav1.6Y371S) cDNA was cloned into the bicistronic pIRESneo3 vector (Clontech).
The Nav1.7 plasmid used was provided by T. Cummins: Human Nav1.7 cDNA was
cloned into the pcDNA3.1vector.
2.1.2 FHF2 Plasmids:
All FHF2 plasmids were constructed to co-express FHF2 and ZsGreen1
Fluorescent Protein using the bicistronic pIRES-ZsGreen1 vector (Clontech). The FHF2A
and FHF2B plasmids were derived by previous Goldfarb lab members (Dover et al.,
2010). Mutant FHF2A plasmids (FHF2A-R11C and FHF2R14T) were generated using
complementary mutagenic primers and confirmed by DNA sequencing. FHF2VY
plasmid was generated by PCR amplification of the FHF2VY-speific segment from
genomic DNA. Our FHF2A-IRES-ZsGreen plasmid was then double digested and
utilized in a ligation reaction with the amplified VY-specific segment. The reaction
product was used to transform ElectroMAX DH10B cells. Individual clones were picked
and extracted plasmids were verified via DNA sequencing.

2.2 Transfection
2.2.1 Nav and FHF2 Expression in HEK 293T Cells
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To assist in investigating the role of FHF2 in cardiac function, FHF expressionnegative 293T human embryonic kidney (HEK) cells were transiently co-transfected with
a 2:1 mixture of Nav1.5-expressing plasmid and a pIRES2-ZsGreen bicistronic plasmid
(Clontech) expressing ZsGreen and mouse FHF2VY proteins. The same pIRES2ZsGreen plasmid without FHF2 coding sequence served as control. Cells were
trypsinized 3 hours post-transfection, seeded onto gelatinized coverslips, and were used
for recording after 48 hr. To investigate the role of FHF2 in the sensory nervous system
the same protocol was followed using Nav1.7-expressing plasmid and a pIRES2-ZsGreen
bicistronic plasmid (Clontech) expressing ZsGreen and mouse FHF2A or FHF2B
proteins.
2.2.2 Nav and FHF2A Expression in Neuro2A cells
To investigate the epileptogenic potential of some FHF2A mutations Neuro2A
cells were transiently co-transfected with a 2:1 mixture of Nav1.6Y371S-expressing
plasmid and a pIRES2-ZsGreen bicistronic plasmid (Clontech) expressing ZsGreen and
either human FHF2A-WT, FHF2A-R11C, or FHF2A-R14T proteins. The same pIRES2ZsGreen plasmid without FHF2 coding sequence served as control. Cells were
trypsinized 3 hours post-transfection, seeded onto gelatinized coverslips, and were used
for recording after 48 hr.

2.3 Embryonic Stem Cells, Blastocyst Transplantation & Pronuclear
Injection
A murine embryonic stem cell line bearing a “knockout first with conditional
potential” cassette integrated into the Fhf2 locus located on chromosome Xq26
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(International Mouse Phenotype Consortium, clone EPD0339_4_F09) was injected into
blastocysts to derive chimeric mice, which were outbred to establish viable mice bearing
the targeted allele. Pronuclear injection of Cre recombinase-expressing plasmid into
fertilized eggs of this lineage yielded progeny bearing Cre-mediated excision. Embryo
manipulations and reimplantations were performed by Kevin Kelley at the Mount Sinai
Mouse Transgenic Core Facility (New York City).

2.4 Mouse Breeding and Genotyping
The original Fhf2-targeted allele and the Fhf2KO allele were bred through four
generations into the 129/SvPas (also termed 129S2) strain before experimentation. The
Fhf2-targeted allele was converted to the conditional Fhf2CON allele by mating with mice
that globally express a nuclear-targeted FLP recombinase ROSA)26Sortm2(FLP*)Sor
(Jackson Labs Stock #012930).
For genotyping all DNA was acquired and PCRs performed using the Phire™
Hotstart II DNA Polymerase Tissue Direct PCR kit by Thermo Scientific. Primer
concentrations, cycling protocols and primer based annealing temperatures were followed
according to kit specifications. Reaction products were analyzed via gel electrophoresis
through a 1.5% agarose gel. All oligonucleotide primers were purchased from Eurofins
MWG Operon and, whenever possible, a three-primer approach was employed to allow
for simultaneous detection of hetero or homozygosity. All primer combinations and
resulting PCR product lengths for each genotype probed were as follows:
FHF2-WT/Targeted PCR: 5’ homology forward primer for wild-type allele
detection (GCCAGGAGTCTGCTCAACTCT) and to detect the targeted allele, a
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downstream forward Neomycin resistance gene primer within the targeted cassette was
used (CCCCCTGAACCTGAAACATAAAATG) with a common reverse primer outside
of the cassette (GACTTTGGTGGGAGCATCCTGA) produced a targeted band of 479 bp
and a wild-type band of 388 bp.

FHF2-WT/KO PCR was performed with the forward primers: 5’ homology
primer for wild-type allele detection present in the region of exon 3 that is deleted in the
knockout after Cre-excision (GGTGAGTCTTTGTGTGCATGCT) and to detect the
knockout allele, a downstream LacZ primer within the cassette, but outside of the Cre
recombinase excised region was used (CCATTACCAGTTGGTCTGGTGT) with a
common reverse primer outside of the cassette (CACAGATGAACACTTCTCAAACCA)
produced a knockout band of 464 base pairs (bp) and a wild-type band of 371 bp.

FHF2-WT/Conditional PCR: Only required a two-primer approach since the two
alleles would give bands of different lengths when using only wild-type primers. This is
due to the shortening of the cassette after Flippase excision of the FRT flanked portion of
the cassette. This excision leaves a ~150 bp remnant of the original ~6000 bp cassette.
This increases the distance between the wild-type allele detecting primers significantly
but is still within range to readily produce a PCR amplicon. The 5’ homology forward
primer for wild-type allele detection (GCCAGGAGTCTGCTCAACTCT) and the wild-
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type reverse primer (GACTTTGGTGGGAGCATCCTGA) produced a conditional allele
band of 533 bp and a wild-type allele band of 388 bp.

2.5 Antibodies Used
Primary Antibodies: Custom Rabbit anti-FHF2 (Schoorlemmer & Goldfarb,
2002), Mouse anti-Pan-Nav of Sigma Catalogue S8809, Mouse anti-Ankyrin-G of Santa
Cruz Catalogue sc-12719, Mouse anti-FHF4 (N56/21) Antibodies Inc., Mouse anti-Atype FHF (N235/22) Antibodies Inc., Rabbit anti-Caspr of Abcam Catalogue ab34151,
Chicken anti-PGP9.5 EnCor Biotechnology Inc. Catalogue CPCA-UCHL1.
Secondary Antibodies: All IgG H+L Cross-Absorbed fluorescent secondary
antibodies as well as TO-PRO-3 Iodide nuclear stain were purchased from Invitrogen.
For chemiluminescence detection, Horseradish peroxidase-conjugated secondary
antibodies were purchased from Jackson ImmunoResearch.

2.6 Western-blot & Co-Immunoprecipitation
Brain and exsanguinated heart tissues were homogenized in cold detergent-free
lysis buffer (20 mM Tris pH 7.4, 137 mM NaCl, 2 mM EDTA, 25 mM bglycerophosphate, 2 mM Na pyrophosphate, 1 mM Na orthovanadate, 10% glycerol)
after which membranes were solubilized by adding 1% Triton X-100. Clarified lysates
were run on 4%–20% precast polyacrylamide gradient gels (Invitrogen) and transferred
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to activated PVDF (Immobilion-P, Millipore) overnight at 4°C. Membranes were then
rinsed with TBST (tris-buffered saline with 0.1% Tween-20) and sectioned based on
molecular weight markers for immunodetection and placed in blocking solution (TBST,
10% FBS, 0.02% sodium azide) on a rocker at room temperature for 3 hours. Blocked
membranes were then incubated with the appropriate primary antibody at 1µg mL-1
overnight on a rocker at 4°C. After 3 cycles of TBST washes membranes were treated
with appropriate HRP-conjugated antibodies (1:10000) in TBST with 2.5% BSA. After
washes membranes are treated with enhanced chemiluminescent solution and blots were
developed on x-ray film using for detection.
Rabbit anti-FHF2 polyclonal antibody was used to co-immunoprecipitate Nav
from cell lysates overnight at 4°C. Antigen antibody complex was pulled out of solution
by G sepharose beads purchased from GE Healthcare Life Sciences at 4°C. After three
wash cycles with ice-cold Triton lysis buffer, proteins were eluted in 50°C Laemmli
sample buffer with b-mercaptoethanol. Eluates were analyzed via western-blot as
described above.

2.7 Immunofluorescence
Tissue Immunofluorescence: Tissues were harvested from adult WT mice and
submersion fixed in 4% paraformaldehyde for 1 hour at 4°C, treated with cryoprotectant
30% sucrose in PBS for 24 hours at 4°C then embedded and frozen in OCT blocks for
cryosections. Cryosections 12-30µm thick were permeabilized with 0.5% Triton X100,
preabsorbed with 10% fetal calf serum, and incubated overnight at 4°C with a
combination of primary antibodies at 0.5 µg/ml ︎each. After three was cycles, the tissue
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were subsequently incubated with 1:200 dilutions of corresponding IgG H+L crossabsorbed fluorescent secondary antibodies at room temperature for 2 hours and treated
with TO-PRO-3 Iodide nuclear stain when necessary. Images were captured with a Leica
TCS2 confocal microscope and images spanning 2–5 mm through the z axis were
merged.
Cultured Cells Immunofluorescence: Cells were grown on poly-d-lysine coated 1
cm glass coverslips in 24-well culture plates. When desired density was reached, freshly
made complete media was applied to the wells and whole culture dish put on ice. Cells
were fixed for 10 minutes on ice by the addition of equal volume 4% paraformaldehyde.
Cells were permeabilized with 0.5% Triton X100, preabsorbed with 10% fetal calf serum,
and incubated overnight at 4°C with a combination of primary antibodies at 0.5 µg/ml
︎each. After three was cycles, the tissue was subsequently incubated with 1:200 dilutions
of corresponding IgG H+L Cross-Absorbed fluorescent secondary antibodies at room
temperature for 2 hours and treated with TO-PRO-3 Iodide nuclear stain when necessary.
Images were captured with a Leica TCS2 confocal microscope

2.8 Electrophysiological Recordings of Sodium Currents in HEK293T
Cells
All electrophysiological recordings were conducted using a MultiClamp700
Amplifier, Digidata 1440 analog/digital converter, and Clampex10 software (Molecular
Devices). Cells were placed in the recording chamber, viewed with a Nikon Eclipse
microscope and temperature was controlled by an in-line heater (Warner Instruments).
For sodium current recordings, coverslips were transferred to recording chamber
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containing carbogen-buffered bath solution (115 mM NaCl, 26 mM NaHCO3, 3 mM
KCl, 10 mM glucose, 4 mM MgCl2, 2 mM CaCl2, 0.2 mM CdCl2, 3 mM myoinositol, 2
mM Na pyruvate, 7 mM NaOH-buffered HEPES pH 7.2) at 25 °C and green fluorescent
cells were whole-cell patched with pipettes filled with 104 mM CsF, 50 mM
tetraethylamine chloride, 10 mM HEPES pH 7.2, 5 mM glucose, 2 mM MgCl2, 10 mM
EGTA, 2 mM ATP, 0.2 mM GTP and having 1–2 MW resistance. For all recording
protocols, voltage-gated current was isolated during data acquisition by P/N subtraction
of leak and capacitive currents (N = -6). To ensure voltage clamping during sodium
channel activation was adequate, cells were subjected to a 19-sweep series of voltage
steps from a hold of ︎-120 mV to between ︎ -80 mV and -10 mV in 5 mV increments. As
criterion for adequate clamp, transient current peaks for all voltage commands were
nested within the larger current trace of a following or preceding voltage step command.
2.8.1 V-Clamp Protocols
Steady-state channel inactivation protocol: To determine the voltage dependence
of steady state channel inactivation, a 19-sweep protocol used a︎ -120 mV holding
command, a 60 ms variable test voltage step (-120 + 5(n ︎-1) mV), followed by a ︎ 25 mV
reporting pulse.
Voltage ramp protocol: As a measure of closed state channel inactivation rate, a
10-sweep protocol used ︎-120 mV hold command followed by depolarization to ︎-30 mV
either instantaneously (voltage step) or as a ramp ranging in time from 2ms (= 45mV ms︎1

) to 18ms (= 5mV ms︎-1).
After recording at 25 °C, temperature was ramped to 35 °C and later to 40 °C. At

elevated temperatures, the cell was first tested as above to ensure maintenance of tight
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clamp, after which the voltage ramp protocol was conducted. For many cells, voltage
ramp protocols could be successfully run at all three temperatures.

2.9 Isolation of Mouse Ventricular Cardiomyocytes
Cardiac cells were dissociated from adult hearts that were Langendorff perfused
and enzymatically digested according to AfCS Procedure Protocols PP00000125. Mice
were heparinized (500 U kg-1) and killed with 100% carbon dioxide. Hearts were
surgically removed via thoracotomy and immersed in ice cold perfusion buffer
(composition (m2): 113 sodium chloride (NaCl), 4.7 potassium chloride (KCl), 0.6
potassium phosphate monobasic (KH2PO6), 0.6 sodium phosphate dibasic (Na2HPO4),
1.2 magnesium sulphate heptahydrate (MgSO4 7H2O), 12 sodium bicarbonate (NaHCO3),
10 potassium bicarbonate (KHCO3), 10 HEPES buffer solution, 30 mM taurine, 5.5 mM
glucose and 10 2,3-Butanedione monoxime (BDM)). The aorta was cannulated and
Langendorff perfused with perfusion buffer at a constant flow rate of 3 ml min-1︎ for 3
min. The perfusate was then switched to myocyte dissociation buffer (composition: 1 ︎X
perfusion buffer, 10 mg Liberase TM and 12.5 µM calcium chloride (CaCl2) at a constant
flow rate of 3 ml min-︎1 for 8 min. Perfusate temperature was maintained at 37 °C. Heart
was removed, placed in a dish containing 2.5 ml myocyte dissociation buffer plus 2.5 ml
stop buffer 1 (composition: 1 X︎ perfusion buffer, 10% bovine calf serum, and 12.5 µM
CaCl2), and tissue above the atrioventricular ring was removed. Ventricles were teased
into several small pieces with fine forceps. Cellular dissociation was achieved by further,
gentle mechanical agitation via 15 ml transfer pipets. Quality of myocyte dissociation
was then assessed by counting myocyte yield and percentage of rod-shaped myocytes.

- 41 -

Only preparations with yields greater than 1 million cells and at least 60% rod-shaped
myocytes were used for further experimentation. Cardiomyocytes were sedimented by
centrifugation at 100 x g for 1 min in 15 ml tubes. The supernatant was discarded after
sedimentation and the pellet was re-suspended in 10 ml of stop buffer (composition: 1 X︎
perfusion buffer, 5% bovine calf serum, and 12.5 µM calcium chloride (CaCl2)) added to
increasing concentration of calcium in 5min intervals until overall CaCl2 reached 1mM.
Viability of myocytes was reassessed using the above quality control guidelines. Only
cell preparations that passed these criteria were used for experimentation.

2.10 Electrophysiological Recordings of Isolated Ventricular
Cardiomyocytes
Excitability of acutely dissociated ventricular cardiomyocytes from Fhf2WT/Y and
Fhf2KO/Y mice was conducted using a MultiClamp700 Amplifier, Digidata 1440
analog/digital converter, and Clampex10 software (Molecular Devices). Cells were
placed in the recording chamber under a Nikon Eclipse microscope and perfused with
carbogen-bubbled bath solution (115 mM NaCl, 26 mM NaHCO3, 3mM KCl, 1.2mM
KH2PO4, 3mM glucose, 2mM myoinositol, 2mM Na pyruvate, 7mM HEPES, 1.2mM
Mg2SO4, 2mM CaCl2, 0.2mM CdCl2 at pH7.2) maintained at 25°C using an in-line
heater (Warner Instruments). Patch pipettes were pulled with a P97 Micropipette Puller
(Sutter Instruments) to yield a resistance of 1-1.5 MΩ when filled with 120 mM K
gluconate, 4 mM NaCl, 5 mM KOH-buffered HEPES, 5 mM KOH-buffered EDTA, 15
mM glucose, 1 mM MgSO4, 3 mM Mg-ATP, 0.1 mM Na2-GTP at pH 7.2. Pipette
approach to cell was visualized using a 60X water immersion lens and infrared
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illumination with differential interference contrast. Following tight seal formation and
break-in to achieve whole-cell access, voltage clamp depolarization steps were used to
confirm presence of large inward sodium current and a hyperpolarizing voltage step used
to measure capacitive current transients before switching to current clamp mode.
All INa recordings in isolated cardiomyocytes were conducted in whole-cell
configuration at 25°C or 30°C by collaborator Xianming Lin (NYU Langone Medical
Center). Recording pipettes were filled with a solution containing (in mM): NaCl 5, CsF
135, EGTA 10, MgATP 5, HEPES 15, pH 7.2 with CsOH. Cells were maintained in a
solution containing (in mM): NaCl 5, CsCl 112.5, tetraethylamine(TEA)Cl 20, CdCl2 0.1,
MgCl2 1, CaCl2, 1, HEPES 20, Glucose 11, pH 7.4 with CsOH.
2.10.1 I-Clamp Protocols
Steadily applied negative current was used to set the amplifier-measured voltage
to -85 mV, which was equal to -95 mV membrane potential due to a 10 mV junctional
potential between pipette and bath solutions. Excitability was assessed in current clamp
by applying 200 millisecond injection sweeps of continuous current ranging from 0 pA to
480 pA in 40 pA steps. Membrane voltage recordings were high-pass filtered at 10 kHz
and digitally acquired at 50 kHz. After data acquisition, the bath temperature was ramped
to 40°C over a 3-5 minute time span, and excitability was retested with the same
protocol. Only cells for which input resistance deviated less than 20% during temperature
ramp were included in analysis.
2.10.2 V-Clamp Protocols for Sodium Current
Voltage clamp sodium current recordings of cardiomyocytes were performed by
Xiangmin Lin (NYU Langone Medical Center). To determine the peak current voltage
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relation, 200 msec voltage pulses were applied to Vm -90 mV to +30 mV in 5 mV
voltage steps, from a holding potential of Vm = - 120 mV. Interval between voltage steps
was 3 sec. Steady state inactivation was determined by stepping Vm to conditioning
voltages of between -130 mV to -20 mV for 60 msec, followed by a 30 msec test pulse to
Vm = -20 mV to elicit INa. Voltage ramp protocol: As a measure of closed state channel
inactivation rate, a 10-sweep protocol used ︎-120 mV hold command followed by
depolarization to ︎-30 mV either instantaneously (voltage step) or as a ramp ranging in
time from 2ms (= 45mV ms︎-1) to 18ms (= 5mV ms︎-1).
After recording at 25°C, temperature was ramped to 30°C and some recordings
were attempted up to 35°C. At elevated temperatures, the cell was first tested as above to
ensure maintenance of tight clamp, after which the voltage ramp protocol was conducted.
The voltage-clamp recordings in cardiomyocytes were not successful at 40°C.

2.11 Isolation of Dorsal Root Ganglion Sensory Neurons
DRG Isolation: All DRG sensory neurons were harvested from 8-12 weeks old
mice following IACUC approved protocols. Mice were anesthetized using isoflurane
prior to decapitation and dissection. Whole spinal column was excised, and muscle and
connective tissue removed. Under a dissection scope and submerged in HBSS, the ventral
base of the spine was removed with two parallel long axial incisions. Spinal cord was
carefully removed while cutting nerve roots leaving behind exposed and accessible
DRGs. DRGs were individually harvested with fine forceps. All associated nerve roots
and meninges were removed. Prepared DRGs were pooled together and suspended in
HBSS in one well of a 12-well culture plate.
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DRG Sensory Neuron Dissociation: DRGs were treated with a digestion medium
consisting of 1.5 mg DNase I, 0.25 mg Collagenase and 1% Trypsin in 1.5 mL HBSS and
incubated at 37°C for 30 minutes. Digestion medium was then replaced with a trituration
medium consisting of a 6:1 mixture of 10% FBS in DMEM to DNase I stock solution
(1.5 mg/ml). Individual sensory neurons were dissociated via trituration with firepolished Pasteur pipettes. Cell suspension was centrifuged at 4°C and 700 rpm for 2
mins. Pellet was washed and resuspended three times in 10% FBS in DMEM to remove
myelin and debris. Dissociated cells were plated on 1 cm glass coverslips coated with
poly-d-lysine and laminin in 24-well cell culture. Cells were maintained with 10% FBS in
DMEM in a 37°C, 5% CO2 cell culture incubator. For long-term cultures of 7 to 10 days,
non-neuronal cell growth was suppressed by treating with 10 µM each of
Arabinocytosine and Deoxycytidine.

2.12 Electrophysiological Recordings of Isolated Dorsal Root Ganglion
Sensory Neurons
2.12.1 V-Clamp Protocols: To isolate sodium currents, cells were placed in the
recording chamber and perfused with carbogen-bubbled bath solution consisting of (final
concentrations): 24 mM NaCl, 3mM KCl, 3 mM CsCl, 26 mM NaHCO3, 50 mM Choline
Cl, 11 mM Glucose, 25 mM TEA-Cl, 2 mM Na Pyruvate, 3 mM Myoinositol, 10 mM
HEPES, 5 mM 4-aminopyridine, 2 mM MgCl2, 1 mM BaCl2, 1 mM CaCl2 and 0.2 mM
CdCl2 at pH 7.2. Patch pipettes were pulled with a P97 Micropipette Puller (Sutter
Instruments) to yield a resistance of 1-1.5 MΩ when filled with 120 mM K gluconate, 4
mM NaCl, 5 mM KOH-buffered HEPES, 5 mM KOH-buffered EDTA, 15 mM glucose,
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1 mM MgSO4, 3 mM Mg-ATP, 0.1 mM Na2-GTP at pH 7.2. All optical, recording,
temperature control equipment and approach was the same as described in section 2.10.
Steady-state channel inactivation protocol: To determine the voltage dependence
of steady state channel inactivation, a 19-sweep protocol used a︎ -120 mV holding
command, a 60 ms variable test voltage step (-120 + 5(n ︎-1) mV), followed by a ︎ 25 mV
reporting pulse.
Steady-state channel inactivation protocol with TTX: To determine the voltage
dependence of steady state channel inactivation of TTX-resistant Nav, 0.5 µM TTX was
added to the extracellular buffer and a 19-sweep protocol used a︎ -70 mV holding
command, a 60 ms variable test voltage step (-70 + 5(n ︎-1) mV), followed by a 25 mV
reporting pulse.
2.12.2 I-Clamp Protocols: Cells were placed in the recording chamber and
perfused with carbogen-bubbled bath solution consisting of (final concentrations): 115
mM NaCl, 26 mM NaHCO3, 3mM KCl, 1.2mM KH2PO4, 3mM glucose, 2mM
myoinositol, 2mM Na pyruvate, 7mM HEPES, 1.2mM Mg2SO4, 2mM CaCl2, 0.2mM
CdCl2 at pH7.2. Patch pipettes were pulled with a P97 Micropipette Puller (Sutter
Instruments) to yield a resistance of 1-1.5 MΩ when filled with 120 mM K gluconate, 4
mM NaCl, 5 mM KOH-buffered HEPES, 5 mM KOH-buffered EDTA, 15 mM glucose,
1 mM MgSO4, 3 mM Mg-ATP, 0.1 mM Na2-GTP at pH 7.2. All optical, recording,
temperature control equipment and approach was the same as described in section 2.10.
Current induced action-potential protocol: Excitability was assessed in current
clamp by applying 200 millisecond injection sweeps of continuous current ranging from
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0 pA to 480 pA in 25 pA steps. Membrane voltage recordings were high-pass filtered at
10 kHz and digitally acquired at 50 kHz.
Heat induced action-potential protocol: To test heat induced excitability, cells
were patched in current clamp configuration and passively recorded from while the
extracellular solution was gradually heated from 30°C to 45°C over approximately three
minutes and back to start temperature.

2.13 Electrophysiological Recordings of Sodium Currents with Epilepsy
Inducing FHF2A Mutants in Neuro2A Cells
All buffers, optical, recording, temperature control equipment and approach were
the same as described in section 2.8.

2.13.1 V-Clamp Protocols
Steady-state channel inactivation protocol: To determine the voltage dependence
of steady state channel inactivation, a 19-sweep protocol used a︎ -120 mV holding
command, a 60 ms variable test voltage step (-120 + 5(n -1) mV), followed by a -25 mV
reporting pulse.
Long-term inactivation protocol: To determine the percentage of channels that
entered the LTI state, patched cells were depolarized to 0 mV for four 16 msec intervals
separated by 40 msec recovery periods at -90 mV to allow for sodium channel recovery
from fast inactivation.
Recovery from LTI protocol: To assess the duration channels that entered LTI
remained in that state, A 20-sweep protocol was used where three rapid depolarization
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steps holding from -90 mV to 0 mV were used (two for 20 ms and one for 10 ms) with 10
ms intervals was used to induce LTI followed by a recovery period that increased with
each sweep (20 ms ´ n) for rapid recovery and (100 ms ´ n) for slower recovery.

2.14 Statistical Analysis
2.14.1 Statistical Analysis of Numerical Data
All calculated values for electrophysiological data, Von Frey hair and paw pinch
assays are expressed as mean ± SEM. Statistical significance between experimental and
control groups was calculated using two-tailed unpaired Student’s t-test.
2.14.2 Statistical Analysis of Observed Phenotypic Data
All phenotypic events including heat sensitivity assessed in vivo via infrared tailflick assay and heat-induced neuronal excitability while whole-cell patch clamp
recordings were scored as occurring or absent and experimental groups were compared
using a 2´2 contingency table Chi-square test.
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Chapter 3: Derivation of Transgenic Fhf2 Mouse Lines
3.1 Derivation of Fhf2Targeted Mice
The original goal of this project was to determine what physiological functions
are dependent upon proper FHF2 function. One of the best methods for determining
physiological functions of a protein is to remove the protein and observe any phenotypic
deficits, and then to design experiments that will hopefully explain how the absence of
that protein is causing the phenotype. There are a number of approaches that allow for
blocking or down regulating protein expression, but the most thorough approach is to
generate a knockout organism which by definition is completely devoid of the expression
of the protein of interest. Since FHF1 and FHF4 have been studied via generation of
knockout mouse lines (Goldfarb et al., 2007) we believed it possible to thoroughly study
FHF2 through the same means.
Prior to my joining the lab there were many failed attempts to target the FHF2
gene, but fortunately upon my arrival a murine embryonic stem cell line bearing a
“knockout first with conditional potential” cassette integrated into the Fhf2 locus located
at chromosome Xq26 (International Mouse Phenotype Consortium, clone
EPD0339_4_F09) became publicly available. Using these cells and the skills of our
collaborator Dr. Kevin Kelley, we derived chimeric mice by injecting these targeted cells
into fertilized blastocysts of C57Bl/6 mice which have a black coat. The resulting
chimeras, detected by agouti coat color, were then bred with wild-type C57Bl/6 mice to
establish viable mice carrying the targeted (Fhf2targeted) allele, which is schematized in
Figure 5A. This mouse line was verified via PCR genotyping using primers that would
verify both the presence of the targeted allele cassette and its proper location in the
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genome (Fig 5A) and western blot analysis showed that the Fhf2targeted line gives
hypomorphic expression of FHF2 (Fig 6A).

Figure 5: Generation of mice carrying Fhf2targeted, Fhf2KO, and Fhf2flox alleles. A) ES
cells carrying X-linked Fhf2Targeted allele were used to derive mice. Dotted lines show
major splicing event, while dashed line shows native splicing around cassette responsible
for low residual FHF2 expression. Cre plasmid injection established germline FHF2KO
allele, while mating with ROSA-FLPo mice generated FHF2flox conditional allele. This
allows for future crossing with any Cre driver mice will induce FHF2 exon 3 excision in
tissue or cell-type specific subclasses. B) Schematic of Fhf2WT and Fhf2KO alleles. The
Fhf2KO allele differs from the Fhf2WT allele by the replacement of a 570-base genomic
segment spanning coding exon 3 with a cassette containing splice acceptor site, internal
ribosome entry site, a β-galactosidase coding sequence, and residual loxP site. Positions
and orientations of three PCR primers are indicated (blue arrowheads). C) PCR
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genotyping of Fhf2WT and Fhf2KO alleles. Simultaneous amplification of wild-type 350 bp
and mutant 430 bp allelic segments were resolved on agarose gel.

3.2 Derivation of Fhf2KO Mice
Given the construct of the targeting cassette, pronuclear injection of Cre
recombinase-expressing plasmid into fertilized eggs of Fhf2targeted lineage would yield
progeny bearing Cre-mediated excision of Fhf2 coding exon 3 (Fig. 5A,B) which
specifies an integral portion of the FHF β-trefoil fold shared by all FHF2 isoforms (Goetz
et al., 2009) thus creating mice carrying an Fhf2 knockout (KO) allele (Fig. 5A) allowing
the derivation Fhf2KO mice which could be screened and validated if viable and fertile.
One round of pronuclear injections of Cre recombinase-expressing plasmid into
Fhf2targeted fertilized eggs (performed at Mt. Sinai Mouse Genetics Core Facility) resulted
in five live female mice, two of which were carrying an Fhf2KO allele as verified by PCR
genotyping (Fig. 5C). Both of these founder females proved viable and fertile and
produced many heterozygous Fhf2KO females. However, the first Fhf2KO males and the
first homozygous Fhf2KO females were not derived until the line was backcrossed onto
the 129S2 strain, suggesting poor viability of Fhf2KO on the C57Bl/6 background.
Following successful generation of a stable mouse line carrying the Fhf2KO allele,
we then wanted to ensure that the knockout allele did indeed result in the absence of the
protein as expected. We probed brain lysates from wild-type, Fhf2Targeted/Y hypomorph,
and Fhf2KO mice by immunoblot using affinity-purified polyclonal antibodies against the
FHF2 carboxyl terminus (anti-FHF2-CT) that detects all FHF2 isoforms. The
immunoblot showed a series of species between 21 kDa to 32 kDa in wild-type brain
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likely reflecting smaller FHF2B and larger FHF2A isoforms (Fig. 6A). All of these
bands are reduced in intensity in the hypomorph brain, while most all of these bands are
undetectable in the Fhf2KO brain (Fig 6A). The same lysates were also probed with antipan-Nav that detects all voltage-gated sodium channels and showed that sodium channel
levels are unaffected by Fhf2 mutation (Fig. 6A). We also probed FHF2 expression by
immunofluorescence in CA1 hippocampus, co-staining for Ankyrin-G, which detects
axon initial segments. . In wild-type hippocampus, all Ankyrin-G labeled axon initial
segments also co-labeled for FHF2 (Fig. 6B-D). In heterozygous Fhf2+/null hippocampus,
there is a clear mosaic pattern as a result of random X chromosome inactivation so that
about half of the AnkG-positive axon initial segments are negative for FHF2 (Fig. 6E-G).

Figure 6: Validation of FHF2 targeted alleles. A) Immunoblots of whole brain lysates
prepared from Fhf2+/Y (WT), Fhf2Targeted (Hypo), and Fhf2null/Y (Null) males. FHF2
antibody detects a series of isoforms in WT that are weaker in hypomorph and absent in
null. * Nonspecific weak band. B-G) Immunofluorescence double labeling of
hippocampal CA1 neurons with FHF2 and AnkG antibodies. All axon initial segments of
pyramidal neurons are FHF2-positive in WT males (B-D), while mosaic expression is
seen in the heterozygous Fhf2+/null female.
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3.3 Derivation of Fhf2Con Mice
We have used mice carrying the Fhf2targeted allele to derive a loxP-flanked
(floxed) conditional allele Fhf2con. The scheme involves Flp recombinase-mediated
excision of the FRT-flanked splice acceptor-IRES-lacZ cassette inserted during original
gene targeting (Fig 5A). The Fhf2con mouse can be mated with any Cre driver allowing
for the generation of temporal and/or tissue-specific Fhf2 knockout. One application of
Fhf2con mice will be described in Chapter 5.
To generate the Fhf2con mouse line, we mated Fhf2targeted mice to transgenic mice
expressing Flp recombinase at the fertilized egg stage (Gt(ROSA)26Sor tm2(FLP*)Sor).
This removed the majority of the targeting construct, which was flanked by FRT sites,
leaving behind only the loxP sites that allow for excision of the vital exon 3 and thus a
knockout of the protein via Cre recombinase (Fig 5A). We confirmed the generation of
these mice via PCR genotyping and have shown by immunoblotting and
immunofluorescence that FHF2 is expressed at wild-type levels (Fig 10E).
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Chapter 4: Absence of FHF2 Causes Temperature-Sensitive Cardiac
Conduction Failure
Abstract from: Park DS*, Shekhar A*, Marra C*, Lin X, Vasquez C, Solinas S, Kelley K,
Morley G, Goldfarb M, Fishman GI. (2016) Fhf2 gene deletion causes temperature-sensitive
cardiac conduction failure. Nature Communications 7, 12966 (* Equally Contributing CoPrimary Authors)

Fever is a highly conserved systemic response to infection (Evans, Repasky, &
Fisher, 2015). Although conferring a survival benefit, fever can negatively impact the
function of excitable tissues, such as the heart and brain, producing cardiac arrhythmias
(Amin, Meregalli, Bardai, Wilde, & Tan, 2008) and febrile seizures (Escayg et al., 2000).
Here we describe fibroblast growth factor homologous factor 2 (FHF2, also termed
FGF13) as a key regulator of myocardial excitability, protecting the heart against
conduction failure under hyperthermic conditions. Mice lacking FHF2 had normal
cardiac rhythm at baseline but increasing core body temperature by as little as 3°C caused
coved-type ST elevations and progressive conduction failure that was fully reversible
upon return to normothermia. Isolated hearts from mutant mice demonstrated the same
temperature-dependent phenotype. Optical mapping revealed severe conduction slowing
in mutant hearts at 37°C that was further exacerbated by temperature elevation. FHF2deficient cardiomyocytes could generate action potentials upon current injection at 25°C
but were unexcitable at 40°C. Absence of FHF2 accelerated the rate of closed-state and
open-state sodium channel inactivation, which synergized with temperature-dependent
enhancement of inactivation rate to severely suppress cardiac sodium currents at elevated
temperatures. Computational modeling supported altered sodium channel inactivation
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kinetics as the mechanism for temperature-sensitive excitation block. Our results identify
an essential role for FHF2 in dictating myocardial excitability and conduction that
safeguards against temperature-sensitive conduction failure, findings that have significant
implications for febrile-onset Brugada syndrome.

Introduction
I was a co-primary author in the paper by Park et al (2016), which is included in
its entirety (Appendix 1) and will be referenced throughout this chapter in the description
and discussion of data collected by collaborators. The cardiac phenotype described in this
paper is being presented first because the findings from this investigation informed a
parallel independent study on nociception, which will be detailed in Chapter 5.
Heart diseases are the leading cause of death worldwide (Olvera Lopez & Jan,
2019), and include ischemic attacks, heart failure, and cardiac arrhythmias. Arrhythmias
are a collection of electrical abnormalities wherein the spatiotemporal propagation of the
cardiac action potential is abnormal. Some arrhythmias are the result of altered
abundance or function of Nav1.5, the primary Nav isoform expressed in the heart (Q.
Wang et al., 1996). Therefore, a better understanding of any Nav1.5 modulator and how
that modulation relates to function could give invaluable insights into how to potentially
deal with certain types of arrhythmias. FHF2 is the most abundantly expressed FHF in
the murine heart (Hartung et al., 1997), but unveiling its true role in cardiac function has
remained elusive. Due to the previous unavailability of an FHF2 knockout mouse all
research has relied on model cell lines and silencing RNA experiments.
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Given the limitations of previous work in the field, we wished to probe for a
potential cardiac phenotype driven by the absence of FHF2 as soon as Fhf2KO mice could
be derived. It has been well established by our lab and a number of others that FHFs bind
directly to Navs and modulate their gating (Dover et al., 2010; Goetz et al., 2009; C. Liu,
Dib-Hajj, & Waxman, 2001; C. J. Liu et al., 2003; Lou et al., 2005; Rush et al., 2006).
We believed that using our Fhf2KO mouse was an open and obvious avenue to investigate
how this relationship contributes to cardiac function.

4.1 The Absence of FHF2 Results in a Temperature Sensitive Cardiac
Conduction Failure
In order to probe for a potential cardiac phenotype, Fhf2KO mice generated in
Chapter 3 were provided to Dr. Glenn Fishman’s lab at NYU for in vivo conduction and
FHF2 in situ expression analysis. Their findings are detailed in sections 4.1.1 to 4.1.4 of
this chapter.

4.1.1 Fhf2KO Mice Have Temperature-Induced Cardiac Conduction Block
The unmasking of the Fhf2KO phenotype resulted when the mice were challenged
during ECG by increasing internal body temperatures to fever-like hyperthermic levels
using at external heat source. While normal wild-type mice maintained normal cardiac
function according to ECG recordings during temperature ramp from 37ºC to 43ºC, the
Fhf2KO mice did not tolerate the elevated temperatures. As core body temperature
increased ECGs showed progressive P and QRS wave prolongation indicative of slowed
conduction and eventual complete conduction block (Fig. 7A, Appendix 1 Fig. 2A) that
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results in death if sustained. Above 40°C, all mutant mice developed coved-type ST
elevations with T wave inversions, reminiscent of the Brugada pattern ECG. Surprisingly,
if the temperature challenged Fhf2KO mice are quickly cooled back to their baseline core
temperature of 37ºC before conduction block causes death, all ECG parameters return to
that of original baseline recordings (Fig. 7A, Appendix 1 Fig. 2A). This is a novel FHFassociated phenotype that is purely a rapidly reversible temperature dependent cardiac
conduction deficit.

4.1.2 Hearts & Cardiomyocytes of Fhf2KO Mice are Structurally Normal
FHF2 has been previously reported to influence cell structure and motility
through its binding to tubulin (Wu et al., 2012). This made it imperative to probe the
structure and organization of the heart and cardiomyocytes of Fhf2KO mice for physical
defects or irregularities.
The targeting vector used to make the FHF2KO allele had an inserted IRES-lacZ.
Hearts taken from these mice could be X-gal stained and whole-mounted for imaging to
detect locus expression. Fhf2 gene expression was detected in atria, ventricles, and the
His-Purkinje system. These results corroborate previous research (Hartung et al., 1997)
and also showed that there are no gross physical abnormalities present in the overall
structure of the Fhf2KO hearts (Appendix 1 Fig. 1A). Immunofluorescence experiments
of Fhf2KO to wild-type dissociated cardiomyocytes were performed to compare
macromolecular organization and abundance. Resulting images showed that FHF2 and
Nav1.5 colocalized to striated T-tubules in wild-type cardiomyocytes. There was no
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noticeable difference in Nav1.5 subcellular localization in the absence of FHF2 when
compared to wild-type cardiomyocytes (Appendix 1 Fig. 1D).

4.1.3 Temperature Sensitive Fhf2KO Phenotype is Heart Autonomous
FHF2 is expressed in tissues outside of the heart, including the central and
peripheral nervous systems. This leaves open the possibility that the observed Fhf2KO
cardiac phenotype results from functional disruption outside of the heart that, in turn,
impacts heart rhythm. For example, impairment in the autonomic nervous system may
result in erroneous neuronal input signals to the heart that secondarily cause cardiac
dysfunction. To exclude this possibility, heart rhythm was monitored ex vivo in isolated
Langendorff-perfused whole hearts. Isolated Fhf2KO hearts were shown to display the
same hyperthermia-induced ECG irregularities as had been seen in vivo (Appendix 1 Fig.
2E).

4.1.4 Flecainide Sensitivity and Slowed Cardiac Conduction Implicates Nav
Dysfunction in the Fhf2KO Heart.
The first evidence implicating Nav involvement in the observed phenotype was
obtained when our collaborators at NYU performed an ECG experiment challenging the
mice with flecainide. Flecainide, being a Nav1.5 blocker, decreases cardiomyocyte
excitability by decreasing Nav1.5 availability. At equal dose treatments of flecainide at
37ºC Fhf2KO mice showed significantly prolonged QRS waveform as compared to wildtype (Fig. 7B, Appendix 1 Fig. 2C). Optical mapping experiments on Langendorff hearts
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perfused with a voltage-sensitive dye also showed that Fhf2KO hearts exhibited markedly
slower epicardial conduction velocity compared to wild-type (Appendix 1 Fig. 2F).
This flecainide hypersensitivity suggests a baseline decrease of Nav availability in
the Fhf2KO myocardium versus wild-type. Slowed conduction velocity in Fhf2KO hearts
also suggests that there may be a reduction in overall Nav conductance. Impaired Nav
current generation has been shown to result in slowed cardiac conduction velocity (King,
Huang, & Fraser, 2013). We believe this is the case in our Fhf2KO mice and hypothesize
that impaired sodium current generation is due to a baseline decrease in Nav availability
in the absence of FHF2.

4.1.5 Fhf2KO Cardiomyocytes Fail to Fire Action Potentials at Elevated
Temperatures
To determine if the absence of FHF2 could affect cellular excitability, whole-cell
patch clamp experiments were performed on individual dissociated ventricular
cardiomyocytes obtained from wild-type and Fhf2KO mice. Once patched in current
clamp, the ability of these cells to generate action potentials was tested by 200ms
depolarizing current injections from 0-480 pA in 40 pA steps at both 25ºC and 40ºC.
We found that both wild-type and Fhf2KO cardiomyocytes readily fired action
potentials at 25ºC (Fig. 7C) with no change in Nav current density or spike threshold
(Appendix I Fig. 3D, Supplementary Fig. 4A, Supplementary Table 4), but Fhf2KO
cardiomyocytes showed a reduced spike amplitude at 25ºC and completely failed to
generate action potentials at 40ºC while wild-type cardiomyocytes still readily generated
action potentials albeit with diminished waveforms (Fig. 7C).
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These results indicate that the temperature dependent cardiac conduction defects
displayed in Fhf2KO mice are at least partially attributed to the decreased excitability at
the level of the individual cardiomyocytes. Taken together with the previous results
showing flecainide sensitivity and slowed conduction velocity despite a lack of any
physical abnormalities, it implies that the phenotype is being caused by dysfunctional
Nav1.5 gating in the absence of FHF2.

Figure 7: Fhf2KO induced temperature-dependent excitation failure. A,
Representative surface ECG traces of adult (8–12 wk) Fhf2WT/Y and Fhf2KO/Y mice
subjected to hyperthermia-induction protocol. External heat lamp was used to raise core
body temperature from 37 to 43°C followed by cooling to 37°C (1°C per min). Fhf2KO/Y
ECG parameters were similar to Fhf2WT/Y animals at 37°C (n = 10) but were significantly
prolonged in mutant mice at elevated temperatures (³40°C) (n = 9 mutants and 7
controls). Coved-type ST elevations and high degree AV block with periods of
ventricular asystole were noted in Fhf2KO/Y mice above 40 °C. Fhf2WT/Y mice did not
exhibit altered ECG parameters at any temperature (37–43°C). Data obtained by
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Shekhar, Park, and Fishman. B, Flecainide challenge was performed in adult (8–12
weeks old) Fhf2WT/Y and Fhf2KO/Y mice (n = 5). Representative surface ECG traces five
minutes after administration of flecainide (15 mg/kg) demonstrates significantly
prolonged ECG parameters in Fhf2KO/Y compared with Fhf2WT/Y mice at 37°C (upper
panels). Representative surface ECG traces 15 min after administration of flecainide (15
mg/kg) in Fhf2KO/Y showing progressive heart block (middle panel). Representative
surface ECG traces of flecainide treated (30 mg/kg) Fhf2WT/Y mice (n = 5) at 37°C and
43°C (lower panel). Fhf2WT/Y mice treated with flecainide did not exhibit any further
prolongation of conduction parameters with elevated temperature (37–43 °C). Data
obtained by Shekhar, Park, and Fishman. C, Ventricular cardiomyocyte excitability.
Superimposed voltage traces of representative patched Fhf2WT/Y and Fhf2KO/Y
cardiomyocytes injected with depolarizing current (0–480 pA in 40 pA steps) at 25°C and
in the same cells after raising temperature to 40 °C. All tested Fhf2KO/Y cells were
inexcitable at 40°C. Data obtained by C. Marra.

4.2 Hyperthermic Cardiac Conduction Failure in Fhf2KO Mice Altered
Inactivation Gating of Cardiac Sodium Channels

4.2.1 Absence of FHF2 Causes Hyperpolarized Shift in Voltage Dependence of
Nav1.5 Steady-State Inactivation
We believed the temperature dependent Fhf2KO cardiac conduction failure
phenotype is a result of loss of cellular excitability due to altered Nav1.5 inactivation
gating in the absence of FHF2. To study how FHF2 could affect Nav1.5 inactivation, we
used human embryonic kidney (HEK) cells transiently transfected to expressed Nav1.5
with or without FHF2VY, which is the most highly expressed FHF2 isoform in the heart
(C. Wang, Hennessey, et al., 2011).
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To test the effect of FHF2 on steady-state voltage dependent Nav1.5 inactivation,
a 19-sweep protocol was used with a holding voltage of -120 mV followed by a 60 ms
variable conditioning test voltage step that increased by 5 mV with each sweep (-120 mV
+ 5(n+1)) then depolarized to a -25 mV reporting pulse. By starting at such a negative
voltage with the first sweep, we can assume all Nav1.5 to be available, allowing us to
identify the maximum possible current generated by the cell. Each current reported from
the following sweeps can be normalized to this maximum current thus deriving the
percentage of channels available at any given voltage. Steady-state voltage dependent
Nav1.5 inactivation at 25°C occurred at a more hyperpolarized potential when FHF2VY
was not present with a V½ = -93.5±0.9 mV (n = 9) in the absence of FHF2 and a V½ = 82.2±1.6 mV (n = 7) in the presence of FHF2VY (P<0.0002, Student’s t-test) (Fig. 8A).
A very similar V½ shift was observed when this experiment was perform using wild-type
versus Fhf2KO derived ventricular cardiomyocytes (Appendix I Fig 3C)
This result indicates that at any given voltage there are less Nav1.5 channels
available when FHF2 is not present. This includes at resting membrane potential. At rest,
an Fhf2KO cardiomyocyte would have a greater percentage of its Nav1.5 population
residing in an inactive state as compared to its wild-type counterpart. This would leave
fewer channels available to open and generate current upon stimulation.
Steady state inactivation reflects the equilibrium between closed and inactivated
channel states. While temperature will affect the rate of channel inactivation (see below)
and recovery, the equilibrium between these states, reflected in V1/2 inactivation, should
be relatively independent of temperature. While we did not systematically measure V1/2
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inactivation at a range of temperatures, some cells were assayed at 25oC and 35oC and
showed virtually indistinguishable V1/2 inactivation (data not shown). Hence, the
observed effect of FHF2VY on steady state Nav1.5 inactivation at 25oC is likely to be
paralleled at physiologically relevant temperatures.

4.2.2 Absence of FHF2 and Elevated Temperatures Accelerate Nav1.5 Open and
Closed-State Inactivation
Action potentials in cardiomyocytes are initiated by depolarizing currents resulting
from positive ion flux from adjacent cells via gap junctions. While this voltage ramp rate
is fast, it is not instantaneous. Therefore, it is important to examine whether FHF2 alters
the rate of closed state inactivation as a function of depolarization rate. As in the
previous experiment, HEK cells were co-transfected to transiently express Nav1.5 with or
without FHF2VY. In an attempt to replicate in situ events, we employed a voltage ramp
protocol utilizing a range of depolarization rates to study Nav1.5 closed-state inactivation
at various temperatures. Relative sodium channel closed-state inactivation rates and how
it translates to percentage of channel availability could be approximated by dividing peak
sodium conductance generated by each voltage ramp by the conductance generated by an
instantaneous voltage step.
The longer ramp duration, i.e. slower rate of depolarization, the greater reduction
in peak conductance is observed under all conditions due in part to increased closed-state
inactivation. Interestingly, the absence of FHF2VY and an increase in temperature both
independently decreased channel availability at any given rate of depolarization by
increasing the rate of closed-state inactivation (Fig. 8C, Fig. 9). These independent
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effects compounded upon one another with the most dramatic results being seen at high
temperatures in the absence of FHF2VY. Most notably, even a 45 mV/msec voltage ramp
at 40°C caused a greater than 50% reduction in Nav1.5 peak conductance in the absence
of FHF2, while more than 80% of channels remained available under these conditions in
the presence of FHF2VY. The same experiment performed on wild-type and Fhf2KO
dissociated ventricular cardiomyocytes gave similar results (Appendix I Fig. 3E), but
patched HEK cells more easily survived temperature ramping than did cardiomyocytes
allowing assessment of Nav1.5 inactivation parameters at 25°C, 35°C, and 40°C often
within the same cell.
Open state inactivation rate can also be a determinant of cellular excitability,
since this parameter determines the total transient sodium flux. The rate of Nav1.5 openstate inactivation at all temperatures (tNav inactivation) was assessed by calculating transient
sodium current decay by fitting a two-term exponential decay function from 90% peak to
baseline. In HEK cells with good voltage clamp, virtually all of the Nav1.5 sodium
current decay fit to the fast time constant. However, due to unusual cell shapes of some
HEK cells, it was not uncommon for the Nav1.5 current to have a more substantial slow
decaying component. We discarded from analysis any recordings in which the fastdecaying sodium current fraction was less than 75% of the total current. The absence of
FHF2VY and elevating temperature each accelerated the rate of Nav1.5 open-state
inactivation on their own. The absence of FHF2 and elevated temperature combined to
produce the fastest rate of open-state inactivation (Fig. 8B). A very similar result was
acquired when this experiment was perform using wild-type versus Fhf2KO derived
ventricular cardiomyocytes (Appendix I Fig 3G).
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These results allows us to conclude that there is decreased sodium conductance in
the absence of FHF2 as the result of less Nav1.5 availability at any given voltage due to
the hyperpolarizing shift in Nav1.5 steady-state inactivation and an acceleration of the
rate of Nav1.5 open and closed-state inactivation further decreasing Nav1.5 availability.
Separately, there is an additional intrinsic acceleration of Nav1.5 inactivation at elevated
temperatures independent of FHF2.
The reduced excitability that we have observed in Fhf2KO cardiomyocytes is likely
being driven by decreased steady-state availability of Nav1.5 at rest and faster rate of both
open and closed-state inactivation of Nav1.5 in the absence of FHF2. Furthermore, this is
compounded with and exacerbated by the natural intrinsic acceleration of Nav1.5
inactivation that occurs at elevated temperatures. This enhances Nav1.5 inactivation to
such an extent that it results in under-excitability driven dysfunction.
.
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Figure 8: Altered sodium channel gating in the absence of FHF2 in transiently
transfected HEK cells. A, Nav1.5 steady-state inactivation ± FHF2VY. Nav1.5
availability at 25°C after 60 ms conditioning voltage at -120 to -50 mV. Absence of
FHF2VY results in a hyperpolarized shift in Nav1.5 steady-state inactivation. Vertical
dashed lines indicate Nav1.5 V1/2 ± FHF2VY. B, NaV1.5 open-state inactivation. Fast t
for NaV1.5 current decay was measured in cells ± FHF2VY at 25, 35 and 40°C. Elevated
temperature and absence of FHF2VY each accelerate NaV1.5 open-state inactivation. C,
Voltage ramp NaV1.5 ± FHF2VY. HEK cells transfected with NaV1.5 ± FHF2VY
subjected to voltage ramps to -30 mV at different rates at 25, 35 and 40 °C. NaV1.5
closed-state inactivation is increased by slowed voltage ramp, temperature elevation and
the absence of FHF2VY. Data represent mean ± s.e.m. *significant P values (all P values
in Appendix I Supplementary Tables 4 and 5); ns, not significant; Student’s t-test. All
data derived by C. Marra.

- 66 -

4.4 Computational Modeling Verifies Accelerated Nav Inactivation
Causes the Observed Phenotype at Elevated Temperatures
To determine whether hyperthermic excitation failure could be driven solely by
the altered Nav1.5 inactivation gating unveiled in our experiments, we modified a
previously generated mouse ventricular cardiomyocyte computational model
(Bondarenko, Szigeti, Bett, Kim, & Rasmusson, 2004) to reflect the differential Nav1.5
gating properties in the presence and absence of FHF2 that we determined through our
whole-cell patch clamp experiments. This modeling was performed by S. Solinas and M.
Goldfarb. All parameters remained the same between our wild-type and Fhf2KO myocyte
models except the open- and closed-state inactivation rate constants of the embedded Nav
12-state Markov model. While the models were indistinguishable in terms of voltage
dependence of activation and peak current generation, the Fhf2KO model displayed all of
the inactivation shifts observed in our experiments and when combined with elevated
temperatures, led to the failure to generate an action potential (Appendix Fig. 4).
Furthermore, using this myocyte model to create a linear strand of cells connected by gap
junctions the Fhf2KO model displays decreased action potential conduction velocity as
well as conduction failure at elevated temperatures replicating the phenotype [Park et al.,
2020, manuscript submitted].
These computational results support the conclusion that altered Nav1.5
inactivation gating in the absence of FHF2 is sufficient to explain the observed Fhf2KO
temperature-sensitive cardiac phenotype.
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Figure 9: Representative traces of recorded HEK NaV1.5 conductance during voltage
ramp protocol. Cells were depolarized from -120 mV to -30 mV either instantaneously
(voltage step) or at different ramp speeds while NaV1.5 currents were recorded. The
voltage command for each ramp rate is shown color coded (top panel). Recorded currents
were converted to conductance offline. Middle panels correspond to a single cell
expressing NaV1.5 + FHF2VY recorded at 25°C, 35°C, and 40°C, while lower panels
correspond to a single cell expressing NaV1.5 without FHF2 recorded at all temperatures.
All data obtained by C. Marra.
Table 2: Recorded HEK NaV1.5 Parameters. Data represents mean ± s.e.m. Significant
P values, Student’s t-test, are shown for NaV1.5 parameter differences recorded in HEK
cells +/- FHF2VY expression.
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4.5 Summary
ECG experiments Fhf2KO mice showed a unique temperature sensitive, fully
reversible cardiac phenotype. This underscored the importance of investigating further
why the presence of FHF2 is necessary, especially under hyperthermic conditions. Since
the phenotype was independent of a neurological component, we focused on the heart
itself and eventually at the level of individual cardiomyocytes.
There were neither gross structural abnormalities nor apparent subcellular
organizational defects in Fhf2KO hearts and cardiomyocytes. Additionally, while there
have been reports that FHF2 could affect voltage-gated calcium currents through
junctophilin (Hennessey et al., 2013), we saw no effect in Cav density or gating in our
FHF2KO mice. This led us to investigate the excitability of Fhf2KO cardiomyocytes versus
wild-type. We found that Fhf2KO cardiomyocytes readily generate action potentials at
room temperature, but they fail to do so at 40°C while wild-type cardiomyocytes were
able to readily generate action potentials at the elevated temperature. We were then able
to determine that this loss of excitability was due to a decrease in Nav1.5 conductance in
the absence of FHF2. This is due to reduced Nav1.5 availability at resting membrane
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potential caused by a hyperpolarizing shift in Nav1.5 voltage-dependence of inactivation
and an acceleration of Nav1.5 inactivation in the absence of FHF2. This is exacerbated by
a separate intrinsic decrease in Nav1.5 conductance brought about by the kinetics of
temperature elevation itself which further accelerated the rate of Nav1.5 inactivation. The
combinatory result is that at elevated temperatures, without FHF2 delaying inactivation,
there are not enough available Nav1.5 to generate the current required to initiate and
propagate an action potential. The end result of this is the temperature-sensitive
conduction block that we discovered in our Fhf2KO mice.
Most of our Nav1.5 analysis was performed in transiently transfected HEK cells
devoid of Navb subunits which are expressed in the heart and modulate channel density
and gating (Bao et al., 2016). The rationale for using HEK cells despite their lack of Navb
was that they are more robust than cardiomyocytes and allowed for temperature
manipulations that were not possible while recording from cardiomyocytes. Our findings
using HEK cells show, however, the effect of FHF2 on Nav1.5 occurs independently of
other accessories including Navb subunits, as the absence FHF2 displays a similar effect
on Nav1.5 steady-state inactivation and inactivation rate and temperature dependence as
observed in FHF2KO cardiomyocytes. This suggests FHF2 modulation of Nav1.5 is both
independent of, and unsuppressed by the presence of Navb subunits. It should also be
noted that cardiomyocytes were successfully recorded at 25oC and 30oC, and the effects
of genotype and temperature were consistent with conclusions drawn from our HEK
recordings (Park et al., 2016).
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We were able to further validate these finding using an established computational
myocyte model. We showed computationally that the measured alterations of Nav
inactivation in the absence of FHF2 alone is enough to cause this temperature-sensitive
cardiac conduction failure phenotype.
Although we described the effect of temperature on Nav current deficit in FHF2KO
and wild-type mice, the elevated temperature increases the rate of Nav inactivation and
activation. However, this has at most a minor effect on sinus rhythm as shown through
the temperature challenged ECG recordings. The reason is that Nav activation is not the
determinant of rhythm. Heart rate is set by rate of depolarization at SA node to actionpotential threshold mediate by a balance of non-voltage-gated potassium and sodium
currents (Scicchitano et al., 2012) driven by conductances that may have less dependence
upon temperature.
The observed Fhf2KO phenotype closely resembles that of a subset of Brugada
Syndrome. While it is rare are to get total conduction block, a complicating feature which
we see in Fhf2KO mice is slowed conduction. When conduction is slowed it is slowed in
different directionality throughout the three dimensional ventricular myocardium. This
sets up possibility of reentrant currents which can lead to arrhythmia. In the human
ventricular myocardium FHF1 is dominantly expressed, not FHF2, and has been
suggested as potential Brugada syndrome locus (Hennessey et al., 2013). If these FHFs
cause the same modulation of Nav1.5, our FHF2KO mouse line may prove a useful tool in
studying how FHF impairment can contribute to arrythmias such as Brugada syndrome.
We hope that better understanding of the role this protein plays in this tissue and
under hyperthermic conditions will lead to information that helps explain what may be
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occurring at the cellular level in patients. Additionally, given the importance of fever as
an immune response to infection and how evolutionarily conserved that response is, we
may have unveiled a previously unknown evolutionary pressure promoting FHF
expression. This hyperthermal-protective effect may have rendered carrying these genes
beneficial and particularly necessary in endothermal organisms.
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Chapter 5: FHF2 Is Necessary for Heat Nociception and Hyperthermic
Conduction of Action-Potentials Through Dorsal Root Ganglion
Sensory Axons

FHF2 is expressed in peripheral sensory neurons (Goldfarb, 2005) and found to
colocalize with Nav throughout the distal axon of these neurons (Wittmack et al., 2004).
FHF2 axonal localization is novel for peripheral neurons. In the central nervous system
(CNS) neurons, FHF2 and other FHFs are expressed at the axon initial segment yet
absent throughout the distal portion of the axon (Dover et al., 2016). Therefore, we
suspected that FHF2 plays essential functions in peripheral axons and, consequently,
peripheral sensation. Possible sensory modalities requiring FHF2 could include
somatosensation and nociception. Among the various types of nociception, a painful
response to heat seemed a particularly intriguing sensation that might demand FHF
function, as heat induces a cardiac conduction deficit in Fhf2KO mice (Chapter 4).
Nociception is a subclass of somatosensation and is the ability of an organism to
sense and react to physically painful and potentially damaging stimuli which is vital to
ensure survival (Ramsey et al., 2006). The ion channel primarily responsible for detection
of noxious heat nociception is the transient receptor potential cation channel subfamily V
member 1 (TRPV1), which opens at or above 40-45ºC. Depolarization due to cation
influx through TRPV1 triggers activation of voltage-gated sodium channels and
generation of action potentials that can be transmitted as an electrical representation of
the heat stimulus (Dubin & Patapoutian, 2010). TRP channels can open in response to
mechanical stretch, such that heat nociceptive neurons are also mechanosensitive
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neurons. It is unknown what adaptations have been made in these specialized sensory
neurons that allow them to function unimpaired electrically when challenged at these
noxious temperatures. It has been shown however that unmyelinated CNS axons, which
appear to lack FHFs (Dover et al., 2016), experience action potential conduction failure
under hyperthermic conditions (Pekala, Szkudlarek, & Raastad, 2016). This has led us to
theorize that FHF2 might be present in on nociceptive peripheral axons specifically to
provide a thermo-protective function similar to what has been described in cardiac tissue.
To test this theory, we utilized our Fhf2KO and Fhf2Con mouse lines to determine if
FHF2 allowed for preservation of electrical function of heat nociceptive neurons by
determining if its absence led to dysfunction. Part of this project was conducted in
collaboration with Dr. Matthias Ringkamp and Dr. Timothy Harke from the Pain Institute
at Johns Hopkins University and their specific contribution is detailed in section 5.3.2 of
this chapter.
The final results of this investigation have been submitted for publication as a
Letter to Neuron – Cell Press, as our findings are at odds with a novel phenotypic
mechanism described in L. Yang et. al. (2017) FGF13 selectively regulates heat
nociception by interacting with Nav1.7. Neuron 93: 806-821. We believe there were
various discrepancies in their investigation and that our data suggests an alternative more
plausible mechanism which is both more convincing and supported by previous work in
the field from various labs. The pertinent differences between the two investigations and
why we believe our findings more accurately explain the role of FHF2 in noxious heat
sensation will be addressed in the summary section of this chapter.
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5.1 Fhf2KO Mice Have a Temperature Specific Nociceptive Deficit

5.1.1 Fhf2KO Mice Do Not Respond to Noxious Heat Stimulation
In order to determine if the absence of FHF2 caused any impairment in heat pain
sensation we assayed the latency of response time to a noxious heat stimulus of Fhf2KO
mice versus wild-type using a tail-flick apparatus [Ugo Basile Tail Flick 7360]. For this
test the mouse is positioned with the tip of its tail resting unrestrained on a disk, which
emits infrared radiant heat upon test initiation. . The mouse’s response to heat-induced
pain is to move its tail, which is recorded by a motion detector in the instrument. Wildtype mice responded to the heat stimulus in 3.0±0.3 seconds (n = 9) while Fhf2KO mice
were completely insensitive to the heat stimulus with none of these mice (n = 8)
responding when heated for 21 seconds (Fig. 10A). Therefore, FHF2 is necessary for
sensing noxious heat induced pain.

5.1.2 Fhf2KO Sensory Deficits are Temperature Specific
To determine if the observed heat nociceptive deficit in Fhf2KO mice is modalityspecific, we tested mutant mice for ability to sense temperature-independent stimuli.
Testing general somatosensation via Von Frey Filament assay resulted in high variability
within each group but the Fhf2KO mice did respond to the filaments indicating no ablation
of somatosensation (Fig. 10C). Fhf2KO mice were also assayed for mechanical
nociception via a paw pinch assay using a force-calibrated forceps pressure transducer
[Ahlborn – Almemo 2450] which allowed us—after conditioning—to determine exactly
how much pressure applied to the hind paw of a mouse elicited a pain induced
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withdrawal response. Paw pinch withdrawal threshold in wild-type mice was recorded as
198.0±26.3 g (n = 7), while the Fhf2KO paw pinch withdrawal threshold was 252.6±30.8 g
(n = 8) (P=0.21, Student’s t-test, no significant difference) (Fig. 10B).
From these results we conclude that since Fhf2KO mice do not have ablated
somatosensation and no significant impairment in their mechanonociception that their
sensory deficits are specifically temperature dependent. This suggests that FHF2 may be
playing a thermo-protective role and its presence is required in order to preserve function
under hyperthermic conditions as we hypothesized.

5.1.3 Inability to Respond to Noxious Heat is Due to a Failure Specifically at the
Level of the Peripheral Nervous System
There are various points throughout the sensory pathway where a disruption could
cause an absence of a response to a stimulus. Since all previous experiments were
performed on our full Fhf2KO line, we could not distinguish whether the sensory deficits
we were observing were a result of a dysfunction at the periphery during acquisition or if
it was due to a processing error occurring at the CNS level or possibly a combination of
both. In order to tease the components apart we took advantage of our Fhf2Con mouse line
by crossing Fhf2Con/+ females with a transgenic Advillin-Cre driver mice [JAX 032536] ,
which express Cre recombinase exclusively in the peripheral sensory neurons (Zhou,
Kamimura, Zhang, & Liu, 2010). This cross enabled us to generate Fhf2Con/Y:Adv-Cre
test mice and Fhf2+/Y:Adv-Cre negative control littermates. The efficiency of this tissuespecific ablation of FHF2 was verified via Western blot (Fig. 10D).
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We then re-ran the tail-flick assay on Fhf2Con/Y:Adv-Cre and control mice .
Fhf2Con/Y:Adv-Cre mice displayed the same phenotype as the Fhf2KO mice, failing show
any response to tail heating (Fig 10C). By contrast, Fhf2+/Y:Adv-Cre mice responded to
the heat stimulus in 3.2±0.5 seconds (n = 7), and Fhf2Con/Y mice responded in 3.0±0.4
seconds (n = 6) (Fig 10C). This result allowed us to conclude that FHF2 is required in
peripheral heat nociceptive neurons for responsiveness to heat.

5.1.4 Sensory Innervation is Unaltered in Fhf2KO Mice
While the tail-flick phenotype of Fhf2Con/Y:Adv-Cre mice showed a peripheral
sensory defect, we wanted to verify that Fhf2KO mice displayed normal cutaneous
innervation. It has been purported by one lab that FHF2 has a neural developmental role
including playing a part in neural migration (C. Wang et al., 2012), and if these mice
have severe innervation deficiencies it could help explain the phenotype.
To test this, tissue was harvested and cryosections made from footpads of either
wild-type or Fhf2KO mice. The sections were treated with an established neuronal marker:
an antibody detecting PGP9.5 (also referred to as UCHL1: ubiquitin carboxyl-terminal
hydrolase isozyme L1), which is highly expressed in, and diffused throughout neurons.
Immunodetection showed no obvious absence or downregulation of neuronal innervation
in the Fhf2KO tissue (Fig. 10E,F). This suggests that the sensory deficits observed in
Fhf2KO mice are not due to a developmental issue and, by default, must reflect a
physiological dysfunction in Fhf2KO nociceptive neurons.
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Figure 10: Fhf2KO Sensory Phenotype. A, Tail-Flick Assay. Wild-type mice responded
to the heat stimulus in 3.0±0.3 seconds (n = 9) while Fhf2KO mice were completely
insensitive to the heat stimulus (n = 8) (chi-square p < 0.0001). Nonresponsive test
duration was 21 seconds. B, Paw pinch withdrawal assay. No significant difference in
mechanonociception between Fhf2KO/Y (n = 8) and Fhf2WT/Y (n = 7) (p > 0.2). C, Von Frey
Filament Assay. Fhf2KO show mild latency, but no ablation of somatosensation. D, TailFlick Assay. Fhf2Con/Y: Adv-Cre mice display same nonresponsiveness to noxious heat
stimulus as Fhf2KO. E. Immunoblot validation of Fhf2 mutant mice. Fhf2Con/WT were
crossed to transgenic Advillin-Cre mice (JAX 032536) to generate Fhf2Con/Y: Adv-Cre and
Fhf2WT/Y: Adv- Cre mice. DRG lysates from Fhf2Con/Y: Adv-Cre mice lack expression of
FHF2. Mobilities of FHF2 isoforms (left) and kilodalton markers (right) are indicated. E,
PGP-9.5 staining of footpad cryosections. Axon bundles projecting towards the epidermis
are detectable in both Fhf2WT and Fhf2KO mice. No apparent innervation defects in Fhf2KO
mice.

5.2 Altered Inactivation Gating of Peripheral Neuronal Sodium
Channels in the Absence of FHF2
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5.2.1 Absence of FHF2 Alters Voltage Dependence of Steady State Nav1.7
Inactivation and Rate of Nav1.7 Inactivation
Since Nav1.7 is the most abundant sodium channel isoform in DRG neuron, we
sought to determine if its inactivation gating was altered by FHF2 in a manner
comparable to FHF2 modulation of other sodium channel isoforms. To test this, we cotransfected HEK cells to transiently express Nav1.7 with either FHF2A, FHF2B or empty
vector and cotransfected cells were assayed for sodium currents during various voltage
clamp recordings.
The voltage dependence of Nav1.7 steady-state inactivation was determined using a
17-sweep protocol with a holding voltage of -120 mV followed by a 60 ms variable
conditioning test voltage step that increased by 5 mV with each sweep (-115 mV +
5(n+1)) then depolarized to a -20 mV reporting pulse. Steady-state voltage dependent
Nav1.7 inactivation at 25 °C occurred at a more hyperpolarized potential when FHF2 was
not present, displaying a V½ = -86.8±1.0 mV (n = 10) in the absence of FHF2 versus a V½
= -72.9±1.9 mV (n = 10) in the presence of FHF2B (P<0.00001, Student’s t-test) and a
V½ = -65.3±2.7 mV (n = 4) in the presence of FHF2A (P<0.001, Student’s t-test) (Fig.
11A).
Utilizing the same voltage ramp depolarization experiment described in section
4.2.2, the rate of NaV1.7 closed-state inactivation could be estimated by comparing peak
transient conductance induced by ramp depolarization versus step depolarization. Nav1.7
conductance was greatest at 25°C in the presence of FHF2. While the absence of FHF2
increased the rate of inactivation at 25°C, there was substantial Nav1.7 conductance at all
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tested depolarization rates. Temperature had its own effect on Nav1.7 inactivation. Even
in the presence of FHF2, Nav1.7 conductance decrease as temperature was elevated.
Similar to our cardiac Nav results, at different rates of membrane depolarization, Nav1.7
peak conductance was poorest at 40°C in the absence of FHF2 (Fig. 11E-G). FHF2B also
slowed the rate of Nav1.7 open-state inactivation across a 25°C to 40°C temperature
range (Fig. 11C,D). Rising temperature also accelerated open-state inactivation rate, so
that Nav1.7 inactivation was fastest at 40°C in the absence of FHF2.
5.2.2 Fhf2KO DRG Sensory Neurons Display Hyperpolarizing Shift in
Inactivation of TTX-Resistant Sodium Channels
While Nav1.7, which is sensitive to tetrodotoxin (TTX), is the most widely
expressed Nav in DRG sensory neurons, it is not the only Nav expressed in these cells.
TTX-resistant Nav1.8 and Nav1.9 are selectively expressed in some DRG sensory neurons
including nociceptors (Hameed, 2019). To determine if FHF2 modulates these Nav
isoforms, whole-cell patch clamp experiments were performed on either wild-type or
Fhf2KO acutely dissociated DRG neurons in the presence of TTX. The voltage
dependence of steady-state inactivation in these neurons was assessed using the same
protocol applied in section 5.2.1. for studying Nav1.7 inactivation. The absence of FHF2
caused a 7 mV hyperpolarizing shift in steady state inactivation (Fig. 11B) of TTX
resistant currents, with wild-type neurons showing a V½ = -24.7±1.9 mV (n = 7) versus
Fhf2KO neurons having a V½ = -31.2±1.2 mV (n = 7) (Student’s t-test, p < 0.025).
These sodium current recording experiments show that lack of FHF2 shifts steady
state inactivation of sodium channels expressed in nociceptive neurons. This would
suggest that nociceptive neurons have fewer sodium channels available at resting
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potential. Furthermore, Nav1.7 was shown to inactivate more rapidly in the absence of
FHF2. FHF2 deficiency and temperature elevation independently accelerate inactivation,
such that channels inactivate fastest at high temperature in the absence of FHF. We
hypothesize that heating of Fhf2KO nociceptors reduces sodium channel availability and
open-state duration to an extent that prevents generation or conduction of action
potentials, thereby causing the observed thermal nociceptive deficit in Fhf2KO mice.

Figure 11: FHF2 modulation of sensory specific sodium channels. A, FHF2 modulates
Nav1.7 steady-state inactivation in HEK293 cells. n, number of cells for each FHF
plasmid. V1/2 inactivation without FHF = -86.8±1.0 mV, FHF2B = -72.0±1.9 mV (p <

- 81 -

0.00001), FHF2A = -65.3±2.7 mV (p < 0.001). B, Steady-state inactivation of TTXresistant sodium conductance in 12 micron-diameter cultured Fhf2WT and Fhf2KO DRG
neurons. V1/2 inactivation Fhf2WT/Y = -24.7±1.9 mV, Fhf2KO/Y = -31.2±1.2 mV (p <
0.025). C-G, FHF2B and temperature modulate Nav1.7 inactivation kinetics in HEK
cells. C, Normalized Nav1.7 currents in transfected cells +/- FHF2B following step
depolarization to -20 mV recorded at either 25°C or 40°C. Temperature accelerated
inactivation, and at each temperature the current decayed faster in the absence of FHF. D,
Time constant for decay of Nav1.7 currents +/- FHF2B at 25°C, 35°C and 40°C. n,
number of recorded cells. **, FHF2B vs. no FHF p < 0.008. E, Peak Nav1.7 conductance
at 25°C following ramp versus step depolarization from -110 to -20 mV. Data are plotted
as peak conductance during ramp depolarization as a fraction of peak conductance upon
step depolarization. At all voltage ramp rates, Nav1.7 conductance is greater in the
presence of FHF2B (p < 0.0005). F, Ramp depolarization at 35°C. At all ramp rates,
FHF2B vs. no FHF p < 0.0004. G, Ramp depolarization at 40°C. At all ramp rates,
FHF2B vs. no FHF p < 0.004.

5.3 Accelerated Nav Inactivation in Fhf2KO Nociceptors Suppresses
Action Potential Conduction at Elevated Temperature

5.3.1 Acutely Dissociated Fhf2KO DRG Heat-Sensitive Nociceptors Have Unimpaired
Heat-Induced Excitability
After establishing that the absence of FHF2 decreases PNS specific Nav
availability and that this effect is exacerbated at elevated temperatures, we wanted to see
if this would result in underexcitability and therefore firing deficiencies in the individual
neurons themselves. Acutely dissociated DRG sensory neurons with diameters of
approximately 12 microns from either wild-type or Fhf2KO mice were patched within two
days in vitro (DIV1-2) and passively recorded from in current-clamp configuration while
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extracellular bath was heated to noxious heat temperature to record heat induced firing.
Fhf2KO nociceptive neurons that fired action potentials upon heating were just as
prevalent (11 out of 31 patched cells) as in the wild-type population (38 out of 96 patched
cells, chi-square p > 0.65) (Fig 12A-C). Surprisingly, excitation parameters of wild-type
and Fhf2KO nociceptors were comparable, including current-evoked spike amplitude at
32°C, temperature threshold for excitation, maximum heat-induced spike frequency, and
spike amplitudes at 43°C or 44.5°C (Fig. 12D-H). Fhf2KO nociceptors did have 25%
reduced inward current upon depolarization from a -90 mV hold potential (Fig. 12I),
which may reflect reduced Nav availability due to a hyperpolarizing shift in Nav
inactivation voltage dependence.
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Figure 12: Acutely Dissociated Cultured DRG Nociceptive Neuron Firing Properties: A,
Voltage recording from patched Fhf2WT/Y neuron (upper plot) while raising and lowering
bath temperature (lower plot) reveals heat-induced excitation. B, Heat excitability of a
Fhf2KO/Y neuron. C, Thermal Nociceptors are equally represented amongst the ~12µm
diameter DRG neuron population in Fhf2WT/Y (n = 96) and Fhf2KO/Y (n = 31) mice. D,
Amplitude of action potential in heat nociceptive neurons at 32°C following current
injection. Number of Fhf2WT/Y and Fhf2KO/Y nociceptors are indicated on the histogram
bars. n.s., not significant (p > 0.07). E, Temperature threshold evoking nociceptor firing.
n.s. (p > 0.4). F, Maximum temperature-evoked spike frequency of nociceptors. n.s. (p >
0.3). G, Nociceptor spike amplitude at 43°C. n.s. (p > 0.6). H, Nociceptor spike
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amplitude at 44.5°C. n.s. (p > 0.6). I, Inward peak current density in Fhf2WT/Y and
Fhf2KO/Y nociceptors upon voltage-clamp step depolarization from -90 mV at 32°C. p <
0.03.

5.3.2 Fhf2KO Sensory Nerve Fibers Fail to Conduct Action Potentials at Elevated
Temperatures
The normal excitability of acutely dissociated thermal nociceptors from Fhf2KO
mice was unexpected. We considered the possibility that acutely dissociated neurons do
not well reflect the properties of mature nociceptors, where excitation occurs at afferent
terminals and spikes are retrogradely propagated. Perhaps the densities of sodium
channels in somatic membrane at DIV1-2 are aberrantly high in comparison to afferents
of mature neurons, thereby masking an excitability deficit. Consequently, we have
analyzed the firing properties of heated DRG neurons at DIV7-10, when axonal processes
are extensive. For wild-type differentiated neurons, 18 % demonstrated heat-induced
excitability (6 out of 34 cells), while only 4% of heated Fhf2KO neurons (1 out of 28 cells)
generated action potentials. While this finding is below statistical significance (chisquare, p = 0.08), it highlighted a potentially important contrast between the experiments
testing firing in DIV1/2 nociceptors and actual in vivo sensory transduction. Therefore,
we sought another assay that can examine action potential generation in heated mature
sensory neurons.
In collaboration with Dr. Matthias Ringkamp and Dr. Timothy Harke from the
Pain Institute at Johns Hopkins University, we examined the ability of unmyelinated
sensory C-type fibers to conduct action potentials at different temperatures. Saphenous
nerves segments, approximately 8 mm in length, were suspended in a heated bath

- 85 -

between a stimulus and recording electrode. Stimulation of wild-type and Fhf2KO nerves
(Klein et al., 2017) generated C-fiber compound action potentials (CCAPs) (Fig. 13A,B).
Each nerve was then stimulated every nine seconds while being warmed to 45°C and then
cooled back to 27°C. As heating induced irreversible damage to between 10-30% of
axons, only CCAPs from the cooling phase of the temperature ramp were analyzed.
Temperature elevation increased CCAP conduction velocity and decreased amplitude
(Fig. 13C-E), reflecting faster rates of voltage-gated channel activation and inactivation.
In wild-type nerves, CCAP amplitudes declined linearly from 27°C to 44°C (Fig.
13C,D,F). CCAP amplitudes in Fhf2KO nerves showed a similar decrement up to 40°C
but declined precipitously between 40°C and 44°C (Fig. 13C,E,F), reflecting conduction
block or severe attenuation in at least half of all mutant fibers. Fhf2KO CCAP impairment
was rapidly reversible with recovery occurring within 27 seconds (3 stimuli) as nerves
were cooled from 44°C to 40°C (Fig. 13E).
We believe the observed conduction block in Fhf2KO nerves at elevated
temperatures is caused by insufficient sodium charging current in the axons as the
combined consequence of reduced Nav availability at resting potential, faster Nav
inactivation rate, and the accelerated rate of inactivation under hyperthermic conditions.
We hypothesize that the distal afferent of thermal nociceptors fails to initiate or propagate
action potentials upon heating.
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Figure 13: Heat dependence of CCAP conduction through Fhf2WT/Y and Fhf2KO/Y
saphenous nerves. A, Recorded CCAP upon stimulus of Fhf2WT/Y nerve at 30.2°C. B,
CCAP at 30.6°C in Fhf2KO/Y nerve. C, Relative peak-to-peak CCAP amplitudes in four
Fhf2WT/Y and four Fhf2KO/Y nerves during stimulation every 9 seconds while cooling from
45°C to 27°C, with amplitude for each nerve at 27°C set to 100%. CCAPs in Fhf2KO/Y
nerves become impaired above 40°C. D, Superimposed CCAP traces (negative voltage
deflections) from a Fhf2WT/Y nerve showing near-linear amplitude decay across a 29.4°C
to 44.3°C range. E, Superimposed CCAP traces from a Fhf2KO/Y nerve reveals collapse of
the CCAP above 41°C. F, Peak-to-peak CCAP amplitude decrements as function of
temperature. Between 40°C and 44°C, Fhf2WT/Y CCAP amplitudes decline 16%, while
Fhf2KO/Y CCAP amplitudes decline 51% (p < 0.0001).

5.4 Summary
Our findings suggest a common mechanism for heat nociception deficit and
cardioarrhythmia in Fhf2KO mice. Elevated temperature and FHF2 deficiency conspire to
impair Nav availability and open-state duration such that sodium charging is insufficient
to drive conduction through unmyelinated nerve fibers or myocardium. It is tempting to
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speculate that febrile seizures in Fhf2KO mice (Puranam et al., 2015) have a similar
underlying sodium channel thermodynamic mechanism. Our data also offers an
evolutionarily sound explanation as to why FHF2 is expressed all throughout the
neuronal processes of PNS sensory neurons while only expressed in the axon initial
segments of CNS neurons, as PNS sensory neurons are liable to encounter temperatures
that CNS neurons never should and they must maintain their functionality.
In the Neuron paper from Yang et al (2017), Fhf2(Fgf13)KO mice were shown to
be insensitive to topical heat application as we have observed. The authors reported that
FHF2 did not modulate inactivation of Nav1.7, but instead argued that FHF2 protected
against heat-induced internalization of Nav1.7 and that, in the absence of FHF2, there is
mass Nav1.7 internalization which would reduce Nav availability and block nociceptor
excitability (L. Yang et al., 2017). Our findings are at odds with this phenotypic
mechanism.
They had considered investigating temperature-induced Nav1.7 internalization in
the absence of FHF2 precisely because they had surprisingly failed to detect the
inactivation gating effects of FHF2 deficiency and temperature on the sodium current.
How these investigators failed to appreciate the modulation of Nav1.7 gating by FHF2 is
unclear. Furthermore, Yang et al. used Nav1.7 biochemical surface labeling to assess
heat-induced internalization, but their biochemical measurements did not reliably
correlate to sodium channel surface density as recorded electrophysiologically. Our
explanation for conduction failure in heated Fhf2KO unmyelinated axons has the benefit
of Occam’s razor, as it is consistent with our earlier determined mechanism of cardiac
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conduction block in these mice and does not require invoking a mechanism of rapidly
induced and rapidly reversed sodium channel internalization.
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Chapter 6: Human FHF2 Missense Mutations Alter Sodium Channel
Long-Term Inactivation and Induce Epileptic Encephalopathy

Over a hundred genes have been suggested as causes of individual cases of EOEE
(Lemke et al., 2012). Still, in over 50% of EOEE cases, a direct cause is never identified
(Hebbar & Mefford, 2020). Various mutations in the genes coding for Nav1.1, Nav1.2 and
Nav1.6—the most abundant Nav in the CNS—have been identified as underlying causes
of specific epilepsy cases (Oyrer et al., 2018). The majority of epilepsy cases, however,
do not involve direct impairment of an ion channel. Mutations in genes that encode ion
channels actually only account for 25% of epilepsy cases. (Oyrer et al., 2018). Since Nav
mutations have been shown to directly cause epilepsy, it is logical to believe that
mutations in the proteins that modulate Nav gating have the potential to do the same.
FHFs modulate Nav gating through the direct binding between the Nav C-terminal
domains and the b-trefoil cores conserved in all FHFs (Goetz et al., 2009 2012; C. Wang
et al., 2012). FHFs cause a depolarizing shift in the intrinsic Nav voltage-dependence of
inactivation. This effect is pro-excitatory because it limits steady-state inactivation of
channels at resting potential. It allows faster recovery and/or slower inactivation onset,
thus providing more Nav availability at a given voltage and time (Lou et al., 2005; Rush
et al., 2006). This delay to fast inactivation increases neuronal excitability and enables
repetitive firing (Goldfarb et al., 2007).
Any FHF mutation that alters how it modulates Nav fast inactivation gating has
the potential to be epileptogenic. A single point mutation in FHF1 causes a pro-excitatory
gain of function resulting in a substantial increase of Nav availability at any given
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voltage, leading to frequent generalized seizures and, in some cases, death (Al-Mehmadi
et al., 2016; Siekierska et al., 2016; Villeneuve et al., 2017). A loss of function FHF2
mutation has also been implicated in a form of epilepsy called Generalized Epilepsy with
Febrile Seizures + (GEFS+). The likely cause of seizures was decreased inhibitory
neuron excitability resulting in overall network overexcitability of excitatory neurons
(Puranam et al., 2015).
In addition to their pro-excitatory function, A-type FHF isoforms also have an
inhibitory function. They can decrease Nav availability by arresting the channels into a
long-term inactivated (LTI) state (Dover et al., 2010; Rush et al., 2006). All A-FHFs can
induce LTI via the highly conserved N-termini and this LTI particle competes with the
intrinsic fast inactivation particle for inactivation (Dover et al., 2010). This A-type FHFinduced LTI contributes to driving spike accommodation in hippocampal pyramidal
neurons, (Venkatesan et al., 2014), suggesting a significant role in CNS neural network
activity. It is conceivable that dysregulation of LTI could possibly cause epilepsy through
aberrant unaccommodated repetitive neuronal firing.
To date, there has been no causative link between an FHF mutation-induced LTI
dysregulation and human epilepsy. Here I describe our collaboration to determine how
newly discovered human EOEE-associated FHF2 missense mutations modulate the
gating of the brain sodium channel Nav1.6. All clinical data discussed in this chapter was
gathered and analyzed by our collaborators Dr. Andrew Fry of Cardiff University, and
Dr. Seo-Kyung Chung of Swansea University and their respective teams. All design,
experimentation and analysis of sodium channel biochemistry and gating was conducted
by Dr. Mitchell Goldfarb and Christopher Marra.
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6.1 Discovery FHF2 Point Mutations in Epileptic Patients
Our collaborators, Dr. Andrew Fry of Cardiff University, and Dr. Seo-Kyung
Chung of Swansea University identified six individuals—from four unrelated families—
with de novo missense variants in FHF2A who all presented with a severe early-onset
seizure disorder. Whole exome sequences showed that five of the individuals all shared
the same recurrent de novo missense variant in FHF2A, p.(Arg11Cys). The sixth
individual had a different apparently de novo mutation at a nearby residue in FHF2A,
p.(Arg14Thr).
Shared clinical features included global developmental delay and severe
intellectual disability. The more able individuals were diagnosed with autism spectrum
disorder. All six individuals had epilepsy. Four presented in the neonatal period. The
predominant epilepsy phenotype was focal seizures often with secondary generalization.
However, a range of other seizure types were reported including epileptic spasms,
gelastic seizures, absence episodes, drop attacks and generalized tonic-clonic seizures.
The focal seizures were associated with motor features (eye twitching or head deviation),
apneas, and oroalimentary automatisms (chewing or repeated swallowing). Autonomic
features included drooling, ictal vomiting and skin flushing. EEGs often found evidence
of temporal lobe foci. Seizures were resistant to a wide range of anti-epileptic drugs
(AED). Two individuals had vagal nerves stimulators implanted. Individual 2 underwent
left anterior temporal lobectomy and partial amygdalo-hippocampectomy at 7 years of
age. She was seizure free for 2 years; however, she is now 13 years old and the focal
seizures have returned despite three AEDs. Constipation was common in the group and
one patient (individual 1) had subtotal colectomy and ileostomy due to chronic
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constipation and recurrent severe abdominal pain. Physical examination revealed normal
or reduced muscle tone. There was no spasticity or hyperreflexia. Subtle dysmorphic
features were noted although these were variable, and likely reflect the effects of AEDs
and facial hypotonia. Brain MRI scans in infancy were normal. A subsequent brain MRI
scan of individual 2 at 6 years of age found mild atrophy. Expanded clinical features for
each individual are summarized in Table 3.
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Table 3. Clinical and molecular findings in the patients with N-terminal FHF2A
mutations
Individual

1
Family 1
15 y
Male
c.31C>T
p.(Arg11Cys)
De novo
53.4cm
@13y10m
Profound

2
Family 1
13 y
Female
c.31C>T
p.(Arg11Cys)
De novo
53.5cm @
6y8m
Severe

3
Family 2
19 y
Male
c.31C>T
p.(Arg11Cys)
De novo
57cm @ 19y

Initial
concerns

11d, apneas,
repetitive
swallowing,
head deviation,
eye twitching

Epilepsy

Focal sz at 2m.
Generalized sz
from 7 m

11d, apneas,
lip smacking,
repetitive
swallowing,
eye deviation,
facial
twitching
Focal sz from
11 m. Never
generalized

EEG

Multiple
epileptogenic
foci in
temporal
regions. MPEI
considered

Current
AED

Zonisamide,
lamotrigine,
gabapentin,
sodium
valproate,
perampanel
Hypotonia, no
hyperreflexia

Subtotal
colectomy and
ileostomy due
to
constipation/
pain at 9y,
gum
hypertrophy

Age
Sex
Mutation
Inheritance
OFC
ID/DD

Neurology

Other
features

4
Family 2
12 y
Male
c.31C>T
p.(Arg11Cys)
De novo
53cm@
12y5m
Severe

5
Family 3
2y3m
Male
c.31C>T
p.(Arg11Cys)
De novo
48.5 @22m

6
Family 4
5y
Male
c.41G>C
p.(Arg14Thr)
Unknown
49cm @5y

Profound

Severe

4w, apneas,
stiffness

~6m, head and
eye deviation,
twitching

5d, head and
eye deviation,
blinking,
repetitive
swallowing

n/k

Focal sz from
2m. Flexor
spasms from
6m.

GTCS at 18
months. Now episodes of
NCSE and
vomiting

Focal
dyscognitive
seizures

Yes

Ictal EEG at
6y8m - focus
in left frontotemporal
region.

Hypsarrhythmia
at 6m

Hypsarrhythmia
at 2.5y

n/k

Sodium
valproate,
lamotrigine,
clobazam

-

Sodium
valproate,
Kepra

Multiple
epileptogenic
foci in
temporal
regions.
Suggestive of
LGS.
Sodium
valproate

Normal tone
and reflexes

Low axial
tone, mild limb
hypertonia, no
hyperreflexia
or tremor

Broad based,
unsteady gait,
normal or
mildly
increased limb
tone

Generalized
hypotonia.
Periodic
abnormal
posturing.

n/k

Left anterior
temporal
lobectomy and
partial
amygdalohippocampectomy
@7y 7m.

Severe
scoliosis

Antenatal
renal pelvic
dilatation,
recurrent UTI,
nephrectomy
at 6y

Hypothyroidism

Atrial septal
defect

Severe
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n/k

6.1.1 FHF2 Point Mutations in Epileptic Patients Align with Sites Crucial to FHF2A
Function
A-type FHFs maintain their pro-excitatory effects of limiting steady-state
inactivation and slowing closed state inactivation (Goldfarb, 2012). They also have a
modulatory inhibitory-based role that is absent in the other FHF isoforms. A-type FHFs
induce LTI via an N-terminal sequence motif, which is conserved among all A-type FHFs
(Dover et al., 2010). LTI contributes to spike accommodation in hippocampal pyramidal
neurons (Venkatesan et al., 2014). The N-terminal sequence itself acts as an open channel
block, competing with the intrinsic Nav fast inactivation mechanism (Dover et al., 2010;
Venkatesan et al., 2014).
The two FHF2 point mutations discovered in these EOEE patients were both
located close to each other in exon 1A of the FHF2 gene. This exon encodes the Nterminal domain specific to the A isoform of the FHF2 protein (FHF2A). The 1A exon
of FHF2 is highly conserved across species and across the four human FHF genes
(Figure 14B-C). The Arg11 and Arg14 residues mutated in the six individuals were fully
conserved in all the A-type FHF sequences. This suggests their potential importance in
FHF2 A-type specific function. This led us to hypothesize these point mutations likely
impair the inhibitory function of FHF2A. This impairment would result in neuronal
overexcitability and dysregulated firing, which could be the cause of the patients’ EOEE.
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Figure 14: Genetic feature of epileptogenic FHF2A mutations. A, Pedigrees of families
1-3 with the faces of four affected individuals. Genotypes are heterozygotes (+/-),
homozygous wild-type (-/-) or testing not done (n.d.). B, Exonic models of the FHF2
transcripts showing alternative splicing of the 5’ coding exons. The FHF2A protein
isoform is derived from the NM_004114.3 transcript which employs and an ATG start
site in exon 1S (also known as exon 1A). The V, Y, U and S nomenclature originates
from Munoz-Sanjuan et al., 2000. The 1S exon encodes the N-terminal domain (NTD) of
FHF2A. The shared C-terminal exons encode the core fibroblast growth factor (FGF)
domain. C, The FHF2 (FGF13) mutations are located at highly conserved residues in the
N terminal domain of the A isoform. Homology alignments for human FHF2
(NP_004105.1, residues 1-30) and a range of orthologues and paralogues. Orthologues
include chimpanzee (XP_001138460.1), rhesus macaque (NP_001252772.1), dog
(XP_549294.2), cow (NP_001092362.1), mouse (NP_034330.2), rat (XP_006257654.1),
chicken (XP_015133693.1), western clawed frog (XP_012824080.1) and zebrafish
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(XP_005173268.1). Paralogues include FHF1/FGF12 (NP_066360.1), FHF3/FGF11
(NP_004103.1) and FHF4/FGF14 (NP_004106.1). The positions of the Arg11 and Arg14
residues are in red

6.2 FHF2A Epileptogenic Mutants Retain Some Wild-type Functions

6.2.1 FHF2AR11C and FHF2AR14T Retain Ability to Bind Directly to Nav
To appropriately test our hypothesis regarding the consequences of FHF2A
mutation, it was first important to determine if the p.(Arg11Cys) and p.(Arg14Thr) point
mutations in the FHF2 gene retained the ability to produce functional proteins. The
Arg11Cys and Arg14Thr mutations were introduced into constructs expressing FHF2A.
Neuro2A cells were transiently transfected to express Nav1.6 and either no FHF, wildtype
FHF2A or one of the FHF2A mutants (FHF2AWT, FHF2AR11C or FHF2AR14T).
To determine if the FHF2 mutants expressed as well as wild-type, transfected
cells were lysed after 36 hours and proteins harvested. Western-blot analysis of total
lysates from these transfections was performed using an antibody against the C-terminal
domain of FHF2. Results showed that there was FHF2 protein present in all experimental
lysates and absent in negative control transfection (Fig. 15A). This suggests the point
mutations do not impair the ability of the gene to produce protein.
FHFs must interact directly with Nav to function as gating modulators (Goetz et
al., 2009). One potential explanation as to how a mutated FHF2A could be epileptogenic
would be a loss of LTI function via inability to interact with Nav. Coimmunoprecipitation experiments were performed to determine if the FHF2AR11C and
FHF2AR14T mutants retained the ability to bind directly to Nav. The lysates from the
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transiently transfected Neuro2A cells above were treated with the FHF2 C-terminal
antibody to pull down FHF2 and any proteins in complex with it. The
immunoprecipitates were subjected to gel electrophoresis and probed with a pan-Nav
antibody. The resulting blot showed Nav1.6 was detected in the anti-FHF2
immunoprecipitates from cells expressing FHF2AWT, FHF2AR11C or FHF2AR14T. This
indicates these epileptogenic FHF2A point mutations do not compromise the FHF2A-Nav
interaction.

6.2.2 FHF2AR11C and FHF2AR14T Retain Ability to Modulate Voltage Dependence of
Nav1.6 Inactivation
It has been suggested that loss of the excitatory functions of FHF2 could be
epileptogenic by causing under-excitability of inhibitory CNS interneurons (Puranam et
al., 2015). To test if FHF2A-R11C and FHF2-R14T modulation of fast-inactivation was
impaired, whole-cell patch clamp experiments were performed on transiently transfected
Neuro2A cells expressing Nav1.6 either with no FHF, FHF2AWT, FHF2AR11C or
FHF2AR14T. Cells were held in voltage clamp configuration and subjected to the steadystate inactivation protocol employed in Chapters 4.2.3 & 5.2.1. Results showed
FHF2AWT (V1/2 = -51.4±1.9 mV n=7) , FHF2AR11C (V1/2 = -49.4±1.0 mV n=9) or
FHF2AR14T (V1/2 = -52.7±0.5 mV n=7) all caused a significant depolarizing shift in
steady-state inactivation versus no FHF (V1/2 = -69.5±0.5 mV n=7)(p < 0.0001 for all
FHFs vs no FHF). There was no distinguishable difference in Nav1.6 steady-state
inactivation between the wild-type or FHF2A mutants(Fig. 15B). Therefore, the epilepsy-

- 98 -

associated mutations preserve the pro-excitatory property of FHF2A. This strongly
suggests LTI impairment as the likely defect causing overexcitability and epilepsy.

Figure 15: Retained properties of FHF2A mutants. A, FHF2AWT, FHF2AR11C and
FHF2AR14T proteins interact with Nav1.6. Neuro2A cells were transiently transfected
with expression vectors indicated at top of figure. Total lysates or anti-FHF2
immunoprecipitates (IP) were subjected to gel electrophoresis and immunoblotting with
anti-FHF2 or anti-pan-Nav antibodies. Nav1.6 is detected in anti-FHF2
immunoprecipitates from cells expressing FHF2AWT, FHF2AR11C or FHF2AR14T. B,
FHF2AR11C and FHF2AR14T retain the ability to induce depolarizing shift in voltage
dependence of Nav1.6 fast inactivation. Both mutant FHF2A proteins retain ability to
induce 17-19 mV depolarizing shifts in voltage dependence of Nav1.6 steady-state
inactivation.

6.3 FHF2A Epileptogenic Mutations Impair Nav Long-term Inactivation
The epileptogenic FHF2A mutants retain all FHF2 functions not unique to the Atype isoform. This, coupled with the point mutations occurring in the functional portion
of the N-terminal, strongly suggests impaired FHF2A-mediated LTI is the likely cause of
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neuronal overexcitability in these EOEE patients. To test the ability of the FHF2A
mutants to mediate LTI, whole-cell patch clamp experiments were performed on
Neuro2A cells transiently transfected to express Nav1.6 and either FHF2AWT, FHF2AR11C
or FHF2AR14T. Patched cells were depolarized to 0 mV for four 16 msec intervals
separated by 40 msec recovery periods at -90 mV to allow for sodium channel recovery
from fast inactivation (Fig. 16E). In cells expressing FHF2AWT, transient Nav1.6 sodium
current amplitude diminishes with each depolarization cycle (Fig. 16A,D). By the fourth
depolarization peak, current generated was 48.6±6.8% (n=11) that of the first, reflecting
accumulating long-term inactivation of Nav1.6. By contrast, the extent of long-term
channel inactivation is greatly reduced in cells expressing FHF2AR11C (83.6±3.6% max,
n=10; (p < 10-7) (Fig. 16B,D), while the sodium currents during four depolarization
cycles in cells expressing FHF2AR14T (92.5±1.5% max, n=6; (p < 10-7) are
indistinguishable from those in cells without FHF (92.6±1.7% max, n=7 ) (Fig. 16C,D),
demonstrating that FHF2AR14 is incapable of promoting Nav1.6 accumulating long-term
inactivation.
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Figure 16: Characterization of the epileptogenic mutant FHF2A ability to induce LTI. AC, Representative sodium current traces in Neuro2A cells expressing Nav1.6 together
with either (A) FHF2AWT , (B) FHF2AR11C, or (C) FHF2AR14T. The mutations impair
channel long-term inactivation. D, Analysis of long-term inactivation induced by wildtype and mutant FHF2A proteins. n, number of recorded cells. The impaired long-term
inactivation of FHF2AR11C and FHF2AR14T in comparison to FHF2AWT upon
depolarizations 2,3,4 is highly significant (p < 10-7). E, Voltage-clamp protocol for
accumulating long-term inactivation used in A-C. The 40 ms intervals at −90 mV allow
for full recovery from fast inactivation, but only partial recovery from long-term
inactivation, which has a far slower recovery rate.
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In a second experiment to assess the effects of the FHF2A mutations on long-term
channel inactivation, cells were subjected to multiple rapid depolarization cycles
followed by a -90 mV recovery period of varying duration (20 msec to 1 sec) before a
subsequent test depolarization (Fig. 17A). In cells expressing FHF2AWT, near-full
recovery of Nav1.6 from long-term inactivation required one second (Fig. 17B,E), while
cells expressing FHF2AR11C channels fully recovered by 200 msec (Fig. 17C,E). Cells
expressing FHF2AR14T again showed no evidence of Nav1.6 long-term inactivation, as
channels fully recovered as quickly as cells lacking FHF (Fig. 17D,E).
These results indicate that the FHF2 gene point mutations present in these six
EOEE patients is indeed the likely cause of their epilepsy. The FHF2R11C and FHF2R14T
mutations fail to induce Nav LTI. These FHF2 variants, however, maintain the proexcitatory properties of wild-type FHF2A. This preservation of excitation paired with
suppression of an accommodation mechanism is likely causing unmitigated overexcitability manifesting in epileptic activity.
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Figure 17: Nav1.6 recovery from FHF2A induce LTI. A, Voltage-clamp protocol for
long-term inactivation recovery used in B-D. A 100 ms interval protocol (Adler et al.)
was used to analyze LTI recovery in presence of wild-type FHF2 to allow full recovery.
A 20 ms interval protocol (bottom) was required to detect stepwise recovery in the
presence of the FHF2 mutants. B-D, Representative sodium current traces in Neuro2A
cells expressing Nav1.6 together with either (B) FHF2AWT , (C) FHF2AR11C, or (D)
FHF2AR14T. Nav1.6 recovers faster in cells expressing FHF2AR11C or FHF2AR14T
compared to cells expressing FHF2AWT. E, Analysis of Nav1.6 recovery from long-term
inactivation at -90 mV.

6.4 Summary
Dr. Andrew Fry of Cardiff University, and Dr. Seo-Kyung Chung of Swansea
University identified six individuals—from four unrelated families—with de novo
missense variants in FHF2A who all presented with a severe EOEE. Five of the

- 103 -

individuals shared a mutation resulting in the same Arg11Cys variant while sixth
individual had an Arg14Thr variant. The patients displayed global developmental delay,
severe intellectual disability and AED resistant epilepsy.
Through mutagenesis, we were able to express these FHF2 variants in a model
cell line. Our biochemical and electrophysiological results showed that these variants
retained most features native to FHF2 including the ability to interact with Nav and the
pro-excitatory modulation of fast inactivation. However, these mutant FHF2A proteins
displayed a severely diminished ability to induce LTI. A-type FHFs, including FHF2A,
contribute to spike frequency accommodation in CNS neurons by inducing Nav LTI
(Dover et al., 2010). A-Type FHF-induced LTI can allow for the attenuation of excitation
by reducing Nav availability during repetitive stimulation or prolonged excitation. Loss of
the inhibitory function of FHF2A while retaining pro-excitatory function is likely causing
neuronal over-excitability. In these patients, this results in unmitigated epileptic events
presenting as neonatally as a type of EOEE. We expect these FHF2 mutations to act in
dominant or co-dominant fashion, as the FHF2A mutant proteins are as competent as
wild-type FHF2A in their ability to bind and, thereby, dictate the gating properties of
sodium channels. There could be interesting differential effects in males versus females
as a consequence of FHF2 residing on the X chromosome. In males it is homozygous by
definition because of the presence of the Y chromosome. In females, because of Xinactivation, mosaic expression anticipates that this mutation will cause random subset of
neurons to be hyperexcitable. We expect that this will result in a less severe phenotype in
females carrying one of these epileptogenic FHF2A mutations. Individuals 1 and 2 are
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respectively male and female siblings carrying the same FHF2 mutation and it should be
noted that Individual 1 does display a more severe phenotype than his sister.
This collaborative study is the first evidence of a single FHF2 point mutation
causing neurological disease in humans and the first example of A-type FHFs being
directly linked to a human disease. We hope that this discovery can be used as a
diagnostic tool as well as an avenue towards development of new treatments for patients
carrying these mutations and suffering this disease. It is also possible that similar
mutations in other A-type FHFs besides FHF2 can be causing a similar phenotype in
additional patients. Soon after the discovery of the previously mentioned FHF1 gain-of function epileptogenic was published, many cases were subsequently discovered and
published by other labs (Al-Mehmadi et al., 2016; Siekierska et al., 2016; Villeneuve et
al., 2017). It is reasonable to suggest a similar outcome as more attention is brought to Atype FHF point mutations including the FHF2 Arg11Cys and Arg14Thr mutations
described in this study.
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Chapter 7: Discussion
7.1 Main Findings
FHF2, like all FHFs, has the ability to modulate cellular excitability by altering
Nav inactivation gating properties. In order to study the resultant physiological
implications, we were able to establish and maintain both Fhf2 conditional and full
knockout mouse lines. Prior to our generation of these mouse lines, it was reported that
Fhf2 knockout resulted in embryonic lethality in mice (Puranam et al., 2015). While the
basis for this inconsistency in not clear, one possibility is that background strain was
influencing phenotype. This reported lethal mutant allele was maintained on a C57Bl/6
background, while ours was backcrossed and maintained on a 129S2 strain.
Most FHFs promote excitability by impeding Nav fast inactivation. FHFs
depolarize voltage dependence of Nav steady-state inactivation resulting in more
available channels at any given voltage, and they also delay the rate of entrance into the
inactivated state, resulting in greater overall sodium influx. Chapters 4 and 5
demonstrate that these pro-excitatory functions of FHF2 are physiologically vital under
hyperthermic conditions in various tissues. Increasing temperature accelerates the
intrinsic rate of Nav open and closed-state inactivation. FHF2 was shown to serve a
thermo-protective role by compensating for this hyperthermic acceleration of inactivation
and preserving physiological function under these conditions.
In addition to its pro-excitatory function, the A-type isoform FHF2A also has an
inhibitory function. FHF2A decreases repetitive excitability by arresting a subpopulation
of a cell’s Nav in a long-term inactivated state. This reduces channel availability and
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raises firing threshold which increases the interval between action potentials within a
spike train. This phenomenon is referred to as spike frequency accommodation. It has
previously been proposed by our lab that an impairment in this function of FHF2A may
cause uncontrolled neuronal firing and potentially result in an epilepsy-type disease.
Chapter 6 describes the first known human cases of a point mutation in Fhf2 that
diminishes its ability to induce LTI. These patients unfortunately suffer from a severe
form of epilepsy known as Early-Onset Epileptic Encephalopathy.

7.2 Role of FHF2 in Cardiac Function
Fhf2KO mice showed a unique temperature sensitive, fully reversible cardiac
phenotype. There were no gross structural abnormalities nor apparent subcellular
organizational defects in Fhf2KO hearts and cardiomyocytes. We determined that the
ability of FHF2 to delay Nav inactivation compensates for the elevated temperature
induced intrinsic acceleration of open and closed-state Nav inactivation. FHF2 allows for
the preservation of cardiac excitability and conduction at physiological temperatures.
FHF2 is particularly vital under hyperthermic conditions where its absence results in
excitation failure, slowed cardiac conduction, and conduction block.
The observed Fhf2KO phenotype closely resembles that of a subset of Brugada
Syndrome, where ECG parameters change from normal to coved-type ST elevations in
the presence of fever or sodium channel blocking drugs. While the electrophysiological
basis of the Brugada pattern ECG is controversial, some have reported focal conduction
slowing in the right ventricular outflow tract as a potential mechanism (Coronel et al.,
2005; Zhang et al., 2015; Guillem et al.,(Lin et al., 2015) 2010). Although optical
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mapping of Fhf2KO hearts demonstrated global myocardium conduction slowing,
additional analysis may be revealing. For example, during sinus rhythm, myocardial
conduction may be differentially affected in particular ventricular zones due to
nonhomogeneity in the array of Purkinje fibers that locally initiate myocardial activation.
Furthermore, exploring the interplay between FHF2-dependent alterations in sodium
current physiology and other ionic currents that have been implicated in the Brugada
pattern ECG will certainly be of significant interest.
The relevance of our findings in Fhf2KO mouse heart to human cardiac
arrhythmias remains to be determined, particularly since FHF2 is not expressed in human
heart, where FHF1 expression predominates and where an FHF1 missense mutation is
associated with Brugada Syndrome (Hennessey, Marcou, et al., 2013). Of relevance to
our findings, some individuals suffer from a form of Brugada Syndrome which is
revealed or exacerbated in the febrile state (Adler et al., 2013).
In summary, our results identify the critical role of FHF2 in maintaining adequate
sodium current reserve in response to hyperthermic stress. These results have direct
implications for fever-induced Brugada syndrome, where loss of function sodium channel
mutations may conspire with FHF-dependent mechanisms, such as allelic expression
levels, to produce temperature-sensitive effects.

7.3 Role of FHF2 in Nociception
We found that generalized and PNS-specific Fhf2KO mice are completely
insensitive to heat-induced nociception, while mechanonociception is unimpaired. We
showed that FHF2 depolarizes the voltage-dependence of inactivation of the Nav
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primarily associated with nociception. Elevated temperature and absence of FHF2 each
individually reduce Nav availability and accelerate both open- and closed-state
inactivation rates such that sodium charging is insufficient to drive conduction through
unmyelinated sensory nerve fibers. Our nerve recordings also showed that, similarly to
the Fhf2KO cardiac phenotype, the temperature induced conduction failure is rapidly
reversible. Our data also offers an evolutionarily sound explanation as to why FHF2 is
expressed all throughout the neuronal processes of PNS sensory neurons while only
expressed in the axon initial segments of CNS neurons, as PNS sensory neurons are liable
to encounter temperatures that CNS neurons never should and they must maintain their
functionality.
In the Neuron paper from Yang et al (2017), Fhf2(Fgf13)KO mice were shown to
be insensitive to topical heat application as we have observed. The authors reported that
FHF2 did not modulate inactivation of Nav1.7, but instead argued that FHF2 protected
against heat-induced internalization of Nav1.7 and that, in the absence of FHF2, there is
Nav1.7 internalization which reduces the Nav conductance and blocks nociceptor
excitability (L. Yang et al., 2017). Our findings are at odds with this phenotypic
mechanism.
We found excitation parameters of Fhf2WT and Fhf2KO nociceptors were
statistically indistinguishable, including current-evoked spike amplitude at 32°C,
temperature threshold for excitation, maximum heat-induced spike frequency, and spike
amplitudes at 43°C or 44.5°C. Yang et al (2017) had considered investigating
temperature-induced Nav1.7 internalization in the absence of FHF2 precisely because
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they had surprisingly failed to detect the inactivation gating effects of FHF2 deficiency
and temperature on the sodium current. How these investigators failed to appreciate the
modulation of Nav1.7 gating by FHF2 is unclear. Furthermore, Yang et al. used Nav1.7
biochemical surface labeling to assess heat-induced internalization, but their biochemical
measurements did not reliably correlate to sodium channel surface density as recorded
electrophysiologically. Our explanation for conduction failure in heated Fhf2KO
unmyelinated axons has the benefit of Occam’s razor, as it is consistent with our earlier
determined mechanism of cardiac conduction block in these mice and does not require
invoking a mechanism of rapidly induced and rapidly reversed sodium channel
internalization.
Our findings suggest a common mechanism for heat nociception deficit and
cardioarrhythmia in Fhf2KO mice. Elevated temperature and FHF2 deficiency conspire
to impair Nav availability and open state duration such that sodium charging is
insufficient to drive conduction through unmyelinated nerve fibers or myocardium. We
believe that our proposed mechanism is both more plausible and better supported than the
alternative offered by Yang et al., 2017. It is tempting to speculate that febrile seizures in
Fhf2KO mice (Puranam et al., 2015) have a similar underlying sodium channel
thermodynamic mechanism.

7.4 Role of FHF2 in Epilepsy
FHF2 missense mutations are associated with human early onset epileptic
encephalopathy. The mutations are proexcitatory because they reduce the inhibitory
function of FHF2A while preserving all of its excitatory properties. The two missense
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variants are located in the N-terminal domain region specific to the A-type isoform of
FHF2. This domain is highly conserved in all A-type FHFs and is responsible for
mediating Nav LTI (Dover et al., 2010).
We showed that epileptogenic FHF2A mutant proteins have reduced ability to
induce Nav1.6 LTI and accelerated recovery from LTI was observed, but these variants
retain all wild-type pro-excitatory function. Mutant FHF2A isoforms continue to coimmunoprecipitate with Nav channels and cause a depolarizing shift in the voltage
dependence of steady-state inactivation. This indicates that the mutations do not disrupt
binding of FHF2 to the Nav CTD. The reduced ability of mutant FHF2A to promote
Nav1.6 long-term inactivation indicates the N-terminal variants impair function of the
inactivation particle. These mutations cause increased neuronal excitability by
suppressing the mechanism by which FHF2A causes spike frequency accommodation
while preserving the pro-excitatory properties of FHF2A.
This is not the first time FHFs have been associated with epilepsy in humans. A
loss of function FHF2 mutation has previously been implicated in a form of epilepsy
called GEFS+. The likely cause of seizures was decreased inhibitory neuron excitability
resulting in overall network overexcitability of excitatory neurons (Puranam et al., 2015).
At present, FHFs have been shown shown to bind and modulate several different voltagegated sodium channels by FHFs, including Nav1.1, 1.5, 1.6, 1.7, 1.8 (Lou et al., 2005;
Dover et al., 2010; Wang et al., 2011; Park et al., 2016, and this thesis). In fact, the Nav
CTD-FHF binding interfaces are virtually identical in sequence and we therefore expect
FHFs will bind to and modulate all Nav in similar manner. We too have observed
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spontaneous seizures in our FHF2KO mice. One can speculate that this particular
phenotype might reflect that inhibitory neurons may lack compensatory effect of other
FHF genes whereas excitatory neurons may express others which mute the effect of
deficiency.
Additionally, a gain-of-function mutation in FHF1 has been identified in patients
with EOEE (Al-Mehmadi et al., 2016; Siekierska et al., 2016; Villeneuve et al., 2017;
Paprocka et al., 2019). There are similarities between this previously described mutant
Fhf1 induced epilepsy and the Fhf2-related epilepsy described here phenotypically, but
not mechanistically. While both sets of patients suffer from EOEE, the Fhf1
epileptogenic mutations are present in the core region of the protein which affects both
the A and B isoforms. The overexcitability cause by the Fhf1 epileptogenic mutations
results from a gain-of-function in the ability for FHF1 to delay fast inactivation. The
cases described here, however, is the first examples of A-type isoform specific FHF and
single FHF2 point mutation induced epilepsy.
Our study provides evidence for the critical role of the FHF2A isoform in
regulating Nav channel function and highlights the value of affected sibling pairs with
shared, apparently de novo mutations for mapping genetic disease.

7.5 Limitations & Future Directions
An important focus moving forward would be screening patients with potentially
FHF2-relevant diseases for FHF2 mutations. It is very possible that there are patients
suffering from Brugada Syndrome who have FHF mutations or SCN5A mutations that
result in a defective FHF protein or impair the binding of FHF to the CTD of Nav1.5. It is
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also very likely that there are additional epilepsy patients who have FHF2A mutations. It
is also possible that similar epileptogenic point mutations that affect other A-type FHFs
will be discovered. FHF1 is an interesting candidate since it is, like FHF2, expressed in
cortical pyramidal neurons.
Regarding its role in heat pain sensation, the Fhf2KO deficit is total and
modulation of sensory-specific Nav by FHF2 is clear. One key piece of data that has
remained elusive is definitive proof of nociceptive deficits in individual Fhf2KO DRG
neurons. Our experiment heating differentiated neurons only gave suggestive data that
did not reach statistical significance. We believe this is because limitations within the
experimental apparatus create suboptimal conditions for testing the hypothesis that
Fhf2KO neurons are not heat excitable. Our current set-up only allows for heating of the
entire culture which includes the entire neuron. To replicate the in vivo scenario, we must
be able to heat only a distal portion of the axon rather than the whole cell. Our nerve
recordings suggest that there is a failure of conduction in sensory nerves in the absence of
FHF2 at elevated temperatures. We believe that if we can heat only the terminal axon of
differentiated Fhf2KO DRG neurons, this will replicate the result from the nerve recording
and show excitation failure in at noxious temperatures. We intend on attempting this by
combining a two-chamber microfluidic in vitro culture system whereby stimuli (heat or
capsaicin) is applied to the distal axon compartment while measuring somatic responses
optically with an externally applied voltage-sensitive dye. Our prediction is that Fhf2KO
nociceptor distal axon will fail to transduce a heat stimulus, while retaining the ability to
mediate chemonociception.
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A primary limitation of the FHF2A-related epilepsy work is that all experimental
data were obtained using transiently transfected model cell lines. It is important to
validate these findings in neuronal cells bearing the desired heterozygous mutations. We
are in the process of developing human induced pluripotent stem cells carrying the
FHF2R11C mutation that can then be differentiated into different types of CNS neurons to
determine the effects of the mutation on neuronal excitability. An additional direction is
to engineer these missense mutations into mice to study how seizures arise and can
potentially be prevented.
The greatest limitation on all Nav-based FHF2 research is that we do not yet have
a complete understanding of the physical mechanism by which FHF2 binding directly to
the CTD of Nav delays and depolarizes inactivation gating. Furthermore, the intrinsic Nav
inactivation mechanism and its voltage dependence are not fully understood. A full
understanding of FHF-associated disorders and potential avenues of treatment shall
require a delineation of the mechanism by which FHF binding to the cytoplasmic tail of a
sodium channel alters inactivation gating.
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Fhf2 gene deletion causes temperature-sensitive
cardiac conduction failure
David S. Park1,*, Akshay Shekhar1,*, Christopher Marra2,3,*, Xianming Lin1, Carolina Vasquez1, Sergio Solinas4,
Kevin Kelley5, Gregory Morley1, Mitchell Goldfarb2 & Glenn I. Fishman1

Fever is a highly conserved systemic response to infection dating back over 600 million years.
Although conferring a survival benefit, fever can negatively impact the function of excitable
tissues, such as the heart, producing cardiac arrhythmias. Here we show that mice lacking
fibroblast growth factor homologous factor 2 (FHF2) have normal cardiac rhythm at baseline,
but increasing core body temperature by as little as 3 !C causes coved-type ST elevations and
progressive conduction failure that is fully reversible upon return to normothermia.
FHF2-deficient cardiomyocytes generate action potentials upon current injection at 25 !C but
are unexcitable at 40 !C. The absence of FHF2 accelerates the rate of closed-state and
open-state sodium channel inactivation, which synergizes with temperature-dependent
enhancement of inactivation rate to severely suppress cardiac sodium currents at elevated
temperatures. Our experimental and computational results identify an essential role for
FHF2 in dictating myocardial excitability and conduction that safeguards against
temperature-sensitive conduction failure.
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Fhf2KO mice exhibit hyperthermia-induced conduction defects.
Female Fhf2KO/KO and male Fhf2KO/Y mice were viable and
fertile. Fhf2KO/Y mice exhibited normal baseline ECG parameters
at 37 !C (Fig. 2a and Supplementary Table 1). Cardiac structural
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Results
Derivation and validation of Fhf2KO mice. We engineered mice
bearing a deletion within the X-linked Fhf2 gene (Fig. 1a,b) in
order to test for possible effects on cardiac rhythm. The absence
of FHF2 protein in Fhf2KO mice was confirmed in immunoblots
of heart and brain tissue (Fig. 1c), and by ventricular myocyte
immunofluorescence (Fig. 1d). Notably, there was no noticeable
change in NaV1.5 protein levels or subcellular localization in
Fhf2KO ventricular myocytes. The IRES-lacZ insertion within the
Fhf2KO allele (Fig. 1a) allowed for whole-mount X-Gal staining of
the heart and demonstrated widespread Fhf2 gene expression in
atria, ventricles, and the His-Purkinje system (Fig. 1e).
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elevation. FHF2-deficient cardiomyocytes generate action
potentials upon current injection at 25 !C but are unexcitable at
40 !C. Loss of FHF2 results in a hyperpolarizing shift of
steady-state inactivation of the sodium current and accelerates
the rate of closed-state and open-state sodium channel
inactivation, which synergizes with temperature-dependent
enhancement of inactivation rate to severely suppress cardiac
sodium currents at elevated temperatures. Our experimental and
computational results demonstrate that FHF2 is a key regulator of
myocardial excitability, protecting the heart against conduction
failure under hyperthermic conditions.
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ever-induced arrhythmias1 and seizures2 are well documented, and are often associated with mutations in sodium
channels, suggesting that deficient sodium current reserve
is an important determinant for electrical instability during
hyperthermic states. Indeed, elevation in core body temperature
by fever or external heating3 is a known trigger for ventricular
fibrillation/malignant syncope in patients with Brugada
syndrome (BrS)4, an inherited arrhythmia condition diagnosed
by characteristic electrocardiographic (ECG) abnormalities in the
right precordial leads. Loss of function mutations in SCN5A,
which encodes the pore-forming subunit of the cardiac sodium
channel NaV1.5, have been identified in B20% of BrS patients5.
Biophysical analyses of mutant sodium channels from febrile
BrS patients have not identified a unifying mechanism for
the temperature-sensitive phenotype6,7. These data suggest that
factors in addition to SCN5A are playing important roles in
regulating the sodium current that ultimately predispose BrS
patients to fever-induced arrhythmias.
FHFs, also termed iFGFs, are a family of proteins that bind
to the cytoplasmic tails of voltage-gated sodium channels
(VGSCs)8–10, modulating channel inactivation and cellular
excitability11–13. We generated mice lacking fibroblast growth
factor homologous factor 2 (Fhf2KO) to study its role in regulating
cardiac excitability under normal and pathological states. Fhf2KO
mice have normal cardiac rhythm at baseline, but exhibit
temperature-sensitive electrocardiographic changes, including
coved-type ST elevations and progressive conduction failure
that is fully reversible upon return to normal body temperature.
Optical mapping reveals severe conduction slowing in mutant
hearts at 37 !C that is further exacerbated by temperature
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Figure 1 | Derivation and validation of Fhf2KO mice. (a) Schematic of Fhf2WT and Fhf2KO alleles. The Fhf2KO allele differs from the Fhf2WT allele by the
replacement of a 570-base genomic segment spanning coding exon 3 with a cassette containing splice acceptor site, internal ribosome entry site,
a b-galactosidase coding sequence and residual loxP site. Positions and orientations of three PCR primers are indicated (blue arrowheads). (b) PCR
genotyping of Fhf2WT and Fhf2KO alleles. Simultaneous amplification of wild-type 350 bp and mutant 430 bp allelic segments were resolved on agarose gel.
(c) Immunoblotting of Fhf2WT/Y and Fhf2KO/Y tissue extracts. 40 mcg protein from Triton X-100-soluble fractions of brain and heart lysates were
electrophoresed and immunoblotted to detect FHF2 (top), NaV1.5 (middle) and GAPDH (bottom). The prominent B30 kDa species in Fhf2WT/Y heart
corresponding to the FHF2VY isoform are not detected in Fhf2KO/Y samples. (d) Immunofluorescence detection of FHF2 and NaV1.5 in Fhf2WT/Y and
Fhf2KO/Y cardiomyocytes. Dissociated cells were fixed and probed with antibodies to FHF2 (red), NaV1.5 (red) and N-cadherin (green) along with DAPI
nuclear stain (blue). FHF2 and NaV1.5 colocalize to Fhf2WT/Y striated T-tubules. NaV1.5 is comparably localized in the Fhf2KO/Y myocyte, while FHF2 is not
detected. (e) Whole-mount X-Gal staining of a Fhf2LacZ/LacZ heart. LacZ at native sites of Fhf2 expression in targeted alleles (a) was detectable throughout
the heart, including atria (A), ventricles (V) and bundle of His (His). Higher magnification views of His bundle (black dashed box) and the left ventricular
free wall (red dashed box). Scale, 25 mm (d); 1 mm (e, left); 250 mm (e, right).
2

NATURE COMMUNICATIONS | 7:12966 | DOI: 10.1038/ncomms12966 | www.nature.com/naturecommunications

ARTICLE

NATURE COMMUNICATIONS | DOI: 10.1038/ncomms12966

and functional assessments by transthoracic echocardiography
were also normal under euthermic conditions (Supplementary
Table 2). However, Fhf2KO/Y mice were highly temperaturesensitive. Elevation of core body temperature by external heat
source resulted in marked conduction slowing as evidenced by
progressive P and QRS wave prolongation and atrioventricular
(AV) block (Fig. 2a and Supplementary Table 1). Above 40 !C, all
mutant mice developed coved-type ST elevations with T wave
inversions, reminiscent of the Brugada pattern ECG (Fig. 2a).
Mutant mice did not tolerate sustained temperature elevation due
to high-grade AV block and progressive conduction failure.
With subsequent cooling to 37 !C, all ECG conduction parameters returned to baseline. In contrast, male wild type
(Fhf2WT/Y) mice displayed normal ECG parameters throughout
the temperature ramp up to 43 !C (Fig. 2a and Supplementary
Table 1). Measurement of intracardiac intervals including atrialHis (AH) and His-ventricular (HV) intervals, which are measures
of AV nodal conduction time and His-Purkinje-mediated ventricular activation time, respectively, were similar to Fhf2WT/Y
mice at 37 !C but were significantly prolonged in mutant mice at
elevated temperatures (Fig. 2b and Supplementary Table 1).
Fhf2KO mice display increased sensitivity to flecainide. Fhf2KO/Y
animals were highly sensitive to the sodium channel blocker flecainide (15 mg kg ! 1), which caused marked P and QRS wave
prolongation and AV block at 37 !C (Fig. 2c and Supplementary
Table 3). In contrast, Fhf2WT/Y mice were able to tolerate
high dose flecainide (30 mg kg ! 1), and despite having marked
prolongation of P, PR and QRS durations, the conduction
parameters remained stable during temperature ramp up to 43 !C
(Fig. 2d and Supplementary Fig. 1).
Isolated Fhf2KO hearts retain temperature-sensitive defects. To
rule out extra-cardiac contributions to the temperature-sensitive
phenotype, including autonomic effects, explanted Fhf2KO/Y and
Fhf2WT/Y hearts were Langendorff-perfused and subjected to a
temperature ramp protocol with a maximum perfusion
temperature of 43 !C (Fig. 2e). Similar to the in vivo findings,
Fhf2KO/Y hearts exhibited progressive P and QRS wave
prolongation, and AV block on volume-conducted ECG with
temperature elevation. Coved-type ST elevations with T wave
inversions were again seen in mutant hearts at temperatures
greater than 40 !C. Fhf2WT/Y hearts displayed stable conduction
parameters throughout the temperature recordings.
Optical mapping of Fhf2KO/Y and Fhf2WT/Y hearts using a
voltage-sensitive dye was performed to evaluate differences in
epicardial conduction velocities (CV) at 37 and 39 !C. Activation
maps of the anterior wall were obtained at a pacing cycle length of
200 ms (Fig. 2f). Epicardial CV were markedly slower in Fhf2KO/Y
compared with Fhf2WT/Y hearts at 37 !C (0.25±0.0063 m s ! 1
versus 0.56±0.01 m s ! 1, KO versus WT, respectively
P ¼ 1.35E-5, Student’s t-test). CV slowing was global and not
confined to the right ventricular outflow tract, as has
been reported in some patients with BrS (refs 14–16). Fhf2KO/Y
hearts showed further reduction in epicardial CV at 39 !C, while
Fhf2WT/Y hearts maintained stable epicardial CV measurements
at higher temperature.
Fhf2KO cardiomyocytes have reduced excitability at 40 !C. To
study the effects of FHF2 on cellular excitability, we acutely
dissociated ventricular myocytes prepared from Fhf2WT/Y and
Fhf2KO/Y mice and tested their ability to generate action
potentials (AP) at 25 and 40 !C in response to current injection
through whole-cell patch. Fhf2WT/Y cells could generate action
potentials at either temperature, although AP waveforms were

significantly attenuated at 40 !C (Fig. 3a and Supplementary
Table 4). By contrast, Fhf2KO/Y cells had reduced amplitude AP
waveforms at 25 !C and failed to fire at 40 !C (Fig. 3a
and Supplementary Table 4). We conclude that the Fhf2KO
temperature-dependent conduction defect reflects, at least in part,
an underlying deficit in excitability of individual cardiomyocytes.
Altered sodium channel inactivation in Fhf2KO cardiomyocytes.
The basis of Fhf2KO cellular excitation deficit was probed by
recording sodium currents from voltage clamped Fhf2WT/Y and
Fhf2KO/Y cardiomyocytes. Voltage step commands elicited similar
transient sodium current densities in Fhf2WT/Y and Fhf2KO/Y cells
at 25 !C, although peak currents in Fhf2KO/Y cells fell by 37% when
recorded at 30 !C (Fig. 3b and Supplementary Table 4). Loss of
Fhf2 altered sodium channel inactivation in several ways. Channels
in Fhf2KO/Y cells underwent steady-state inactivation at more
hyperpolarized potential than did channels in Fhf2WT/Y cells at
25 !C (Fig. 3c and Supplementary Table 4). Fhf2 deficiency also
accelerated the rate of sodium current decay when recorded at
either 25 or 30 !C, with mutation and elevated temperature
combining to produce the fastest rate of open-state inactivation
(Fig. 3d and Supplementary Table 4). Sodium channel closed-state
inactivation rates were assayed by comparing peak sodium
conductance generated by voltage ramps to conductance generated
by instantaneous voltage step. While longer ramp durations
reduced peak sodium conductance under all conditions due to
closed-stated channel inactivation, higher temperature and Fhf2
mutation each enhanced the effect of ramp duration on channel
availability, with Fhf2 mutation and elevated temperature
combining to yield the most severe reduction in availability
(Fig. 3e, Supplementary Fig. 2 and Supplementary Table 4).
Sodium channel inactivation kinetics were further studied in
human embryonic kidney (HEK) cells transfected to express
cardiac sodium channel Nav1.5 with or without FHF2VY, the
principal protein isoform of FHF2 expressed in mouse heart13.
Patched HEK cells more easily survived temperature ramping than
did cardiomyocytes allowing assessment of Nav1.5 inactivation
parameters at 25, 35 and 40 !C often within the same cell. Steadystate voltage dependent Nav1.5 inactivation at 25 !C occurred with
V1/2 ¼ ! 82.2±1.6 mV (n ¼ 7) in the presence of FHF2VY and
V1/2 ¼ ! 93.5±0.9 mV (n ¼ 9) in the absence of FHF2
(Po0.0002, Student’s t-test) (Supplementary Table 5). The
absence of FHF2VY also increased the rate of NaV1.5 closedstate and open-state inactivation at all temperatures (Fig. 3f,g,
Supplementary Fig. 3 and Supplementary Table 5). Most notably,
even a 45 mV ms ! 1 voltage ramp at 40 !C caused a greater than
50% reduction in Nav1.5 peak conductance in the absence of
FHF2, while more than 80% of channels remained available under
these conditions in the presence of FHF2VY (Fig. 3f and
Supplementary Fig. 3).
Computational models of Fhf2WT and Fhf2KO cardiomyocytes.
To establish whether hyperthermic excitation failure is
attributable to altered cardiac sodium channel inactivation gating,
we modified a previously generated mouse ventricular
cardiomyocyte computational model17 to reflect the differential
Nav gating properties in the presence and absence of FHF2. The
Fhf2WT and Fhf2KO myocyte models differed only in the openand closed-state inactivation rate constants of the embedded Nav
12-state Markov model. Both models generated the same peak
Nav conductance in response to step depolarization and the same
voltage dependence of Nav activation (Supplementary Fig. 4).
But in comparison to the Fhf2WT model, Nav conductance in
the Fhf2KO model displayed a hyperpolarizing shift in the
voltage dependence of steady state inactivation (Supplementary
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Fig. 4), exhibited faster closed-state inactivation in voltage ramp
simulations (Fig. 4a), and faster open-state inactivation
(Fig. 4b). Analogous to recorded channels, inactivation rates
were temperature-dependent, such that Fhf2 mutation and
temperature elevation combined generated the fastest Nav
inactivation rates (Fig. 4a,b, Supplementary Fig. 4). Current
injection simulations (Fig. 4c) demonstrated the consequences of
altered NaV inactivation gating. The Fhf2WT model fired action
potentials at both 25 and 40 !C, although AP waveforms were
4
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attenuated at higher temperature, while the Fhf2KO model
exhibited complete excitation failure at elevated temperature.
Discussion
Preservation of cardiac sodium current density is critical for survival.
Here we demonstrate that FHF2 acts to dampen the temperaturedependent acceleration of NaV1.5 open and closed-state inactivation
and thereby maintain cardiac excitability and conduction
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Figure 2 | Hyperthermia-induced electrocardiographic (ECG) changes and conduction block in the Fhf2KO/Y heart. (a) Representative surface ECG
traces of adult (8–12 wk) Fhf2WT/Y and Fhf2KO/Y mice subjected to hyperthermia-induction protocol. External heat lamp was used to raise core body
temperature from 37 to 43 !C followed by cooling to 37 !C (1 !C min ! 1). Fhf2KO/Y ECG parameters were similar to Fhf2WT/Y animals at 37 !C (n ¼ 10) but
were significantly prolonged in mutant mice at elevated temperatures (Z40 !C) (n ¼ 9 mutants and 7 controls). Coved-type ST elevations and high degree
AV block with periods of ventricular asystole were noted in Fhf2KO/Y mice above 40 !C. Fhf2WT/Y mice did not exhibit altered ECG parameters
at any temperature (37–43 !C). QRS duration is plotted against core body temperature. (b) Representative intracardiac electrogram traces during
hyperthermia-induction protocol. Intracardiac conduction intervals (AH, HV, AVI) of Fhf2KO/Y were similar to Fhf2WT/Y animals at 37 !C but were
significantly prolonged in mutant mice (n ¼ 3) at elevated temperatures (Z40 !C). HV interval duration is plotted against core body temperature.
(c) Flecainide (15 mg kg ! 1) challenge was performed in adult (8–12 wk) Fhf2WT/Y and Fhf2KO/Y mice (n ¼ 5). Representative surface ECG traces five minutes
after administration of flecainide demonstrates significantly prolonged ECG parameters in Fhf2KO/Y compared with Fhf2WT/Y mice at 37 !C (upper panels).
Representative surface ECG traces 15 min after administration of flecainide 15 mg kg ! 1 in Fhf2KO/Y showing progressive heart block (lower panel).
(d) Flecainide (30 mg kg ! 1) challenge was performed in adult (8–12 wk) Fhf2WT/Y mice in combination with the hyperthermia-induction protocol.
Representative surface ECG traces of flecainide treated Fhf2WT/Y mice (n ¼ 5) at 37 !C and 43 !C. Fhf2WT/Y mice treated with flecainide did not exhibit any
further prolongation of conduction parameters with elevated temperature (37–43 !C). (e) Langendorff-perfused Fhf2WT/Y and Fhf2KO/Y whole hearts (n ¼ 4)
subjected to hyperthermia-induction protocol. Volume-conducted ECG recordings of isolated Fhf2KO/Y hearts recapitulated the in vivo findings.
(f) Representative ventricular activation maps from Fhf2WT/Y and Fhf2KO/Y at 37 and 39 !C (n ¼ 3). Hearts were paced at a 200 ms basic cycle length.
Isochrones are drawn 5 ms apart. AH, atrial-His; HV, His-ventricular; AVI, atrioventricular interval; CV, conduction velocity. Scale, 1 mm (f). Data represent
mean±s.e.m. *significant P values, Student’s t-test.

throughout a range of physiologically relevant body temperatures.
The importance of FHF2 becomes most apparent during
hyperthermia when the intrinsic inactivation kinetics of NaV1.5, if
left unchecked, can be brisk enough to severely impair sodium
current density, leading to excitation block and conduction failure.
Although the ECG parameters of Fhf2KO mice were normal at
37 !C, the degree of conduction slowing measured by optical
mapping was substantial. This difference may reflect that in vivo
ECGs, unlike the optical maps, were measured during sinus
rhythm, where near simultaneous multi-site activation of the
ventricular myocardium by the His-Purkinje system can mask
myocardial conduction slowing. Purkinje myocytes express
additional FHF isoforms18, which may confer some degree of
protection against conduction slowing within the specialized
conduction system in Fhf2KO mice. The full extent of conduction
slowing observed in the isolated heart preparations may
also reflect the increased dependence of sodium current density
on the slope of initial membrane depolarization in Fhf2KO
myocytes. In the intact heart, action potentials are triggered
following non-instantaneous depolarization mediated by gap
junctional currents passing from upstream cells19. Therefore,
sodium current density in Fhf2KO hearts should be exquisitely
sensitive to conditions that increase intercellular resistivity
between cardiomyocytes, such as the increase in interstitial
volume that may be seen with Langendorff perfusion20. Indeed,
the observation that FHF2 may modulate the dependency of
sodium current density on junctional conductance has
important implications for arrhythmia mechanisms associated
with conditions that produce intercellular uncoupling, such as
acute ischaemia21 or pathologic gap junction remodelling22.
The dynamic nature of the ECG abnormalities in FHF2KO
hearts is highly reminiscent of Brugada syndrome, where ECG
parameters change from normal to coved-type ST elevations in
the presence of fever or sodium channel blocking drugs. While
the electrophysiological basis of the Brugada pattern ECG is
controversial, some have reported focal conduction slowing in the
right ventricular outflow tract as a potential mechanism14–16.
Although optical mapping of Fhf2KO hearts demonstrated global
conduction slowing, additional analysis may be revealing.
Furthermore, exploring the interplay between FHF2-dependent
alterations in sodium current physiology and other ionic currents
that have been implicated in the Brugada pattern ECG will
certainly be of significant interest.
It should also be noted that in contrast to our results, Puranam
et al.23 recently reported embryonic lethality in their lineage
of Fhf2KO mice. While the basis for this discrepancy is unclear,

one possibility is that this other reported mutant allele was
maintained on a C57Bl/6 background, with background
strain influencing phenotype. Whether this lineage of Fhf2KO
mice survives to adulthood in other background strains should
be evaluated.
In summary, our results identify the critical role of FHF2 in
maintaining adequate sodium current reserve in response to
hyperthermic stress. These results have direct implications for
fever-induced Brugada syndrome, where loss of function sodium
channel mutations may conspire with FHF-dependent
mechanisms, such as allelic expression levels, to produce
temperature-sensitive effects. It will be of interest to extend our
studies in Fhf2 mutant mice to additional fever models, such as
challenge with lipopolysaccharide24 or cytokines25,26. It is also
worth noting that the co-expression of FHFs and NaVs in the
heart and brain may point to a unifying theory for both febrile
arrhythmias and seizures23.
Methods

Fhf2KO mouse derivation. All protocols conformed to the Association for the
Assessment and Accreditation of Laboratory Animal Care and the NYU School of
Medicine Animal Care and Use Committee. A murine embryonic stem cell line
bearing a ‘knockout first with conditional potential’ cassette integrated into the
Fhf2 locus located on chromosome Xq26 (International Mouse Phenotype
Consortium, clone EPD0339_4_F09) was injected into blastocysts to derive
chimeric mice, which were outbred to establish viable mice bearing the targeted
allele. Pronuclear injection of Cre recombinase-expressing plasmid into fertilized
eggs of this lineage yielded progeny bearing Cre-mediated excision of Fhf2 coding
exon 3, which specifies an integral portion of the FHF b-trefoil fold10. The
Cre-excised allele specifies bicistronic transcripts encoding truncated FHF2
peptides (from exons 1 to 2) and E. coli LacZ (Fig. 1a). A 3-primer polymerase
chain reaction reaction with Phyre DNA polymerase allows simultaneous detection
of wild-type (WT) and knockout (KO) alleles (Fig. 1a,b). Mice carrying the KO
allele were backcrossed three generations to the 129/svPas strain before use in all
cardiac physiology experiments.
Antibody reagents. Immunofluorescence antibodies [target, dilution, (species,
company)]. Primary antibodies: FHF2 (ref. 27) 1:500 (Epitope GGKSMSHNEST,
Rabbit), NaV1.5 1:50 (mouse, Alomone, ASC-005), Sarcomeric Actinin 1:100
(mouse, Sigma, a7811), N-cad 1:100 (mouse, BD Biosciences, 610921). Mounting
medium with DAPI (Vectashield, H-1200).
Western blot antibodies. Primary antibodies: FHF2 1:1,000 (rabbit, Sigma,
HPA002809); NaV1.5 1:500 (rabbit, Alomone Labs. ASC-005); GAPDH 1:750
(mouse, Millipore: mab374). Secondary antibodies: Goat anti-Rabbit 1:15,000
(Li-Cor 926-32211); Goat anti-Mouse 1:15,000 (Li-Cor 926-32220).
Immunoblotting. Brain and exsanguinated heart tissues were homogenized in cold
detergent-free buffer, after which membranes were solubilized by adding 1% Triton
X-100. Clarified lysates were run on 4–20% precast polyacrylamide gradient gels
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Figure 3 | Temperature-dependent excitation failure and altered sodium channel gating in the absence of FHF2. (a) Ventricular cardiomyocyte
excitability. Superimposed voltage traces of representative patched Fhf2WT/Y and Fhf2KO/Y cardiomyocytes injected with depolarizing current
(0–480 pA in 40 pA steps) at 25 !C and in the same cells after raising temperature to 40 !C. All tested Fhf2KO/Y cells were inexcitable at 40 !C.
(b) Cardiomyocyte NaV peak conductance (gNaV-peak). gNaV-peak following ! 120 mV to ! 35 mV depolarization step was measured for Fhf2WT/Y
and Fhf2KO/Y cells at 25 !C and 30 !C. (c) Cardiomyocyte NaV steady-state inactivation. Available gNaV at 25 !C after 60 ms conditioning at ! 140 to
! 40 mV is expressed as fraction maximal gNaV. Vertical dashed lines indicate V1/2 inactivation in Fhf2WT/Y and Fhf2KO/Y cells. (d) Cardiomyocyte NaV
open-state inactivation rate. Superimposed representative traces (left) from Fhf2WT/Y (black line) and Fhf2KO/Y (grey line) cardiomyocytes at 25 !C
(top) and 30 !C (bottom) following depolarization to ! 35 mV. Fast exponential time constant (t) for decay of sodium current in response to voltage
step to ! 35 mV are plotted for Fhf2WT/Y and Fhf2KO/Y cells at 25 and 30 !C (right). (e) Voltage ramp NaV inactivation in cardiomyocytes. gNaV-peak in
response to voltage ramps to ! 50 mV at different rates was expressed as percentage of gNaV-peak elicited by step depolarization (N ramp rate).
Slower ramp rates decrease gNaV–peak through closed-state inactivation, which is sensitized by both elevated temperature and Fhf2 mutation
(histogram). See Supplementary Fig. 2 for representative conductance traces. (f) Voltage ramp NaV1.5 inactivation with and without FHF2VY.
HEK cells transfected with NaV1.5±FHF2VY subjected to voltage ramps to ! 30 mV at different rates at 25, 35 and 40 !C. NaV1.5 closed-state
inactivation is increased by slowed voltage ramp, temperature elevation and the absence of FHF2VY. See Supplementary Fig. 3 for representative
conductance traces. (g) NaV1.5 open-state inactivation. Fast t for NaV1.5 current decay was measured in cells±FHF2VY at 25, 35 and 40 !C. Elevated
temperature and absence of FHF2VY each accelerate NaV1.5 open-state inactivation. Data represent mean±s.e.m. *significant P values (all P values in
Supplementary Tables 4 and 5); ns, not significant; Student’s t-test.
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Figure 4 | Computational models of Fhf2WT and Fhf2KO cardiomyocytes. The two models have the same gNaV–peak in response to instantaneous
depolarization steps (Supplementary Fig. 4) and the same NaV temperature-dependent kinetic scaling factor (Q10 ¼ 3, see Methods), and differ only in
their NaV inactivation parameters. (a) Voltage ramp NaV inactivation in cardiomyocyte models. Simulations were conducted at 25, 35 and 40 !C.
NaV sensitivity to closed-state inactivation during slower voltage ramp is potentiated in the Fhf2KO model at all temperatures, closely resembling NaV1.5
recordings ±FHF2VY (Fig. 3f). (b) NaV open-state inactivation rate. t for decay of sodium current in response to voltage step to ! 20 mV are plotted for
both models cells at 25, 35 and 40 !C. Open-state inactivation is accelerated in the Fhf2KO model at all temperatures. (c) Model cardiomyocyte excitability.
100 ms current injections ranging from 0 to 600 pA (insets) were applied to Fhf2WT and Fhf2KO models at 25 and 40 !C. Both models are excitable at 25 !C,
but only the Fhf2WT model is excitable at 40 !C, comparable to cardiomyocyte recordings (Fig. 3a).
(Invitrogen) and transferred to nitrocellulose (Bio-Rad) overnight at 4 !C.
Nitrocellulose membranes were incubated in blocking buffer consisting of
PBS (NaV1.5) or TBS (FHF2) with Tween-20 (0.05%) and 5% nonfat dry
milk. Membranes were then incubated with specific primary antibodies
diluted in 5% nonfat dry milk in PBST/TBST (0.05%) overnight at 4 !C followed
by wash steps and secondary antibodies (Li-Cor). Antigen complexes were
visualized and quantified with the Odyssey Imaging System (Li-Cor). The
uncropped western blot images shown in Fig. 1c are displayed in Supplementary
Fig. 5.
Cardiomyocyte enzymatic dissociation experiments. Cardiac cells were
dissociated from adult hearts that were Langendorff perfused and enzymatically
digested according to AfCS Procedure Protocols PP00000125. Mice were
heparinized (500 U kg ! 1) and killed with 100% carbon dioxide. Hearts were
surgically removed via thoracotomy and immersed in ice cold perfusion buffer
(composition (mmol l ! 1): 113 sodium chloride (NaCl), 4.7 potassium chloride
(KCl), 0.6 potassium phosphate monobasic (KH2PO4), 0.6 sodium phosphate
dibasic (Na2HPO4), 1.2 magnesium sulphate heptahydrate (MgSO4.7H2O),
12 sodium bicarbonate (NaHCO3), 10 potassium bicarbonate (KHCO3), 10 HEPES
buffer solution, 30 mM taurine, 5.5 mM glucose and 10 2,3-Butanedione monoxime
(BDM)). The aorta was cannulated and Langendorff perfused with perfusion buffer
at a constant flow rate of 3 ml min ! 1 for 3 min. The perfusate was then switched to
myocyte dissociation buffer (composition: 1 # perfusion buffer, 10 mg Liberase TM
and 12.5 mM calcium chloride (CaCl2) at a constant flow rate of 3 ml min ! 1 for
8 min. Perfusate temperature was maintained at 37 !C. Heart was removed, placed
in a dish containing 2.5 ml myocyte dissociation buffer plus 2.5 ml stop buffer 1
(composition: 1 # perfusion buffer, 10% bovine calf serum, and 12.5 mM CaCl2),
and tissue above the atrioventricular ring was removed. Ventricles were teased into
several small pieces with fine forceps. Cellular dissociation was achieved by further,
gentle mechanical agitation via 15 ml transfer pipets. Quality of myocyte
dissociation was then assessed by counting myocyte yield and percentage of
rod-shaped myocytes. Only preparations with yields greater than 1 million cells
and 460% rod-shaped myocytes were used for further experimentation.
Cardiomyocytes were sedimented by centrifugation at 100g for 1 min in 15 ml
tubes. The supernatant was discarded after sedimentation and the pellet was

re-suspended in 10 ml of stop buffer 2 (composition: 1 # perfusion buffer,
5% bovine calf serum, and 12.5 mM calcium chloride (CaCl2)) added to increasing
concentration of Ca2 þ in 5 min intervals ( þ 50 ml 10 mM Ca2 þ (62 mM), þ 50 ml
10 mM Ca2 þ (112 mM), þ 100 ml 10 mM Ca2 þ (212 mM), þ 30 ml 100 mM Ca2 þ
(500 mM) and þ 50 ml 100 mM Ca2 þ (1 mM)). Viability of myocytes was
reassessed using the above quality control guidelines. Only cell preparations that
passed these criteria were used for experimentation.
Immunocytochemistry. Dissociated ventricular myocytes were fixed in 4%PFA
for 5 min. Cells in suspension were spun onto slides using Shandon Cytospin II
(Speed 250 r.p.m., 2 min). Cells were blocked with 10% serum and 0.01% Triton in
PBS for 1 h, and then incubated with primary antibodies overnight. Cells were then
washed in PBS and incubated with secondary antibodies conjugated to Alexa Fluor
dyes (Invitrogen) for 1 h before mounting. Slides were coverslipped with
Vectashield mounting media with DAPI (Vector Laboratories). Stained cells
were visualized using a Leica TCS SP5 confocal microscope with Leica LAS AF
acquisition software.
Whole-mount staining for b-galactosidase activity. Tissues were collected in
ice-cold PBS and perfusion fixed for 1 h in fix solution (2% formaldehyde, 0.2%
glutaraldehyde, 0.02% Nonidet P-40 (NP-40), 0.01% sodium deoxycholate in PBS).
After fixation, tissues were rinsed in PBS three times and then stained overnight at
37 !C in the dark with stain solution (5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6,
1 mg ml ! 1 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (X-gal), 2 mM
MgCl2, 0.02% NP-40, 0.01% sodium deoxycholate in PBS). Bright field images of
hearts were taken using the Zeiss Discovery V8 microscope equipped with a Zeiss
AxioCam Colour camera interfaced with Zeiss Zen 2012 software.
Mouse in vivo electrophysiology and flecainide drug challenge. ECGs were
obtained using subcutaneous electrodes attached at the four limbs (MP100,
BIOPAC Systems). 8–12 week-old, male mice were anaesthetised with inhaled
(2% v/v) isoflurane. Heart rate and core body temperature (rectal temperature
probe) were continuously recorded. Flecainide (15 mg kg ! 1 or 30 mg kg ! 1) was
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administered via intraperitoneal injection. ECG analysis was performed in an
unbiased fashion where 100 beats at each temperature endpoint were analysed
using LabChart 7 Pro version 7.3.1 (ADInstruments, Inc). Detection and analysis of
P wave, PR interval and QRS wave intervals were set to Mouse ECG parameters.
Intracardiac recordings were obtained in 8–12 week-old, male mice under
isoflurane anaesthesia (1.5% v/v) using an octapolar catheter (EPR-800, Millar
Instruments) placed via the right internal jugular vein for bipolar recordings at the
level of the His bundle. Intracardiac intervals were measured from the His bundle
catheter when the atrial, His, and ventricular electrograms were stable over 425
beats. Measurement of the AH interval was taken from the His bundle recording
from the onset of deflection from baseline of the local atrial electrogram to the
onset of deflection from baseline of the His bundle electrogram. Measurement of
the HV interval was taken from the onset of deflection from baseline of the His
bundle electrogram to the onset of deflection from baseline of the earliest
ventricular electrogram, whether on surface ECG or intracardiac recordings. Core
body temperature was initially maintained at 37 !C and gradually elevated up to
43 !C at a rate of 1 !C min ! 1 using an external heat lamp.
Transthoracic echocardiography. Echocardiography was performed using the
Vevo 2,100 high-resolution ultrasound imaging system with a real-time 30 MHz
linear array scanhead (MS400) at a frame rate of 235 fps, a focal length of 8 mm,
and a 10 # 10-mm field of view (Visualsonics; Toronto, Canada). 8–12 week-old,
male mice were anaesthetised with 2% isofluorane, and hair was removed from the
chest using a depilatory cream (Nair; Church & Dwight Co, Inc; Princeton, NJ).
Warmed ultrasound transmission gel was placed on the chest and used to obtain
left ventricular endpoints of cardiac function. B-mode cardiac imaging was
conducted on transverse (short axis) plane. The papillary muscles were used for the
short axis imaging landmark. M-mode recordings of the left ventricle were also
recorded at the short axis B-mode imaging plane to obtain left ventricular function
and dimensions through the cardiac cycle. Heart rate was monitored and core body
temperature was maintained at 37.5 !C using a heated platform and a hair dryer
throughout the procedure. Data analysis was performed on VisualSonics Vevo
2,100 V1.5.0 software (Visualsonics; Toronto, Canada). The following parameters
were measured using three cardiac cycles from short axis M-mode images: diastolic
and systolic left ventricular internal diameter, anterior wall thickness, and posterior
wall thickness. From these measurements, left ventricular ejection fraction, per cent
fractional shortening, stroke volume, and cardiac output were calculated within the
Vevo software.
Heart isolation and Langendorff perfusion. Male mice of 8–12 week-old were
heparinized (500 U kg ! 1) and killed with 100% carbon dioxide. Hearts were surgically
removed via a thoracotomy. While fully immersed in oxygenated (95% O2, 5% CO2)
Tyrode’s (composition (mmol l ! 1): NaCl 114, NaHCO3 25, dextrose 10, KCl 4.6,
CaCl2 1.5, Na2PO4 1.2, MgCl2 0.7), the aorta was cannulated and Langendorff
perfused at a constant pressure of 70 mm Hg. Perfusate temperature was initially
maintained at 37 !C and increased by increments of 1 !C to a maximum temperature
of 41 !C (optical mapping) or 43 !C (volume-conducted ECG). Perfusate temperature
was allowed to reach steady state between temperature ramps.
Optical mapping. High-resolution optical mapping experiments were performed
as follows: excised hearts from 8 to 12 week-old, male mice were initially perfused
with Tyrode’s solution to clear blood and stabilize the heart, followed by Tyrode’s
solution containing 10 mM blebbistatin. Hearts were allowed to recover for 20 min
and then stained with the voltage-sensitive dye, Di-4-ANEPPS (Molecular Probes
Inc., Eugene, OR, USA). Light from green LEDs (530 nm; ThorLabs) was used as an
excitation source and the emitted light (620 nm long pass) was detected with 1
high-resolution CMOS camera (Mi-CAM Ultima-L;SciMedia) at 1,000 frames per s
in bin mode (100 # 100 pixels) with 14-bit resolution. Images were processed using
a custom software package.
Action potential recordings from adult cardiomyocytes. Excitability of acutely
dissociated ventricular cardiomyocytes from FHF2WT/Y and FHF2KO/Y mice was
conducted using a MultiClamp700 Amplifier, Digidata 1,440 analogue/digital
converter and Clampex10 software (Molecular Devices). Cells were placed in the
recording chamber under a Nikon Eclipse microscope and perfused with
carbogen-bubbled bath solution (115 mM NaCl, 26 mM NaHCO3, 3 mM KCl,
1.2 mM KH2PO4, 3 mM glucose, 2 mM myoinositol, 2 mM Na pyruvate, 7 mM
HEPES, 1.2 mM Mg2SO4, 2 mM CaCl2, 0.2 mM CdCl2 at pH 7.2) maintained at
25 !C using an in-line heater (Warner Instruments). Patch pipettes were
pulled with a P97 Micropipette Puller (Sutter Instruments) to yield a resistance of
1–1.5 MO when filled with 120 mM K gluconate, 4 mM NaCl, 5 mM
KOH-buffered HEPES, 5 mM KOH-buffered EDTA, 15 mM glucose, 1 mM
MgSO4, 3 mM Mg-ATP, 0.1 mM Na-GTP at pH 7.2. Pipette approach to cell was
visualized using a 60 # water immersion lens and infrared illumination with
differential interference contrast. Following tight seal formation and break-in to
achieve whole-cell access, voltage clamp depolarization steps were used to confirm
presence of large inward sodium current and measure capacitive current transients
before switching to current clamp mode. Steadily applied negative current was used
to set the amplifier-measured voltage to ! 85 mV, which was equal to ! 95 mV
8

membrane potential due to a 10 mV junctional potential between pipette and
bath solutions. Excitability was assessed by applying 200 ms injection sweeps of
continuous current ranging from 0 to 480 pA in 40 pA steps. Membrane voltage
recordings were high-pass filtered at 10 kHz and digitally acquired at 50 kHz. After
data acquisition, the bath temperature was ramped to 40 !C over a 3–5 min
time span, and excitability was retested with the same protocol. Only cells for
which input resistance deviated less than 20% during temperature ramp were
included in analysis.
Nav1.5 currents in HEK cells. 293T human embryonic kidney cells previously
described in28, and displaying little or no endogenous sodium channel expression29
were transiently cotransfected with a 2:1 mixture of Nav1.5-expressing plasmid30,
and a pIRES2-ZsGreen bicistronic plasmid (Clontech) expressing ZsGreen and
mouse FHF2VY proteins. The same pIRES2-ZsGreen plasmid without FHF2
coding sequence served as control. Cells were trypsinized 3 h post-transfection,
seeded onto gelatinized coverslips, and were used for recording after 48 h. For
sodium current recordings, coverslips were transferred to recording chamber
containing carbogen-buffered bath solution (115 mM NaCl, 26 mM NaHCO3,
3 mM KCl, 10 mM glucose, 4 mM MgCl2, 2 mM CaCl2, 0.2 mM CdCl2, 3 mM
myoinositol, 2 mM Na pyruvate, 7 mM NaOH-buffered HEPES pH 7.2) at 25 !C
and green fluorescent cells were whole-cell patched with pipettes filled with
104 mM CsF, 50 mM tetraethylamine chloride, 10 mM HEPES pH 7.2, 5 mM
glucose, 2 mM MgCl2, 10 mM EGTA, 2 mM ATP, 0.2 mM GTP and having
1–2 MO resistance. For all recording protocols, sodium current was isolated during
data acquisition by P/N subtraction of leak and capacitive currents (N ¼ ! 6).
To ensure voltage clamping during sodium channel activation was adequate, cells
were subjected to a 19-sweep series of voltage steps from a hold of ! 120 mV to
between ! 80 mV and þ 10 mV in 5 mV increments. As criterion for adequate
clamp, transient current peaks for all voltage commands were nested within the
larger current trace of a following or preceding voltage step command.
Steady-state channel inactivation protocol. To determine the voltage dependence of steady state channel inactivation, a 19-sweep protocol used ! 120 mV
holding command, a 60 ms variable test voltage step ( ! 120 þ 5(n ! 1) mV),
followed by a ! 25 mV reporting pulse.
Voltage ramp protocol. As a measure of closed state channel inactivation rate, a
10-sweep protocol used ! 120 mV hold command followed by depolarization to
! 30 mV either instantaneously (voltage step) or as a ramp ranging in time from
2 ms ( ¼ 45 mV ms ! 1) to 18 ms ( ¼ 5 mV ms ! 1).
Temperature elevation. After recording at 25 !C, temperature was ramped to
35 !C and later to 40 !C. At elevated temperatures, the cell was first tested as above
to ensure maintenance of tight clamp, after which the voltage ramp protocol was
conducted. For many cells, voltage ramp protocols could be successfully run at all
three temperatures (examples in Supplementary Fig. 3).
Sodium current recordings in adult cardiomyocytes. All INa recordings in
isolated cardiomyocytes were conducted in whole-cell configuration at 25 or 30 !C.
Recording pipettes were filled with a solution containing (in mM): NaCl 5, CsF 135,
EGTA 10, MgATP 5, HEPES 15, pH 7.2 with CsOH. Cells were maintained in a
solution containing (in mM): NaCl 5, CsCl 112.5, TEACl 20, CdCl2 0.1, MgCl2 1,
CaCl2, 1, HEPES 20, Glucose 11, pH 7.4 with CsOH. To determine the peak current
voltage relation, 200 ms voltage pulses were applied to Vm ! 90 mV to þ 30 mV in
5 mV voltage steps, from a holding potential of Vm ¼ ! 120 mV. Interval between
voltage steps was 3 s. Steady state inactivation was determined by stepping Vm to
conditioning voltages of between ! 130 mV and ! 20 mV for 60 ms, followed by a
30 ms test pulse to Vm ¼ ! 20 mV to elicit INa. The steady state voltage-dependent
inactivation curves were fitted to Boltzmann’s functions. As a measure of closed
state channel inactivation rate, a 10-sweep protocol used ! 140 mV hold command
followed by depolarization to ! 50 mV either instantaneously (voltage step) or as a
ramp ranging in time from 2 ms ( ¼ 45 mV ms ! 1) to 18 ms ( ¼ 5 mV ms ! 1). All
recordings were obtained utilizing an Axon multiclamp 700B Amplifier coupled to
a pClamp system (versions 10.2, Axon Instruments, Foster City, CA).
Cardiomyocyte excitation parameters. Spike threshold was defined as the point
of accelerated upward voltage deflection at the base of a spike, mathematically
defined as the voltage when d2V/dt240 as determined using Clampfit software
(Molecular Devices).
Spike Vamplitude ¼Vpeak !Vthreshold :

ð1Þ

Values for FHF2WT/Y versus FHF2KO/Y were assessed for significant difference by
two-tailed Student’s t test. The number of FHF2WT/Y versus FHF2KO/Y cells that
could spike and that failed to spike at 40 !C was used to assess significant
difference by two-tailed Fisher Exact Probability test using an online calculator
(http://vassarstats.net/odds2x2.html).
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Cardiomyocyte passive properties. Capacitance of each cell was measured as

such that

ð2Þ

Con ¼ACon #Q10

ð11Þ

where Dq is the current transient time integral to a negative voltage step command
DV. Leak conductance was measured as

Oon ¼AOon #Q10

ð12Þ

Coff ¼ACoff #Q10

ð13Þ

Ooff ¼AOoff #Q10

ð14Þ

a ¼ Aa#Q10#10^ ðVmembrane ! Vshift Þ=Va

ð15Þ

b ¼ Ab#Q10#10^ ð ! Vmembrane þ Vshift Þ=Vb

ð16Þ

g¼Ag#Q10

ð17Þ

d¼Ad#Q10

ð18Þ

Cap ¼DV=Dq

gleak ¼Istep =DVm ;

ð3Þ

where DVm is the steady-state change in membrane voltage in response to a
negative current clamp command Istep.
Cardiomyocyte sodium conductance density.
gNavPeak ¼INavPeak =ðVcom ! ENa Þ

ð4Þ

where ENa is the sodium reversal potential and INavPeak is the peak inward current
in response to a voltage command Vcom within the linear ohmic range of the
current/voltage relationship.
Voltage dependence of steady state sodium channel inactivation. Peak sodium
current accompanying the ! 25 mV reporting pulse was measured at each test
voltage, and the fraction of channels available (not inactivated) at test voltage
equalled INa-peak(Vtest)/INa-peak(maximum). To obtain V1/2 and k values for
voltage dependence of steady state inactivation, current data were fitted to
Boltzmann equation:
h
i!1
f ðVtest Þ¼ 1 þ eðV1=2 !Vtest Þ=k
þC
ð5Þ
Open-state sodium channel inactivation kinetics. Transient sodium current
decay from 90% current peak to baseline was fitted to a two-term exponential decay
function
IðtÞ ¼I1 #e ! t=tfast þ I2 #e ! t=tslow þ C

ð6Þ

where I1 and I2 are the fast and slow decaying components of the transient current.
The fast component I1 associated with decay constant tfast constituted between 70
and 100% of the total current in all analysed cells.
Closed-state sodium channel inactivation kinetics. Data from voltage ramp
protocols provided an estimate of closed-state channel inactivation rate as a
function of voltage ramp rate. For each ramp command at each time point, we
calculated
gNav ¼INav =ðVcom ! ENa Þ

ð7Þ

yielding sodium conductance traces as shown in Supplementary Fig. 3. Similarly,
!
"
gNavPeak ¼INavPeak = VcomðatPeakÞ ! ENa
ð8Þ

Parameter values shared by both Fhf2WT
Aa ¼ 2.44375 ms ! 1, Ab ¼ 0.01325 ms ! 1,

Fhf2KO

and
models are
Ag ¼ 150 ms ! 1, Ad ¼ 40 ms ! 1,
Va ¼ Vb ¼ 6 mV, n1 ¼ 5.422, n2 ¼ 3.279, n3 ¼ 1.83, n4 ¼ 0.738, a ¼ (Oon/Con)^0.25,
b ¼ (Ooff/Coff)^0.25. For the Fhf2WT model, ACon ¼ 0.001 ms ! 1, ACoff ¼
0.108 ms ! 1, AOon ¼ 1.05 ms ! 1, AOoff ¼ 0.003 ms ! 1, and Vshift ¼ ! 58 mV, while
in the Fhf2KO model ACon ¼ 0.054 ms ! 1, ACoff ¼ 0.027 ms ! 1, AOon ¼ 1.5 ms ! 1,
AOoff ¼ 0.001 ms ! 1, and Vshift ¼ ! 61 mV. These parameter differences preserved
the voltage dependence of NaV activation in the models while causing a 7 mV
hyperpolarizing shift in voltage dependence of inactivation for the Fhf2KO model
(Supplementary Fig. 4) and accelerating closed-state and open-state inactivation
rates (Fig. 4a,b) compared with the Fhf2WT model.
Voltage–clamp and current–clamp simulations were run using the Myokit
software interface32 and were initiated with a 200 ms channel state equilibration
phase. Voltage–clamp simulations included single-step and double-step protocols
to measure voltage dependence of NaV activation and inactivation along with a
ramp protocol comparable to that employed for experimental recordings to assess
closed-state inactivation. For current-clamp simulations, an initial constant
negative current was applied to adjust membrane voltage to ! 95 mV before
adding positive current steps in multiples of 50 pA (0.7 pA pF ! 1).
Statistics. Quantitative values are expressed as mean and standard error of the
mean for each group. Two-tailed Student’s t test was used to compare differences in
continuous variables between mutant and control animals and cells. Po0.05 was
considered statistically significant. Sample size calculations were done using
preliminary data to design the experiment for measuring continuous variables.
Groups were constructed to detect a 30% difference between experimental and
control groups with a power of 90% and a significance level of 0.05. Experimental
groups were blinded until the endpoints were analysed. Animal studies were done
before genotyping ensuring blinded observations. The Prism statistical package
(version 6, GraphPad) was used for analyses.

from which was calculated

% maximal gNavPeak ðrampÞ¼ 100#gNavPeak ðrampÞ=gNavPeak ðstepÞ

ð9Þ

Computational modelling. The Fhf2WT and Fhf2KO cardiomyocyte models were
generated by introducing modifications to the murine ventricular cardiomyocyte
model from Bondarenko et al.17. These changes included (1) adjusting membrane
capacitance to 70 pF to more closely match our recorded measurements,
(2) recalibrating the ‘leak’ conductances by dividing the inward rectifying postassium
conductance two-fold and replacing with an equal density of potassium conductance
to achieve nonspiking responses to current injections similar to cardiomyocyte
recordings (Fig. 4c), (3) changing the densities of ultrarapid-activating delayed
rectifier and rapid-activating delayed rectifier potassium conductances to
0.112 mS mF ! 1 and 0.234 mS mF ! 1, respectively, in order to obtain more
realistic post-spike repolarization and (4) replacing the fast sodium conductance with
a 12-state Markov model sodium conductance:
n1·α
C1
Coff

n4·β
Con

I1

n2·α
C2

Coff·b

n3·β
Coff·b2

n1·α·a

Con·a
n2·α·a

n4·β·b

I2

n3·β·b

n3·α
C3

n2·β

γ

n4·α
C4

Coff·b3

n1·β

C5
Coff

·b4

δ

O
Ooff

Con·a4
Con·a2
Con·a3
γ
n3·α·a
n4·α·a
I3
I4
I5
n2·β·b
n1·β·b
δ

Oon
I6

This NaV model is an adaptation of the 13-state model of Raman and Bean31,
with the blocked open state and consequent resurgent current omitted. All rate
constants were scaled by a thermodynamic factor
Q10 ¼ 3^ ðdegC ! 32:76Þ=10

ð10Þ

Data availability. Cardiomyocyte computational model files are available for
download at the ModelDB portal (https://senselab.med.yale.edu/modeldb/).
The mouse lines will be made publicly available through a mouse repository.
All other data and materials are available upon corresponding author request.
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SUPPLEMENTARY INFORMATION

Supplementary Figure 1. Surface electrocardiograms (ECG) of flecainide challenged adult
(8-12wk) Fhf2WT/Y mice during the hyperthermia-induction protocol. Fhf2WT/Y mice were
administered flecainide (intraperitoneal) at 0, 15, or 30mg/kg ten minutes prior to
hyperthermia-induction (n=5). Cardiac conduction intervals measured as HR, P wave
duration, PR interval, and QRS duration are plotted with respect to core body temperature.
ECG parameters remained stable during temperature ramp 37°C-43°C. HR; Heart rate. Data
represents mean ± s.e.m. *P<0.05, 0mg/kg vs 15mg/kg; #P<0.05, 0mg/kg vs 30mg/kg,
Student’s t-test at each temperature.

Park et al.

Supplementary Figure 2. Recorded cardiomyocyte NaV conductances during voltage ramp
protocol. Cardiomyocytes were depolarized from -140 mV to -50 mV either
instantaneously (voltage step) or at different ramp speeds while sodium currents were
recorded. The voltage command for each ramp rate is shown color coded (top panel).
Recorded current were converted to conductance offline and plotted as a percentage of
maximum conductance. Middle panels correspond to a representative cardiomyocytes
trace from Fhf2WT/Y heart recorded at 25oC and 30oC, while lower panels correspond to a
representative cardiomyocytes trace from an Fhf2KO/Y heart.
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Supplementary Figure 3. Recorded HEK NaV1.5 conductances during voltage ramp
protocol. Cells were depolarized from -120 mV to -30 mV either instantaneously (voltage
step) or at different ramp speeds while NaV1.5 currents were recorded. The voltage
command for each ramp rate is shown color coded (top panel). Recorded current were
converted to conductance offline. Middle panels correspond to a single cell expressing
NaV1.5 + FHF2VY recorded at 25oC, 35oC, and 40oC, while lower panels correspond to a
single cell expressing NaV1.5 without FHF2 recorded at all temperatures.
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Supplementary Figure 4. Additional NaV properties in Fhf2WT and Fhf2KO cardiomyocyte
models. A) Peak transient sodium current. NaV current traces in response to step
depolarization (-120 mV to -35 mV) have the same peak amplitude in Fhf2WT and Fhf2KO
models at 25oC, with current decaying faster in the Fhf2KO model. B) Voltage dependence of
NaV activation and inactivation. NaV steady state inactivation in the Fhf2KO model occurs at
more negative potential than in the Fhf2WT model, while activation of peak NaV
conductance have same voltage dependence in both models.
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FHF-independent conduction of action potentials
along the leak-resistant cerebellar granule cell axon
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Neurons in vertebrate central nervous systems initiate and conduct sodium action potentials
in distinct subcellular compartments that differ architecturally and electrically. Here, we
report several unanticipated passive and active properties of the cerebellar granule cell’s
unmyelinated axon. Whereas spike initiation at the axon initial segment relies on sodium
channel (Nav)-associated fibroblast growth factor homologous factor (FHF) proteins to delay
Nav inactivation, distal axonal Navs show little FHF association or FHF requirement for
high-frequency transmission, velocity and waveforms of conducting action potentials. In
addition, leak conductance density along the distal axon is estimated as o1% that of
somatodendritic membrane. The faster inactivation rate of FHF-free Navs together with very
low axonal leak conductance serves to minimize ionic fluxes and energetic demand during
repetitive spike conduction and at rest. The absence of FHFs from Navs at nodes of Ranvier in
the central nervous system suggests a similar mechanism of current flux minimization along
myelinated axons.
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eurons in the central nervous system (CNS) generate
action potentials at the axon initial segment (AIS) in
response to polysynaptic and intrinsic somatodendritic
currents that traverse the soma and hillock and depolarize the
AIS membrane to spike threshold1–3. Somatic capacitance
extends the depolarization phase of excitatory postsynaptic
potentials (EPSPs) to several milliseconds, and the slower EPSP
decline phase allows for summation of successive excitatory
inputs over longer timeframes. These temporal features
necessitate the protection of voltage-gated sodium channels
clustered in the AIS from inactivation during depolarization
phases preceding spike threshold. In cerebellar granule cells
(GrCs), cytoplasmic fibroblast growth factor homologous factors
(FHFs) bound to sodium channels play an essential role in
intrinsic excitability by raising the voltage dependence and
slowing the rate of sodium channel inactivation as well as
accelerating channel recovery on repolarization4,5. FHF
modulation of fast inactivation has been shown to apply to
several neuronally expressed sodium channel isoforms, including
Nav1.1, Nav1.2 and Nav1.6 (refs 6–9).
In contrast, regenerative axonal spike conduction may not
benefit from a comparable tuning of sodium channels distributed
more distally along the axon and parallel fibres. The 25–30-fold
greater surface-to-volume ratio of a GrC’s 150 nm diameter
parallel fibres compared with its 5 mm diameter soma demands
that a single action potential peaking at 60 mV generate a
minimum 0.35 mM increase in intracellular sodium ion concentration along the axon and parallel fibres, assuming that all
sodium influx were to be matched by outward capacitive current.
If distally situated sodium channels were slow to inactivate,
allowing for significant temporal overlap between the open states
of voltage-gated sodium and potassium channels, sodium influx
per spike could be far greater, and conduction of high-frequency
spike trains would create a greater energy burden for rapid
Na þ /K þ pumping and ATP synthesis.
These theoretical considerations motivated our investigation of
axonal conductance properties using biochemical, genetic, optical
and computational tools. We show here that spike conduction
along the GrC axon occurs in an FHF-independent manner
predicted to minimize current fluxes. These active properties
combined with an unexpectedly low-leak conductance serve to
minimize energy expenditure within the ultra-thin axon.
Results
Most sodium channels on GrC distal axon lack FHF. A
potential mechanism for accelerating inactivation of sodium
channels along the axon is for channels to have limited association with FHF proteins. To test this hypothesis, we performed
immunoblot analysis on isolated distal axons of GrCs obtained
using a hanging filter culture system (Fig. 1a). Neurons plated on
top of the filter project axons that can pass through pores (10 mm
length, 3 mm diameter) and further extend on the lower surface.
Immunofluorescence can detect the AIS and soma of neurons on
the upper surface of the filter (Fig. 1b), but owing to the 5 mm
length of the granule cell AIS10, axon processes on the lower
surface are all distal in nature (Fig. 1c). Lysates prepared from
scrapes of upper and lower filter surfaces were directly analyzed
by immunoblotting using an FHF monoclonal antibody that
recognizes an epitope common to the A-type isoforms encoded
by all four Fhf genes11 and another monoclonal that detects all
voltage-gated sodium channels12. Compared with upper-surface
whole-cell lysates, the ratio of A-type FHF to sodium channels in
lower-surface distal axon lysates is reduced 5–10-fold (Fig. 1d,
left). This finding was reproducible in five independent
preparations of lysates from hanging cultures. A similar result
2

was obtained when analysis was restricted to surface membraneassociated proteins prepared by streptavidin-agarose capture of
surface-biotinylated proteins (including sodium channels)
(Fig. 1d, center). Furthermore, when lysates were
immunoprecipitated with a mixture of antibodies that recognize
all protein isoforms encoded by the Fhf1 and Fhf4 genes, a much
smaller fraction of sodium channels was detected in the distal
axon preparation compared with whole cells (Fig. 1d, right). Since
the mouse Fhf3 gene is only known to generate an A-type
transcript (Mouse Genome Informatics) and the Fhf2 gene is not
expressed in the GrCs (Allen Brain Atlas), our analysis provides
complete coverage of all expressed FHF isoforms and
demonstrates that most sodium channels on granule cell distal
axons are not associated with FHFs.
FHFs are absent from nodes of Ranvier in the CNS. In order to
test whether FHFs are associated with sodium channels on distal
axons in the CNS, we assayed for localization of FHFs to nodes of
Ranvier along myelinated axons, as the low density and uniform
distribution of sodium channels along unmyelinated axons precluded potential detection of associated FHFs on unmyelinated
axons. A-type FHFs were readily detected at the AIS of virtually
all large-diameter CNS neurons, including brain stem motoneurons and pyramidal neurons in cerebral cortex and hippocampus (Fig. 2a, and ref. 11). However, these FHFs were not seen
on Nav-positive axonal nodes within the corpus callosum
(representative nodes and Caspr-flanking paranodes in Fig. 2b)
or cerebellar white matter (Supplementary Fig. 2). Similarly,
antibodies to FHF2 proteins strongly stained the AIS of all hippocampal pyramidal neurons (Fig. 2c), but did not detect these
proteins at nodes in the corpus callosum (representative nodes in
Fig. 2d). Furthermore, FHF4 proteins were detected at the AIS of
cerebellar Purkinje cells (Fig. 2e), as previously reported13, but
were not detected at any nodes of Ranvier within the cerebellar
cortical white matter, which bears the descending Purkinje cell
axons along with ascending axonal projections (representative
nodes in Fig. 2f). Hence, restriction of FHFs from distal axonal
sodium channels is a feature common to both unmyelinated and
myelinated CNS axons.
FHFs are not required for GrC axonal spike conduction. The
above biochemical analysis suggested that action potential
conduction along granule cell axons does not require sodium
channel modulation by FHFs. To test this prediction, we prepared
GrC cultures from wild-type (WT) and Fhf1 " / " Fhf4 " / " mice4.
Cultured neurons bear between one and four short thick
dendrites and a thin axon extending over 1 mm, often with one
or more major collaterals and varicosities spaced an average of
5 mm apart (Supplementary Fig. 3A). Whereas cultured WT
neurons fired repetitively when injected with continuous positive
current, cultured mutant neurons could only fire once or twice in
response large current injection (Supplementary Fig. 3B,C),
recapitulating the behaviour of these cells in acute brain slice
preparations4. To study the properties of conducting action
potentials, individual cells were each patched with a pipette
containing the voltage-sensitive ANEPPS fluorophore JPW3028
(ref. 14). Following 15 min of filling by passive diffusion, the
pipette was removed and the dye was allowed to permeate the
axon for 60 min before re-patching and recording. Voltage
clamping of the electrically compact somatodendritic
compartment10 showed that dendritic fluorescence and
membrane voltage display a linear relationship over the span
from " 100 to þ 60 mV (Supplementary Fig. 4).
Individual action potentials were triggered by a 0.2 ms 2 nA
current pulse delivered through the patch pipette, and change in
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fluorescence intensity was monitored at a frame rate of 5 kHz.
Dye permeation down the axon was sufficient to allow
fluorescence measurements at up to 250 mm from the soma.
Figure 3a shows a composite of high-resolution images from a
WT cell, while Fig. 3b is a high-speed, low-resolution image of the
same cell taken at lower magnification during voltage-sensitive
dye recording. Temporal fluorescence data from spatiallyaveraged axon pixels highlighted in Fig. 3b are shown in the
graph in Fig. 3c. The current pulse triggered an action potentialrelated optical signal with peak height of 6.5% resting light
intensity, full width at half height of B0.7 ms at a point 155 mm
along the axon, and conduction velocity of B0.2 mm ms " 1
(Fig. 3c), consistent with spike conduction velocities along
ascending axon15,16 and parallel fibres17,18 of these neurons
in situ. A movie of spike generation and conduction visualized
with voltage-sensitive fluorescent dye (Supplementary Movie 1)
illustrates spike initiation in a proximal axonal region within
10 mm from the soma followed by both backpropagation to the
soma and forward propagation along the axon and spike
bifurcation at axonal branchpoints. An Fhf1 " / " Fhf4 " / " (KO)
granule cell conducted an axonal spike with similar velocity,

a
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10 µm
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Upper

b

amplitude, and width (Fig. 3d–f). A cohort of WT (n ¼ 9) and KO
(n ¼ 10) granule cells showed small, insignificant differences
in axonal spike peak amplitude (WT 7.1±0.3% DF versus
KO 6.5±0.2% DF; P40.1) and conduction velocity (WT
0.20±0.02 mm ms " 1 versus KO 0.17±0.01 mm ms " 1; P40.2).
In order to test for faithful conduction of action potentials
generated at high frequency, dye-filled neurons were stimulated
in current clamp with biphasic current pulses (positive current
700 pA for 1 ms followed by equal negative current for 1 ms) at
60 Hz. The negative phase of each current pulse helped drive the
somatic and proximal axonal membrane voltage quickly back
near resting potential, facilitating the recovery from inactivation
of proximal sodium channels even in mutant neurons lacking
FHFs. Using this stimulation protocol, all tested WT (n ¼ 6) and
KO (n ¼ 9) cells were capable of conducting a 60 Hz train of
action potentials down their axons (examples in Fig. 3g,h).
We further tested whether a KO granule cell can conduct a
train of antidromic spikes in response to pulsed stimulation of the
distal axon. As shown in Fig. 3i,j, a 60 Hz train of spikes induced
in the axon at a distance of 250 mm from the soma can be
conducted back to the neuron’s soma and dendrites. These data
confirm that FHFs reside on sodium channels in the proximal
axon where they promote spike initiation while being largely
excluded from more distal channels that mediate spike conduction in an FHF-independent manner.
Passive properties of the GrC distal axon. An understanding of
the passive cable properties of the granule cell axon could help
answer two questions related to spike conduction. First, what is
the leak conductance along the axon that will influence both the
sodium influx needed to generate a conducting spike and the
velocity of spike conduction? Second, is passive charging
consistent with an axonal diameter similar to the 150 nm
diameter of parallel fibres in vivo19? To address these questions,
fluorescence changes in JPW3028-filled axons were monitored in
response to voltage-clamped step commands elicited at the soma.
Figure 4a shows axonal fluorescence measurements during a
100-ms step from " 60 to " 100 mV and a return to " 60 mV
thereafter. All measured points along the axon, ranging from
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Figure 1 | Limited association of FHFs with sodium channels on distal
axons of cultured GrCs. (a) Schematic depiction of culture system. Granule
cells dissociated from juvenile mice (P8) are seeded onto the upper surface
of hanging culture filter membranes (10 mm thick, 3 mm diameter pores) and
cultured for 25 days. Growing axons can traverse pores and continue
extension along lower surface. (b) Confocal fluorescence imaging of an
upper surface showing TOPRO iodide-stained nuclei (pseudocoloured blue)
and short B5 mm AISs visualized with anti-AnkyrinG monoclonal antibody
(green). (c) Fluorescence imaging of a lower surface showing distal axons
detected with neurofilament-A antibody (red) and lacking cell soma (blue).
(d) FHF, Nav and FHF/Nav complexes in lysates of total cells and distal
axons. Left; 20 mg protein extracted from upper surface (whole cell) and
10 mg protein extracted from lower surface (distal axons) were directly
electrophoresed and immunoblotted for detection of sodium channels with
pan-Nav antibody and detection of all A-type FHFs with pan-A-FHF
antibody. Center; live cultures were surface-biotinylated before extraction
and streptavidin-agarose pull-down of labelled proteins, which were then
immunoblotted for sodium channels and A-type FHFs. Right; equal amounts
of whole cell (upper surface) and distal axon (lower surface) lysates were
immunoprecipitated with a combination of antibodies specific for all
isoforms of FHF1 and FHF4 followed by immunoblot detection of sodium
channels. A much smaller fraction of sodium channels in distal axons show
association with any of the FHFs tested. The corresponding uncropped
immunoblots are shown in Supplementary Fig. 1.
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18 to 213 mm from the soma, experienced very similar
fluorescence changes, reflecting similar voltage changes and
implying a very low axonal leak conductance. The same data
presented on an expanded time axis (Fig. 4b) shows that axonal
charging time is slower as a function of distance from soma, as
expected. To better visualize charging times along the axon in
voltage clamp, a step from þ 80 to " 80 mV was employed in the
presence of voltage-gated channel inhibitors. As shown in Fig. 4c,
fluorescence changes in response to the large voltage step were
very similar at all measured points along the axon, with charging
times increasing as a function of distance. These fluorescence
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Computational modelling of the GrC axon. The empirical data
described above has been used to update a prior multicompartment model of the GrC10. The revised model scheme is
shown in Fig. 5a.
The limited decay of fluorescence change over distance during
passive charging implies a very low axonal leak conductance. To
estimate the maximal possible axonal leak conductance density,
voltage clamp simulations were conducted by applying
a hyperpolarizing voltage step in the parallel fibre and measuring
the voltage changes along the fibre after 100 ms. Leak
conductance densities up to 5 mS cm " 2 have small effects on
fibre charging, while higher leak causes a greater fall-off of
charging over a 200 mm distance (Supplementary Fig. 5A). As our
empirical data shows that somatic voltage steps induce axonal
fluorescence changes that diminish no more than 5% over a
200 mm distance (Fig. 4), axonal and parallel fibre leak was set at
5 mS cm " 2 (Fig. 5a). This axonal leak density is less than 1%
that in somatodendritic membrane, where inwardly rectifying
potassium channels (KIR, 2 mS cm " 2) are the major carrier of
somatic leak current (Fig. 5a)10. Given the 26-fold greater surfaceto-volume ratio in the axon and parallel fibres compared with the
granule cell soma, low-distal leak affords substantial energy
benefit and lessens energy consumption previously predicted for
maintaining the granule cell resting potential20.
There is a disparity between the change in axonal fluorescence
intensity during a conducting spike (DF ¼ 6.8±0.2% , n ¼ 19;
examples in Fig. 3) compared with the change in fluorescence
induced by passive somatic voltage commands (40 mV step gave
DF ¼ 1.55±0.2%, n ¼ 6; examples in Fig. 4). Given the linear
relationship between DF and DV (Supplementary Fig. 4), the
fluorescence data would suggest a spike amplitude greater than
170 mV, which is untenable given a sodium ion reversible
potential of B80 mV. This disparity was accommodated by
assuming that a region of the axon proximal to distances of
reliable measurement (o20 mm from soma) has higher leak
conductance that acts as a partial current shunt. Accordingly, leak
conductance in the AIS of the model (first three segments of axon
spanning 7 mm, Fig. 5a) was set at 2 mS cm " 2, comparable to
somatic leak density.
Voltage clamp simulations run on cell models with axon
diameter ranging from 100 to 300 nm all failed to produce passive
axonal charging rates along the axon consistent with fluorescence
measurements on several recorded cells (Supplementary Fig. 5B).
By incorporating an elevated axial resistance into the AIS of a

Merge

10

FHF4

data can be used in conjunction with computation modelling
(see below) to achieve better quantitative understanding of the
granule cell axon’s passive properties.

Figure 2 | Preferential absence of FHFs from nodes of Ranvier along
CNS-myelinated axons. (a) Immunofluorescence colocalization of A-type
FHFs (green) and sodium channels (red) at hippocampal CA1 pyramidal
neuron AISs. (b) Absence of A-type FHFs (green) from corpus callosal
nodes of Ranvier visualized by sodium channels (red) flanked by paranodal
Caspr (blue) (**). Further A-type FHF immunofluorescence is provided in
Supplementary Fig. 2. (c) Colocalization of FHF2 (green) and sodium
channels (red) at AIS of CA1 pyramidal neurons. (d) Absence of FHF2
(green) from corpus callosal nodes of Ranvier (red) flanked by paranodal
Caspr (blue) (**). (e) Colocalization of FHF4 (green) and sodium channels
(red) at a cerebellar Purkinje cell AIS (arrow) along with AIS of numerous
granule cells (arrowheads). (f) FHF4 (green) is absent from nodes of
Ranvier (red) in the cerebellar cortical white matter (**), while present in
adjacent granule layer AISs (arrowheads). Scale bars, (a,c,e) 10 mm and
(b,d,f) 4 mm.
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Figure 3 | Fluorescent imaging of action potential conduction along axons of WT and Fhf1 " / " Fhf4 " / " cultured GrCs. (a) High-resolution image
composite for WT neuron filled with voltage-sensitive fluorophore JPW3028. Dendrites (arrowheads) and axon (yellow arrows) are indicated. (b) Same cell
as in A photographed at 0.2 ms exposure with high-speed, low-resolution camera used for dynamic fluorescence imaging. Coloured pixels are regions along
axon monitored during spike conduction. (c) Spike conduction along axon of cell in a,b in response to 0.2 ms 2 nA somatic current pulse (arrow).
Fluorescence was sampled at 5 kHz in regions indicated by colours corresponding to b. Stimulation induced spike with DF of 6.5% that conducted down
axon at B0.2 mm ms " 1. Data shown are the average from 40 stimulus trials. I ¼ fluorescence intensity, RLI ¼ resting light intensity at the sampled region.
(d) High-resolution image composite for Fhf1 " / " Fhf4 " / " neuron, with dendrites (arrowheads) and axon (yellow arrows) indicated. (e) Same mutant
cell imaged at high-speed and low-resolution. (f) Spike conduction along mutant cell axon (d,e) in response to somatic current pulse (arrow) was
indistinguishable in amplitude (beyond 150 mm) and conduction velocity compared with spike from WT cell (c). (g) 60 Hz spike conduction along WT axon.
The JPW3028-filled neuron was injected in the soma with biphasic current pulses (700 pA for 1 ms followed by " 700 pA for 1 ms) at 60 Hz to induce
spike train. Fluorescence was sampled at 2 kHz at different distances along the axon, and data averaged over 15 trials. The spike train faithfully conducted
over 230 mm. (h) A total of 60 Hz spike conduction along Fhf1 " / " Fhf4 " / " axon. The mutant cell was subjected to same analysis as in g, and showed
faithful transmission of the spike train over 250 mm. (i,j) Antidromic spike conduction along axon of Fhf1 " / " Fhf4 " / " cell. A mutant granule cell axon was
stimulated at 60 Hz at a point 250 mm from the soma, and fluorescence was analyzed at proximal regions, as indicated in high-speed still image (i). All
spikes back-propagated towards soma and were detectable in dendrites (j).
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150-nm diameter axon model19, a more accurate simulation of
the passive charging was obtained (Supplementary Fig. 5C).
Elevated resistance along the AIS may result from the
documented dense packing of cytoskeletal fibrils in this
specialized structure21,22.
The high-density voltage-gated sodium channels in the AIS
were modelled as being associated with FHF proteins that favour
excitability, while less dense channels on more distal axon and
parallel fibres were modelled as lacking FHFs (Fig. 5a), consistent
the data in Figs 1 and 3. For channels with or without FHFs,
12-state Markov models were employed with much slower
activation and deactivation kinetics than described in several
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previous Nav Markov models10,23 (see ‘Methods’ section for
details and necessary rationale). With these modifications,
transient sodium current activation and inactivation kinetics
(Supplementary Fig. 5D,G), voltage dependence of activation
and inactivation (Supplementary Fig. 5E), and recovery rates
from inactivation (Supplementary Fig. 5F) are good approximations to empirical data reported for granule cell sodium
channels with or without FHFs in our earlier studies4 (Supplementary Table 1).
When positive current is continuously injected into the soma
of the granule cell model, repetitive firing initiates in the AIS and
each spike back-propagates to the soma and conducts down the
axon and parallel fibres (Fig. 5b–d). Spike peaks at the soma are
between 0 and þ 20 mV, consistent with granule cell recordings
in cerebellar slices and primary culture9,15, while conducting
spikes peak at þ 60 mV in the parallel fibres, consistent with
spikes that have been recorded at presynaptic axonal termini24.
As shown in Fig. 5d, conducting spikes display velocity
(0.22 mm ms " 1), width (1 ms 50%-to-50%), and absence of
after-hyperpolarization consistent with spikes imaged using
voltage-sensitive dye (Fig. 3). Due to the accelerated inactivation of FHF-free sodium channels along the axon and parallel
fibres, the voltage-gated sodium and potassium currents for each
conducting spike have little temporal overlap (Fig. 5e, left graph).
In conjunction with negligible outward leak current, virtually all
ionic currents can drive capacitive currents underlying rise and
decline of the spike. For a 150-nm axon cable, the theoretical
minimum ionic currents for driving an action potential peaking
at þ 60 mV results in 0.35 mM sodium influx and equal
potassium efflux. The model predicts sodium and potassium
fluxes less than double the theoretical minimum (0.59 mM),
which is comparable to prior model predictions of energy
efficiency for granule cell conducting spikes25.
To assess the importance of accelerated distal sodium channel
inactivation, we remodelled the distal axon and parallel fibres
with sodium channels that bear FHFs, comparable to channels at
the AIS4. Sodium and potassium channel densities were
rebalanced to achieve a conducting spike waveform with shape
and amplitude matching that simulated in the absence of FHF
(Fig. 5e) (all parameters in ‘Methods’ section and Supplementary
Table 2). With FHFs present on sodium channels, there is
substantially greater temporal overlap between voltage-gated
sodium and potassium currents (Fig. 5e, right graph), resulting

Figure 4 | Passive charging of cultured GrC axons in response to somatic
voltage clamp. (a) Axonal response to somatic hyperpolarization. A WT
neuron filled with JPW3028 was patched on the soma, held at " 60 mV
and subjected to a 100 ms " 100 mV step followed by step return to
" 60 mV. Fluorescence was sampled at 2 kHz, and data were averaged over
50 trials. At each axonal position, fluorescence intensity (I) was normalized
to that position’s resting light intensity (RLI). The voltage step induced
very similar fluorescence changes at points ranging from 18 to 213 mm,
suggesting comparable charging and limited leak conductance.
(b) Expanded time scale of data in a, showing slower charging of axon
as function of distance from soma. (c) Passive axonal response to large
somatic voltage change. A WT neuron filled with JPW3028 was patched on
the soma in the presence of tetrodotoxin, tetraethylamine, 4-amino purine
and cadmium to inhibit voltage-gated sodium, potassium and calcium
channels. The soma was stepped from " 80 to þ 80 mV for 100 ms
followed by return to " 80 mV and images collected at 2 kHz intervals.
Fluorescence at different points along axon are shown for the repolarization
step initiating at t ¼ 0 ms. All points along axon ranging from 36 to 178 mm
undergo very similar change in fluorescence, with longer charging times as
function of distance from soma. Data shown are the average of 50 trials.
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in B50% greater (0.86 mM) sodium influx and potassium efflux
per spike than in the simulation where FHFs are excluded
from distal sodium channels. These findings underscore the

importance of spatially restricted FHF modulation of sodium
channels along the axon, particularly during conduction of highfrequency spike trains.
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Discussion
Data reported here in conjunction with prior findings identify
three zones along a GrC’s unmyelinated axon having distinct
reliance on FHF protein functionality. At the AIS, FHFs associate
with sodium channels to delay onset of fast inactivation
and accelerate recovery from inactivation, thereby promoting
neuronal excitability4. As shown here, sodium channels beyond
the AIS function in an essentially FHF-independent manner,
thereby shortening the duration of the open-state phase during
spike conduction and lessening energy burden. Recent data
from other investigators describe a distinct role for FHFs at
presynaptic terminals along axonal parallel fibres, promoting
neurotransmitter release by enhancing glutamate vesicle loading
via VGluT1 transport26. What mechanisms may enable the
preferential delivery of FHFs to proximal sodium channels and
still allow FHFs to act at distal presynaptic terminals? All FHF
isoforms bear a common b-trefoil core domain that can interact
with a cytoplasmic tail domain that is also highly conserved
among all voltage-gated sodium channels27,28. The preferential
association of FHFs with proximal sodium channels may result
from other molecular constituents that stabilize FHF/Nav
interactions within the AIS. More simply, the presence of dense
FHF affinity sites in the form of sodium channels at the AIS
together with the AIS’s diffusion barrier property21 may serve to
limit FHF access to more distal axonal channels. FHFs are also
known to associate with the kinesin-binding protein IB2 (ref. 29),
providing a potential mechanism for microtubule-based transport
of FHFs to presynaptic terminals for their contribution to
neurotransmission.
The low axonal leak conductance in the GrC may serve several
distinct functions. First, the total surface area of axonal and
parallel fibre membranes is over 4,000 mm2, over 10-fold greater
than the area of somatodendritic membrane. Without reduced
fibre leak, maintenance of sodium and potassium concentration
gradients across the plasma membrane at rest would require far
greater energy consumption, as had been predicted previously20.
Second, low axonal leak helps minimize sodium current density
needed to conduct action potentials. Third, low-leak conductance
accounts for documented long-range passive electrical
transmission along this axon. Pugh and Jahr30,31 have demonstrated that molecular layer GABA transmission onto parallel
fibre GABAA receptors induces axonal depolarization that
undergoes passive antidromic spread towards the soma
resulting in enhanced somatic excitability of granule cells. In
the absence of low axonal leak, this retrograde effect would be
more limited or absent.
The physiological benefit afforded to the unmyelinated GrC
axon may also apply to many CNS-myelinated axons, where FHFs

are not detected on nodal sodium channels (Fig. 2; Supplementary
Fig. 2). Shorter spike current duration in the absence of FHFs may
reduce the needed leak conductance that serves as the primary
carrier of outward current driving the nodal spike repolarization
phase32. In contrast, myelinated sensory axons in the peripheral
nervous system display prominent clustering of FHF2 at nodes of
Ranvier33, indicating a fundamental difference in sodium channel
modulation along these peripheral axonal fibres. Indeed, for larger
diameter axons where energetics is a somewhat less serious
imperative, FHF association with distal axonal sodium channels
may be better tolerated and serve to regulate sodium conductance,
action potential waveform, conduction velocity and synaptic
transmission.
While our reported findings provide new insight into the ionic
mechanisms and energetic burden in an unmyelinated CNS axon,
two limitations of these studies serve as impetus for further
investigation. First, dynamic fluorescence imaging was conducted
here only at 25 !C. As temperature elevation will impact kinetics
of voltage-gated channel state transitions as well as the
conductance of open channels, the granule cell conducting spike
waveform and underlying ionic currents at 37 !C will differ in
ways that are not fully predictable without further recordings.
Nonetheless, the energetic benefit of FHF-independent spike
conduction due to accelerated sodium channel inactivation will
still apply. Second, as our dynamic fluorescence measurements
employed somatic loading of dye into cultured neurons, we were
not able to assess the impact of en passant parallel fibre-Purkinje
cell synapses on the passive and active properties of the granule
cell axon and its multi-millimetre parallel fibres. The emerging
technology of genetically engineered voltage indicators34,35 and
their targeted expression to subsets of GrCs may allow for similar
analysis of axon electrical properties in situ.
Methods

GrC culture. The husbandry and use of all mice followed protocols approved by
the Hunter College Institutional Animal Care and Use Committee. GrC cultures
were prepared from P8-P9 WT and Fhf1 " / " Fhf4 " / " mouse pups as previously
described4,9. Dissociated neurons were seeded onto either 12 mm coverslips for
later recordings or onto the upper surface of submerged hanging culture
membranes (3 mm pore diameter, 10 mm thick) (Catalogue PISP30R48, EMD
Millipore). Coverslip cultures were maintained for 20–40 days for recordings, while
hanging cultures were maintained 25 days before harvesting for protein analyses.
Protein analysis of granule cells. To prepare lysates for protein detection,
hanging culture inserts were washed and each side was separately scraped in
ice-cold lysis buffer (20 mM Tris–HCl pH 7.4, 137 mM NaCl, 2 mM EDTA, 25 mM
b-glycerophosphate, 2 mM pyrophosphate, 50 mM NaF, 10% glycerol, 0.1 mM
sodium orthovanadate, 1 mM PMSF, 10 mg ml " 1 aprotinin, 10 mg ml " 1
leupeptin). Upper-surface scraped material was directly solubilized with 1% Triton
X100, while lower-surface material was concentrated by high-speed centrifugation

Figure 5 | Revised GrC computational model predicts energy benefit of FHF-independent spike conduction. (a) Schematic of revised model. Clustered
sodium channels at hillock and AIS are modelled with associated FHFs (O), while low-density sodium channels on distal axon and parallel fibres are
modelled without FHFs (O) (see Supplementary Fig. 5 for Nav simulations þ / " FHF). Fibre leak conductance (LKG3) is set to 2 mS cm " 2 at the AIS

(

) and to 5 mS cm " 2 along distal axon and parallel fibres (

). Somatic leak conductance (LKG1) combines with inward rectifying potassium

conductance (KIR) to set somatic resting membrane potential to " 70 mV. The AIS also has elevated axial resistance (500 Ohm*cm, ) compared with all
other cellular compartments (100 Ohm*cm, ). (b) Somatic spikes simulated in response to 10 pA somatic current injection. Spike frequency is similar to
that described in the earlier version of the GrC model10. (c) Current-to-spike relationship. Plot of spike number over 240 ms during 2–10 pA simulated
current injections. (d) High-frequency spike initiation and propagation. Voltage in soma and axonal and PF compartments (distance from soma indicated)
are plotted in response to simulated 8 pA somatic injection generating a 47 Hz spike train. Spikes initiating at AIS conduct down axon and parallel fibres and
back-propagate to soma. Parallel fibre spike conduction velocity (0.22 mm ms " 1) and 50–50% width (1.0 ms) are within 10% of fluorescence
measurements (Fig. 3c,e). (e) Parallel fibre spike currents modelled with or without associated FHFs. Left; sodium (blue) and potassium (red) currents in a
parallel fibre compartment during a conducting spike (inset) as in d. On the basis of current fluxes, axoplasm volume, and equation 1 C ¼ 10 mmol cations,
calculated Na þ influx and K þ efflux from parallel fibre are 0.59 mM per spike. Right; parallel fibres were remodelled with all sodium channels associated
with FHF, and Nav and Kv densities were adjusted to preserve shape and amplitude of the conducting spike (inset). Slower Nav inactivation due to FHF
increased temporal overlap between Nav and Kv currents, thereby increasing calculated Na þ influx and K þ efflux (0.86 mM) per spike.
8
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and then solubilized. Triton X100-treated samples were vortexed, maintained on
ice for 15 min, and cleared of insoluble material by high-speed centrifugation.
For some cultures, surface proteins were covalently biotinylated using sulfo-NHSbiotin (Catalogue 21217, ThermoFisher Scientific) before scrape harvesting as
above. Biotinylated protein complexes were captured with streptavidin-agarose
(Catalogue 20347, ThermoFisher). FHF immunoprecipitations were performed
using a combination of 1 mg ml " 1 custom rabbit anti-FHF1 (ref. 29) and mouse
anti-FHF4 (N56/21, Catalogue 75–096, NeuroMab), both of which have been prior
validated for immunoprecipitation competence. Streptavidin-agarose-captured,
immunoprecipitated/protein G Sepharose-captured (Catalogue 17-0618, GE
Healthcare), and total protein samples were electrophoresed through precast
4–20% polyacrylamide SDS gels (Catalogue 25204, ThermoFisher), transferred to
PVDF membrane, and probed with 0.5 mg ml " 1 mouse monoclonal antibodies to
A-type FHF (N235/22, Catalogue 75-246, NeuroMab) and pan-sodium channel
(K58/35, Catalogue S8809, Sigma Aldrich) followed by secondary peroxidaseconjugated antibodies (1:10,000, Catalogue 115-035-166, Jackson Immunoresearch) and enhanced chemiluminescence detection. Images in Fig. 1d were
cropped for presentation. Full size images are presented in Supplementary Fig. 1.
For immunofluorescence, hanging culture membranes were fixed in 4%
paraformaldehyde, permeabilized with 0.5% Triton X100, preabsorbed with 10%
fetal calf serum, and incubated overnight at 4 !C with a combination of primary
antibodies at 0.5 mg ml " 1 each: mouse anti-ankyrin G (Catalogue sc-12719, Santa
Cruz Biotech) and chicken anti-neurofilament-A (Catalogue AB5539, EMD
Millipore). The membrane was subsequently incubated with 1:200 dilutions of
anti-mouse IgG ALEXA488 (Catalogue A-11001, ThermoFisher), anti-chicken Ig
ALEXA594 (Catalogue A-11042, ThermoFisher) and 1:1,000 TOPRO iodide
solution (Catalogue T3605, ThermoFisher). Images of upper and lower membrane
surfaces were captured with a Leica TCS2 confocal microscope.
Brain slice immunofluorescence. Sagittal cryosections of paraformaldehyde
submersion-fixed brain from adult WT mice were probed by immunofluorescence,
as above, with different combinations of primary antibodies at 0.5 mg ml " 1: mouse
anti-FHF4 (N56/21), mouse anti-A-type FHF (N235/22), custom rabbit anti-FHF2
(ref. 31), pan-sodium channel (K58/35), and rabbit anti-CASPR (Catalogue
ab34151, Abcam) followed by incubations with secondary antibodies conjugated
to fluorophores ALEXA488, ALEXA594, or ALEXA643 (1:200 dilution)
(ThermoFisher). When employing two primary antibodies from a common host
species, each primary antibody and corresponding secondary antibody were
incubated successively to ensure against primary antibody recognition by off-target
secondary reagent. In some cases, nuclei were stained with TOPRO iodide.
Confocal images were captured and images spanning 2–5 mm through the z axis
were merged.

current-clamp protocol, and image capture at either 2 or 5 kHz. Direct axonal
stimulation at 60 Hz with 0.2 ms current pulses from the theta pipette were
delivered using a Grass Stimulator and stimulus isolator unit also under the control
of the Neuroplex software.
Voltage clamp step protocols were repeated for 30–50 trials, fluorescence data
were captured at 2 kHz, and data from trials were averaged. In some experiments,
voltage-gated currents were block by the adding 0.2 mM CdCl2, 5 mM 4-amino
purine, 30 mM tetraethylamine and 1 mM tetrodotoxin (TTX) (Catalogue 1069,
Tocris) to the extracellular solution and reducing the concentration of NaCl to
maintain iso-osmolarity. Current-clamp protocols were used to induce action
potentials. Single action potentials were generated with a 0.2 msec positive current
pulse, which was repeated every 3 s for 30–50 trials while capturing images at
5 kHz. To achieve more accurate measurement of the conducting spike waveform,
fluorescence data from all trials were averaged using the somatically recorded spike
for alignment of data from each trial. To improve the signal-to-noise ratio of
fluorescence signals, data from 3–5 neighbouring pixels were averaged. For 60 Hz
current stimulations from either soma or distal axon, 10–15 trials were conducted
with 2 kHz image capture rate. Somatic current injections were biphasic (700 pA
1 ms, " 700 pA 1 ms). Biphasic pulses facilitated recovery from inactivation of
soma-proximal sodium channels, allowing for repetitive firing even in Fhf1 " / "
Fhf4 " / " neurons. Control experiments in the presence of voltage-gated channel
inhibitors demonstrated that biphasic stimulation currents do not influence axon
membrane voltage beyond 100 mm from the soma (Supplementary Fig. 6), showing
that this stimulation protocol does not artificially bias measurements of repetitive
spike conduction.
After completing a dynamic fluorescence experiment, cell fluorescence was
photographed in a series of high magnification and resolution images (9.5 pixels
per mm). The axon was then traced in graphics software as a 1-pixel-wide line, and
axonal distances from soma were calculated from the pixels in the trace.
Computational modelling of GrC excitation and conduction. The cell model
bears the same number of compartments as described previously10, including four
dendrites, soma, hillock, 56 axonal segments (2.3 mm length each), and 500 parallel
fibre (PF) segments (10 mm length each) (Fig. 5a). The proximal three axonal
segments ( ¼ 6.9 mm length) are designated as the AIS. The axon and PFs are
150 nm diameter. The conductances in the model are described in Supplementary
Table 2, with the exception of dendritic conductances, which are unchanged from
previous description10.
We employed a 12-state Markov model for voltage-gated sodium channels, as
diagrammed in the schematic below.
n1.α

C1

Electrophysiology. Neurons on coverslips were visualized by video camera with
infrared light and differential interference contrast optics from the recording
chamber of a Nikon Eclipse FN1 microscope using a 63 $ water-immersion lens
and a 2 $ optical magnifier in the light path. The cells were continuously perfused
in carbogen-bubbled artificial cerebrospinal fluid (120 mM NaCl—26 mM
NaHCO3—3 mM KCl—1.2 mM KH2PO4—3 mM D-glucose—2 mM Na pyruvate—
3 mM myo-inositol—2 mM CaCl2—1.2 mM MgSO4). Cells were whole-cell patched
with borosilicate pipettes pulled to resistance of 16–20 MO when filled with pipette
solution (126 mM K gluconate—4 mM NaCl—5 mM HEPES—15 mM D-glucose—
1 mM MgSO4—50 mM CaCl2—150 mM BAPTA—3 mM Mg ATP—100 mM GTP
adjusted to pH 7.2 with KOH). Voltage clamp and current-clamp commands and
recordings were made using a MultiClamp700 amplifier, Digidata1440 analogue/
digital interface, and pCLAMP10 software (Molecular Devices). All recordings
were conducted at 25 !C.
Dynamic fluorescence in dye-filled GrC processes. All fluorescence imaging was
conducted at 25 !C. Individual granule cells were filled with the amphiphilic
voltage-sensitive dye JPW3028 (ref. 14). Patch pipettes were first back-filled with
dye-free pipette solution and then filled with pipette solution containing 0.8 mM
JPW3028. A neuron’s soma was whole-cell patched and voltage clamped to
" 70 mV for 15 min to allow for passive diffusion of dye in the cell soma. The dyecontaining pipette was carefully pulled off the cell generating an outside-out patch
on the pipette tip while sealing the cell, and the cell was maintained one hour to
allow for dye permeation of the axon. The cell was then repatched in the soma with
a pipette containing dye-free solution and placed in voltage-clamp or currentclamp mode. Alternatively, a theta glass pipette coated with rhodamine-conjugated
serum albumin and attached to a bipolar stimulus electrode was positioned under
fluorescence guidance to a point along the distal axon. Fluorescence imaging
of the neuron was performed using a SOLA-SE LED Light Engine (Lumencor), a
NeuroCCD-SM high-speed camera (Redshirt Imaging), and a filter cube consisting
of a 520±45 nm excitation interference filter, a dichroic mirror with 570 nm
central wave length, and 610 nm barrier emission filter. The CCD camera was
attached to a separate port on the microscope that contained a 0.1 $ demagnifier
to allow low-magnification imaging of a 280 mm diameter area with pixel
dimension of 3.54 mm $ 3.54 mm. Neuroplex software (Redshirt Imaging)
controlled timing of the light source, triggered initiation of a voltage-clamp or
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This model is an adaptation of the 13-state model of Khaliq et al.23, with the
blocked open state and consequent resurgent current omitted. While resurgent
current has a small effect on high-frequency firing in granule cells36, our omission
was due to the incompatibility of even small resurgent current in the distal axon
and parallel fibre on post-spike repolarization, due to the very low-distal leak
conductance in our model. n1 ¼ 5.422, n2 ¼ 3.279, n3 ¼ 1.83, n4 ¼ 0.738, as in the
previous version of the channel model4. Rate parameters Aa, Ab, Con, Coff, Oon, Ooff,
and Vshift are listed in Supplementary Table 2 and were differentially set to values
that simulated the voltage-dependent and kinetic properties of channels either in
the absence or presence of associated FHF proteins (Supplementary Fig. 5) in
approximate agreement with somatic recordings of sodium currents in WT and
Fhf1 " / " Fhf4 " / " granule cells4 (see Supplementary Table 1 for comparisons).
The maximal sodium conductance in the parallel fibres (110 mS cm " 2)
corresponds to an estimated 250–300 channels per 10 mm segment, assuming a
single-channel conductance of 14–20 pS37,38.
We note that in comparison to the original Nav model of Khaliq et al.23, the Nav
model here has comparable voltage dependence of activation but displays slower
activation at negative potentials near or below V1/2 activation (Supplementary
Fig. 5G). These kinetics are a better fit to recorded sodium currents in granules
cells4 (Supplementary Fig. 5G) or in transfected cells expressing Nav1.6 (ref. 9).
While slowing Nav activation/deactivation kinetics impacts excitability, it does not
significantly affect Nav currents associated with spike conduction, which is
primarily affected by Nav open-state inactivation dictated by the rate constant Oon.
In comparison to the previously used model for delayed rectifier potassium
channel (Kv)4, the revised Kv model has 4.5-fold slower activation and deactivation
rate constants (Aalpha_n ¼ " 0.00222, Abeta_n ¼ 0.0285), while preserving the
same voltage dependence of activation. This modification to Kv kinetics was crucial
for achieving realistic simulations of conducting action potentials by delaying the
spike Kv current onset relative to the depolarizing Nav current and by delaying Kv
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deactivation, facilitating the post-spike return of axonal and parallel fibre
membrane to resting potential. Even a twofold faster Kv kinetics than employed
here increases the temporal overlap between spike Nav and Kv currents, resulting in
substantially narrower spikes inconsistent with voltage-sensitive dye recordings
and increasing current flux per spike several-fold.
In order to test the importance of FHF exclusion from sodium channels beyond
the AIS, the parallel fibres were remodelled to bear FHFs while maintaining the
waveform of the conducting action potential. Parameters for the PFs were changed
as follows: Con ¼ 0.003464 ms " 1, Coff ¼ 0.4157 ms " 1, Oon ¼ 1.8186 ms " 1,
Ooff ¼ 0.006928 ms " 1, Vshift ¼ " 22 mV, gNav ¼ 13.5 mS cm " 2,
gKv ¼ 18.5 mS cm " 2.
Current-clamp simulations of spike initiation and conduction were performed
by injecting a continuous current into the soma. During simulations, membrane
voltage and ionic currents in axonal compartments were monitored. Spikeassociated currents were used to calculate ion fluxes per spike, which together with
dimensions of the axon and parallel fibre and the relationship of charge to
monovalent ion number (1 C ¼ 10 mmol ions) enabled calculation of changes in ion
concentration within the cell process. To determine the theoretical minimum
charge transfer needed to raise the voltage from " 70 to þ 60 mV, we assume that
all inward sodium current serves to charge the membrane with no inward current
wasted to countervailing outward ionic current or axial current. A parallel fibre
10 mm segment of 150 nm diameter has volume of 1.77 fl and capacitance of 47 fF.
To achieve a DV of 130 mV, DQ ¼ C $ DV ¼ 6.12 fC, which is an intracellular ion
concentration of 0.35 mM.
The passive charging along an axon in response to a somatic voltage step is
influenced by the axon’s axial resistance, leak conductance, diameter, and length. In
order to compare modelling simulations to passive charging measurements
obtained using voltage-sensitive dye, the cell model’s axonal length required
adjustment to those of cultured neurons. Based on the measured length of several
cultured granule cell axons filled with cadaverine-ALEXA488 conjugate
(1.31±0.17 mm, n ¼ 4), the cell model was adjusted to bear an unbranched axon of
1.2 mm length. Simulations were conducted by application of a 10 mV
hyperpolarizing voltage step to the soma, and membrane voltages at different
points along the axon were monitored. The model axon’s leak, diameter and axial
resistance were manipulated to give passive charging simulation in agreement with
fluorescence empirical measurements.
All simulations were performed with the NEURON simulation software39.
Data availability. GrC model files will be made available for download at
https://senselab.med.yale.edu/modeldb/.
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